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UlTra-gelUiDsonDerzoek
“…ultrageluid wordt het ook wel genoemd. Tegenwoordig zetten ze het in om overlast 
gevende jongeren te verjagen van hun hangplekken. In sommige gemeenten zweren 
ze bij die techniek. De Mosquito. Wie jonger is dan pakweg 25 jaar hoort een mateloos 
irritant geluid. Wie ouder is hoort niets. Voor de één klinkt er dus een hels kabaal, terwijl 
het voor de ander weldadig stil is. Gelijktijdig, op dezelfde plek! Wat er voor de één is, is 
er voor de ander niet. Wie beweert dat het er niet is heeft gelijk. Maar wie volhoudt dat 
het er wel is heeft ook gelijk. 
Het is maar net hoe je het bekijkt. Niets is wat het lijkt’. 
UlTra-soUnD examinaTion
“…also known as ultrasound, it is often used as a deterrent against antisocial behaviour. 
With some borough councils it is the preferred method to make NEET1 hangouts un-
popular. It is nicknamed “The Mosquito” and causes people under 25 years of age to hear 
an intensely annoying sound. Those over 25 do not hear a thing. While NEETs complain 
about a bloody racket, older people experience peace and quiet in the same place, at 
the same time. You may argue that there is no sound, while you can equally maintain 
that there is. 
It all depends on the perspective. Nothing is what it seems.”
(translation (c) 2015 Marc Weide)
Uit ‘Echo, prenataal onderzoek en keuzevrijheid’, Maarten Slagboom, 2011 uitgeverij Augus-
tus, p. 18, ISBN 9789045704586
1 NEET - young people Not in Employment, Education or Training” (16-24 years, UK)
ISBN: 978-94-6169-700-4
http://www.e-pubs.nl?epub=s.galjaard
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general aim
The research in this doctoral thesis is focused on the dynamic effects of pregnancy in the 
background of the obese women. Effects of maternal obesity on short term changes in 
outcomes of body and cardiovascular development during pregnancy are investigated. 
Obesity research in pregnancy is not focused on static relationships, but is a domain 
based on dynamic changes that occur during two transitions: from woman to mother 
and from fetus to newborn. Maternal weight for example can be unchanged while preg-
nant, but during most pregnancies weight changes are striking (both weight gain and 
weight loss). In addition, glucose intolerance increases and insulin sensitivity decreases 
during pregnancy. If these changes meet predefined criteria, it is regarded as a disease, 
known as gestational diabetes mellitus (GDM). Important cornerstones for metabolic 
research in pregnancy are the effects of maternal adiposity (body mass index -BMI-), 
nutrient intake and storage (gestational weight gain -GWG-) and abnormal glucose 
Figure 1. The role of ‘gestational programming’ in population shifts towards obesity and metabolic syn-
drome. Normal weight mothers usually give birth to normal-weight infants with normal adiposity. These 
offspring develop into normal adults with normal body fat content and a normal metabolic profile. The 
increased incidence of prematurity and intrauterine growth restriction (IUGR) resulting from undernutri-
tion, among other factors, combined with improved neonatal survival, formula feeding and exposure to a 
Western postnatal diet has resulted in increased offspring obesity and metabolic syndrome. A small portion 
of obese mothers give birth to newborns with increased body fat, as a result of overnutrition (consumption 
of a high-fat diet). These processes may contribute to the population shift towards an obese phenotype, 
with second generation obese women at  increased risk for giving birth to newborns with increased body 
fat content, and who in turn, are at risk of developing obesity and metabolic syndrome. (Reproduced with 
permission of the author and publisher, Desai et al., 2015)2
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tolerance (GDM). These three contributors play an important role in the development of 
complications in the mother and the fetus, both short and long term.1 Therefore the in 
utero development of the fetus is regarded as a time of vigorous growth and develop-
ment.2 The fetal period is often conveniently summarized by its resultant ‘birthweight’, 
an outcome parameter used to compare ‘intra-uterine’ effects on long- and short term 
complications (figure 1). 
This thesis explores in detail how and why changes in obese pregnant women impact 
the development of the unborn child. Specifically it aims to elucidate the develop-
ment of fetal body composition and vascular properties, with specific attention for the 
dynamic vascular changes which occur in the pregnant mother and which through 
the child’s environment, impact the child. To provide insight into these processes and 
achieve the aims of this thesis requires extensive use of non-invasive techniques, like 
ultrasound, to examine both mother and her unborn child.  It is therefore necessary to 
explain in more detail the background of this frequently used method and to provide a 
general background on the research domain of obesity. The introduction to this thesis 
will provide the reader with this background.  The introduction will elaborate on how 
ultrasound has evolved (part 1) and on how obesity effects pregnancy (part 2). Subse-
quently we will discuss the maternal- and fetal vascular changes of the great arteries 
(part 3). We conclude the introduction with discussion of ultrasound limitations in the 
obese pregnant population (part 4).
The populations in chapter 5, 6, 8 and 9 are based on  three clinical studies:
· Dali (vitamin D And Lifestyle Intervention) study to prevent GDM in the ‘obese’ 
(BMI ≥29kg/m2) pregnant women. European, multicentre, randomized controlled 
trial.  Three chronological sub-studies: pilot study, main (lifestyle) study and vitamin 
D-lifestyle study. FP7/2007–2013, 242187 (ISRCTN70595832). Local EC number: 
S52172. Pilot and lifestyle participants recruited in our centre, are investigated as 
sub-studies for this thesis. The vitamin D trial is currently ongoing. 
· manoe (MAternal Nutrition and Offspring’s Epigenome). A prospective, monocentre, 
observational study. Relationship between intake of maternal methyl-group donors 
(methionine, food folate, choline, and betaine) during pregnancy and offspring DNA 
methylation. Local EC number: S54026. Currently ongoing.
· VaBUlos (VAscular and Biometry Ultrasound measurements in LOw risk pregnancy 
Study). Prospective, observational cohort for maternal and fetal ultrasound measure-
ments in low-risk pregnancies. Local EC number: S55325. Study completed.
The objective of this thesis was to investigate the effects of pregnancy dynamics (GWG 
and glucose intolerance) on the short term outcomes of infant body and cardiovascular 
development from the perspective of different prepregnancy BMI classes. These early 
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life developments impact the infants’ start in life and it is thought that this start may 
potentially induce long-term metabolic effects.  
The research conducted for this thesis is unique as it combines: very high quality 
ultrasonic sensing with prospective and longitudinal measurements performed with a 
substantial number of patients under highly controlled conditions. This allowed for a 
series of primary studies which advance the current state of knowledge on the dynam-
ics of pregnancy and infant development. The thesis consists of the following chapters. 
Chapter one provides an overall overview and introduction of key history and concepts. 
Chapters two and three reveal general risk factors for adverse fetal growth and the role 
of fetal gender on separate intra-uterine development and (adverse) perinatal outcome. 
Chapter 4 highlights maternal influences on the timing of adverse fetal growth. Chapters 
5 and 6 perform a fetal sequencing in order to find early predictors for neonatal adipos-
ity. And chapters 7 to 9 discern with novel techniques interesting new information on 
the modulation of maternal and fetal great arteries during pregnancy.
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oUTline anD aims oF The DoCToral Thesis
Chapter 2.  Review on the role and mechanisms of events during the antenatal, peri-
natal and postnatal period, resulting in later life diseases. Animal studies 
and clinical research.
Chapter 3.  To develop fetal growth curves for a low risk Caucasian population accord-
ing to WHO Multicentre Growth Reference Study Group recommenda-
tions. Further customize antenatal growth for fetal gender and compare 
immediate birth outcomes between boys and girls to align them with 
neonatal growth curves.
Chapter 4.  Prospective cohort study to examine clustered gestational weight gain 
patterns in obese and non-obese population, related to fetal growth and 
fetal weight development.
Chapter 5.  Prospective cohort study to determine distinctive fetal body composition 
features as a reflection of early fetal adiposity in normoglycemic mothers.
Chapter 6.  Prospective cohort study to detect early fetal predictors for neonatal 
adiposity in normoglycemic mothers.
Chapter 7.  Prospective cohort study to investigate the feasibility of vascular mea-
surements (intima media thickness) at four pre-defined fetal and four 
pre-defined maternal arterial locations in order to determine vascular 
changes that could be associated with impaired vascular function.
Chapter 8.  Prospective cohort study to detect modifications of the vascular proper-
ties in the maternal common carotid artery (CCA) with radio-frequency 
ultrasound in relation to maternal characteristics.
Chapter 9.  Prospective cohort study to detect modifications in the fetal abdominal 
aorta (fAA) with radio-frequency ultrasound in relation to maternal char-
acteristics and fetal growth and development.
Chapter 10. Summary and future perspectives
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inTroDUCTion
Fetal growth: historical overview and growth charts
Historical overview
In the 1960’s medical visualisation technology was introduced in practice to support 
diagnostics and therapy in pregnancy. The first fetal images were obtained as static 
Röntgen recordings, which resulted in snapshots of the intra-uterine life. Through these 
snapshots clinicians could gain insight onto the number of fetuses, the location of the 
baby and fetal skeleton abnormalities. As a supporting technique X-ray amniography 
was used. In this technique a water- and fat dissolvable contrast medium was injected 
into the amniotic sac to subsequently visualise the outlines of the skin and the fetus’ 
bowels in Röntgen snapshots. Sir William Liley used the X-ray amniography to apply the 
first intra-uterine therapy, in 1963, a fetal blood transfusion for rhesus allo-immunisation. 
The first reports on the use of ultrasound instead of Rontgen for care during pregnancy 
appeared no earlier than the late sixties. The very first ultrasound used the A-mode 
technique in which only one-dimensional peaks were visible. The A-mode technique 
was quickly replaced by the superior B-mode technique. With B-mode ultrasound, 
two-dimensional images were obtained with some variation in contrast. In this way one 
could ‘expose’, for instance, the fetal head.3 
Measuring fetal growth
Stuart Campbell, a British pioneer in obstetrical ultrasound, made the first steps towards 
a standardized fetal measurement. Campbell standardised the BiParietal Diameter (BPD): 
the head diameter of the fetus.4 The ‘BPD’ was used to determine ‘the age’ (gestational 
age) of the fetus.5 In addition to this first item, ultrasound was increasingly used to gain 
information on the fetal development in general.6 The neural tube defect was one of 
the first prenatal diagnoses and the arrival of ‘real-time’ scanners in the late seventies, 
further increased the possibilities to assess fetal condition.7 In the same period -and 
stimulated by improving imaging techniques-, growth charts were developed for femur 
length, abdominal- and head circumference. Finally, this has led to the guidelines of the 
International Society on Ultrasound in Obstetrics and Gynaecology (ISUOG), standard-
izing the fetal parameters, used for fetal growth and development.8 Globally, ultrasound 
was only used in high risk pregnancies, but in Germany routine ultrasound became 
available for every pregnancy from the eighties onwards. This progress generated a lot 
more data on ‘normal´ physiological fetal growth than before. 
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Growth charts and limitations
Routine ultrasounds in Germany initially also led to the release within short intervals of 
many different fetal curves. The diversity of reference curves was caused by the many dif-
ferences in study population and methodology, that were used. The populations differed 
for example with respect to: ethnicity, fetal gender and biological and demographic de-
terminants. Most importantly, methodological differences between the growth studies 
increased the risk of certain research biases. Examples of these differences include the 
use of cross-sectional or longitudinal design and the specific approach used to analyse 
and interpret the data. A review in 2012, found 83 growth curves, published between 
1971-2008.9 Only a few of the reviewed studies sufficiently controlled the inclusion of 
women, to widely exclude the influence of confounding factors. Underlying ‘confound-
ing’ factors were not excluded or statistically corrected for in many of the studies, while it 
is demonstrated that they influence fetal growth. Examples of confounding factors were: 
maternal smoking, chronic maternal diseases (pre-existent hypertension), hypertension 
developed during pregnancy and congenital abnormalities or pre-term birth. Excluding 
these factors could be seen as an approach to establish a ‘normal growth’ trajectory 
and is regarded by some clinicians as a desired phenomenon since these curves would 
detect early growth deviation. However, this approach also presents a different type 
of problem as confounding factors may be associated with factors the study does not 
want to exclude. For instance, the prevalence of ‘smoking’ is associated with maternal 
age, -ethnicity and -parity. In an attempt to create a ‘normal population’ by excluding 
smokers, the examined population is now out of balance with respect to maternal age, 
ethnicity and parity. This is called skewing of the population, which leads to a highly 
sensitive, but less specific growth charts for abnormal fetal growth. Overall there is 
much scepticism on these ‘supernormalised’ study population. Therefore many current 
growth studies should be interpreted as studies with an observational character. These 
population based reference growth charts can show how a baby grows, but they are less 
equipped to predict how a baby should grow. Another limitation in the construction 
of growth curves is the lack of a clearly implemented protocol on pregnancy dating. 
A gestational age confirmation is essential in the development of both normative and 
descriptive growth curves.9 
Developments in the use of growth charts
Developments in the area of growth monitoring and growth charts attempt to improve 
upon the shortcomings addressed above. So called ‘customized growth charts’ take ac-
count of influential factors such as ethnicity, smoking and maternal length.10-12 These 
customised models of fetal growth should create the possibility for clinicians to obtain a 
better growth reference for a specific baby from specific parents with its specific features 
and background. It is based upon entering the required parameters in the software 
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which then produces a reference curve.13 These curves have the opportunity to distin-
guish both sensitively, and specifically abnormal growth. In addition to customising 
growth charts with respect to parental or fetal characteristics, increased longitudinal 
measurements provide further possibilities for translation into postnatal growth curves. 
The development of longitudinal- instead of cross-sectional growth curves, provides the 
opportunity to discriminate a constitutionally small fetus from a real growth restricted 
fetus.14 Statistically, the longitudinal growth curves are challenging to construct. In 
2006, the World Health Organization (WHO), published their Multicentre Growth Refer-
ence Study Group results on the different statistical models for growth in children. They 
advised the GAMLSS (Generalized Additive Models for Location, Scale and Shape, www.
gamlss.org) model for longitudinal growth studies and centile estimation.15,16 It has 
already been applied by several study groups, one of which (Papageorghiou et al) has 
already published both postnatal and prenatal growth data.17,18,19
Third trimester scan
Regarding the longitudinal aspect of fetal growth, it should be noted that it is char-
acterized by fast progressive growth, starting at 180 – 200 days (26 – 28 weeks) post 
menstrual age. Therefore fetal growth is not linear. This profile supports the rationale for 
a mid-third trimester (28-32 weeks) ultrasound scan. This scan could allow early detec-
tion of a high risk for growth restriction for a specific fetus. Furthermore, an ultrasound 
scan at this gestational age has the beneficial aspect that it provides information on the 
fetus’ position (head-, breech- and transverse position), the location of the placenta and 
on the evolution of certain organ structures. Certain organ structures are susceptible for 
signs of abnormal development in the third trimester, such as the fetal heart, brain and 
kidneys. Despite these theoretical advantages, there doesn’t seem to be much evidence 
in current literature for the implementation of a routine third trimester scan in the 
clinical care for the pregnant woman. A Cochrane review published in 2008 reports no 
improvements at all on perinatal outcome after an ultrasound carried out after 24 weeks 
pregnancy.20 Therefore, in many countries there is no third trimester (growth) scan for low 
risk pregnancies within standard prenatal healthcare programs.21,22 Until now, only one 
Norwegian study, using 20 year old data (but recently published), showed an improve-
ment in the ability to detect aberrant growth by using a third trimester ultrasound.23 This 
randomised prospective study compared an extra third trimester ultrasound scan with 
the existing routine of a second trimester ultrasound followed by a clinical diagnostic 
examination of the fundus-symphysis height in the third trimester. Detecting constitu-
tional small growth (-2SD, -22%) had a better sensitivity of 80% (vs 46%) and a specificity 
of 87% vs 94% for the ultrasound group compared to the physical examination group. 
Detecting constitutional large growth (+2SD, +22%) had a sensitivity of 91% vs 36% and 
specificity of 70% vs 90% for ultrasound scans.When using third trimester ultrasounds 
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more anatomical disorders were found (especially from the urinary system), although 
this difference was not statistically significant.23 Skrastad et al showed an improved 
detection of aberrant growth, but confirmed the Cochrane conclusion that no improve-
ment was added by the third trimester scan with regard to the perinatal morbidity and 
mortality. In general, growth estimation (estimated fetal weight) by ultrasound has a 
variation of 6-12% of the actual fetal weight.24 
In summary, ultrasound for fetal growth and development provides an estimate of the 
measured parameter. Currently there is an ISUOG guideline available, standardizing the 
separate fetal parameters, but no guidelines are available for the preference of a certain 
growth chart. Thus, there are mostly local charts available, which are geographically 
oriented, normative or descriptive, customized or population based and cross-sectional 
or longitudinal. Recently longitudinal growth curves are investigated with the WHO sta-
tistical model, the GAMLSS method. Finally, there is no evidence for the implementation 
of a routine third trimester scan in the absence of improved perinatal morbidity and 
mortality. On an individual basis, though, there seems to be some benefit in detecting 
fetal developmental abnormalities for heart, brain and kidney. 
maternal obesity and fetal growth & development
Obesity and Gestational Weight Gain (GWG)
In 2009 the Institute of Medicine (IOM) released new guidelines on weight gain during 
pregnancy.25 The guidelines recommend lower and upper limits per BMI class and the 
BMI classes were synchronized with the cut-offs used in the WHO BMI classes (table 1). 
The IOM started in 1990 with weight gain recommendations per BMI class in order to 
prevent premature births and small for gestational age (SGA <2.5kg) children. There 
were signs that these adverse outcomes were associated with too low GWG. In 2009 the 
focus of the IOM shifted towards recommendations for the obese women and upper 
GWG limits related to worldwide rise of obesity. The IOM was concerned because of the 
association of crossing the upper limits of GWG in the obese women and the risks for 
macrosomia, caesarean section and postpartum weight retention.25 Recently Bogaerts 
Table 1. Recommended ranges of GWG per prepregnancy BMI, according to the IOM 2009 revised crite-
ria.25
Prepregnancy Bmi recommended gWg rates of gWg per week, 2nd & 3rd 
trimester, mean (range) kg/week
Underweight (<18.5kg/m2) 12.5-18kg 0.51 (0.44-0.58)
normal weight (18.5-24.9kg/m2) 11.5-16kg 0.42 (0.35-0.50)
overweight (25.0-29.9kg/m2) 7-11.5kg 0.28 (0.23-0.33)
obese (≥30kg/m2) 5-9kg 0.22 (0.17-0.27)
General Introduction 15
et al. demonstrated a decreased adverse perinatal outcome for obese women who 
lose weight, without increasing the risks for low birth weight or SGA babies.26 Around 
the same time, looking at obese and overweight women, Catalano et al. showed an 
increased incidence of SGA babies and decreased neonatal fat mass, when women had 
insufficient GWG according to the revised 2009 IOM guidelines.27 In summary, the IOM 
guidelines on GWG for each BMI class are useful and easy to use in clinical studies and 
epidemiology, but are also constantly monitored and updated with new insights.
Influence of obesity on fetal growth
The determinants of fetal growth changes are traditionally categorized into three 
causality groups: pre-placental (‘maternal’), placental and post-placental (‘fetal’). Fetal 
abnormalities are regarded as post-placental causes and can be expressed in fetal 
growth restriction (chromosomal abnormality) or fetal overgrowth (fetal syndrome, 
e.g. Beckwith Wiedemann). A malformed placenta is often associated with early growth 
restriction and causes can be intrinsic (placental infarction or bleeding) or related to 
maternal characteristics (smoking, DM). 
Maternal obesity is associated with both fetal overgrowth and fetal growth restriction. 
Therefore obesity shows a U-shaped fetal growth distribution, with an overrepresenta-
tion of obese mothers on both (extreme) growth sides. On the left side of the distribu-
tion we see a concentration of small fetal growth caused by underdevelopment of the 
placenta in obese mothers with bad metabolic function (hypertension or a unknown 
overt diabetes) and therefore resulting in bad blood vessel formation. On the right side 
of the U-shaped fetal growth distribution, obesity causes fetal overgrowth through an 
impaired glucose tolerance and higher insulin resistance.28 Maternal obesity -and espe-
cially when associated with an android fat distribution (‘central adiposity’)- is regarded 
as a pre-diabetic state with an increased risk to develop insulin resistance and a reduced 
β-cell function in the maternal pancreas. This causes increased maternal blood sugar 
levels, which are transported trans-placental to the fetus. This in turn leads to increased 
β-cell activity within the fetal pancreas. The baby will produce more insulin and Insulin 
Growth Factors (IGF) and hereby increase its body volume. Research focused on IGF-1 
and IGF-2 has found that IGF-2 is a very important prenatal growth stimulator for the 
fetus’ organs in particular.29 Animal studies again emphasize the regulatory function 
of the placental protein IGF-2, showing a central role for the protein in trans-placental 
transport of nutrients, resulting in fetal overgrowth.30 These mechanisms explain why 
obesity is associated with an increased fetal growth, which manifests in the third 
trimester of pregnancy and results in the end in heavy (macrosomic) babies. Indeed, 
even when an official diagnosis of diabetes mellitus or gestational diabetes could not 
be made, a positive correlation between the glucose value in the mothers blood during 
third trimester and the birth weight can be observed.31,32 In a study of 68 obese pregnant 
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women compared to 53 pregnant women with a normal BMI, a positive correlation was 
found between maternal insulin resistance and the neonatal fat mass. This relationship 
was based on the same principle of higher maternal blood-sugar levels, even though 
those women did not yet meet the (gestational) diabetes criteria.32 Also, in the same 
study maternal BMI was correlated with neonatal insulin resistance as measured in 
umbilical cord-blood samples.32 
Obesity and fetal-neonatal body composition
As mentioned above, the fetus’ biggest weight gain is achieved during the second half 
of pregnancy caused by the growth of both lean- and fat mass. The fat mass increase is 
considered the main cause for the baby’s growth acceleration in the third trimester. The 
increase of fat mass is strongly determined by intra-uterine nutrition, whereas the lean 
mass (muscle- and bone tissue) is more dependent on the parents' genetic potential.33,34 
The difference in the amount of fat deposition in the fetus and neonate is also reflected 
by the traditional classification for ‘small-for-gestational age’ (SGA <2.5kg), ‘appropriate-
for-gestational age’ (AGA) and ‘large-for-gestational age’ (LGA >4.0kg) children.35 The 
last definition is often referred to as ‘macrosomia’. Although this classification is officially 
defined by birth weight, there is increasing awareness on the fact that the distribution of 
fat at birth contains more information about the preceding prenatal period and therefore 
also contains information about the risk profile for metabolic disorders of the neonate 
in the future.36 Overall there is a difference in the body composition of a neonate born 
in normal glucose tolerant pregnant women and those babies born in mothers who 
were diagnosed with GDM. In this last group Catalano et al. found a significantly (p = 
0.002) higher fat mass (436 ± 206g) in the neonates, when compared to newborns from 
mothers without GDM (362 ± 198g).36 In obese/overweight women the neonates also 
showed an increased (p = 0.003) body fat mass (11.6 ± 4.7%, 420 ± 220g) at birth when 
compared to babies’ from lean/normal BMI mother (9.7 ± 4.3%, 380 ± 170g).37 The lean 
mass from the babies in this last study did not differ between the two BMI clusters. To 
assess neonatal body composition, different measurements methods are in use and 
guidelines for recommendation of a certain techniques are lacking. Also for children 
under the age of two years, there is no actual definition present of an aberrant body 
composition or of the ‘neonatal obese infant’ up until now. One of the suggestions in 
literature to define a ‘baby BMI’ is the Ponderal Index (PI). This is birth weight divided by 
height raised to the power of 3 (g/cm3).38  This measure could be used to discriminate 
more reliably after birth a tall proportioned baby and a smaller disproportioned baby 
of the same weight. The latter child being considered as ‘adipose’. Body proportionality 
indexes such as birth weight/birth length and birth weight/birth length2 have been 
proposed by the WHO multicentre growth study group, but they still have to prove their 
value as predictors of metabolic changes in later life.17,39 Several studies have addressed 
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neonatal body composition by air displacement plethysmography (ADP), bio-electrical 
impedance analysis (BIA), anthropometry measurements or skinfold measurements.34-40 
Skinfolds measurements are practical and bed-side, but need training, and there have 
been concerns on the reproducibility. The reported coefficients of variation vary from: 
2.6-6% for various skinfolds measurements in neonates.31,34 A benefit of skinfold mea-
surements, is that it informs on the distribution of neonatal fat (trunk or extremities), 
a quality that is not available in the alternatives (ADP or BIA). ADP/BIA give a general, 
but objective, fat- and lean-mass outcome and is therefore regarded to be the current 
normative for study purposes, but indeed no information is obtained on the location of 
the fat depositions.40 
Fetal body composition and adiposity
Evaluation of the nutritional state in utero, by estimating fetal body composition, might 
improve the prediction of specific perinatal risks in (i.e. ‘neonatal adiposity’) conditions 
of under- and overgrowth of the fetus.28,41 Anthropometric ultrasound measurements 
have shown a unique exponential pattern of the growth profile during the second half of 
gestation, both in lean- and in fat mass in the normal fetus. This suggests that the mea-
surement of fetal fat could provide a more sensitive and specific marker of abnormal fe-
tal growth (figure 2).41,42 Larciprete et al. demonstrated this growth pattern with prenatal 
Figure 2. Typical presentation of a macrosomic fetus on 32 weeks of gestational age. There is clearly sub-
cutaneous fat deposition visible around the shoulders (‘schouder’) and trunk (‘romp’). Finally a healthy son 
was born of >4.0kg at 39 weeks. (Galjaard-Devlieger, thesis, 2015).
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ultrasound measures of fetal body composition with skinfold thickness and by analysing 
the humerus (upper arm) and femur (upper leg) extremities (figure 3).42 In addition to 
these fat measurements, specific ‘metabolic’ organs can be examined like the fetal liver.43 
Partially correlated to the fetal liver size, is the fetal abdominal circumference (AC), which 
appears to be a good predictor for the neonatal PI, in the third trimester.44 First cautious 
steps are taken to include fetal fat measures into antenatal weight estimates although 
the number of cases included in this study is relatively small.45,46 It has to be mentioned, 
though, that these measurements are still controversial and strongly dependent on the 
examiners’ expertise, which is why they are not yet part of routine clinical care.41 Better 
detection of the high risk fetus may help to break the vicious circle in which prenatal 
abnormal development occurs under influence of maternal environmental factors, with 
the aim to prevent neonatal and eventually adult metabolic diseases.1,2
maternal and fetal vascular development
The evaluation of fetal body composition and adiposity in utero, might improve the pre-
diction of the intra-uterine development as a risk factor for cardiovascular disease.28 Low 
birth weight or intra-uterine growth restriction (IUGR) is associated with cardiovascular 
disease (CVD), non-insulin-dependent diabetes and hypertension in later life.47 Some 
authors have suggested that fetal undernourishment causes adaptations that involve 
cardiovascular structures and may even cause early vessel abnormalities. This has been 
Figure 3. Fetal subcutaneous tissue thickness.  Ultrasound images (a, c, e) and schematic representations 
(b, d, f ) showing how the different subcutaneous tissue thickness measurements are obtained. (a,b) Axial 
view of the fetal arm showing mid‐arm fat mass (MAFM) and mid‐arm lean mass (MALM) evaluation; the 
process is similar for mid‐thigh fat and lean mass. (c,d) Evaluation of the subscapular fat mass (SSFM) mea-
surement. (e,f ) Evaluation of the abdominal fat mass (AFM). (Reproduced with permission of the author and 
publisher, Larciprete et al., 2003)42
General Introduction 19
called the ‘fetal origin’ theory where adults, who were small at birth, show higher blood 
pressure and increased risk of cardiovascular diseases.48,49 In addition, although studies 
are still limited, there is data showing that being born large for gestational age (LGA) is 
associated with an increased aortic intima media thickness in childhood.50-52 Hemody-
namic changes in pregnancy have been well described, but vascular research has focused 
mainly on hyperdynamic changes (preeclampsia) in the mother.53,54 Information on wall 
thickness (intima-media thickness, IMT) is available, but data on stiffness changes in the 
great arteries is scarce.55,56 Vascular changes have also been demonstrated in newborns 
with intra-uterine growth restriction through measurement of the abdominal aortic 
IMT, which is a sensitive marker for the development of atherosclerosis in later life.57-59 
Histology of the abdominal aorta wall of a stillborn infant with prenatally increased IMT, 
revealed inflammation of the thickened intima layer.60 Post-mortem studies performed 
on humans in early adulthood (15-34 years) showed the abdominal aorta to be the first 
site involved in the process of atherosclerosis61 However few studies have measured IMT 
in the fetus during pregnancy, and up to now only a single technique has been used 
to investigate the IMT in the fetus.62-64  More functional vascular properties (distension, 
stiffness and elasticity) have not yet been investigated in the fetus. 
In mothers there is inconsistency on whether IMT is increased in the Common Carotid 
Artery (CCA) during pregnancy.65,66 A gestational age-dependent factor has been pro-
posed.66,67 Recently pre-eclamptic women were found to have increased IMT measure-
ments of the CCA in late third trimester pregnancy compared to normotensive women 
(459±95µm vs. 351±85µm).68 A difference remained between the two groups after 18 
months. This was the first report of the maternal CCA with high resolution ultrasound, 
based on Radio Frequency (RF ultrasound). No longitudinal study until now has reported 
on fetal or the maternal great arteries for functional vascular properties (elasticity and 
stiffness) during pregnancy with RF ultrasound.
maternal obesity and visualisation
It can be challenging to achieve a high quality ultrasound result for fetal growth and 
development when examining an overweight or obese pregnant woman. This is mainly 
caused by the additional fat tissue located between the ultrasound probe and the 
fetus.69 The end result is practically always inferior when compared to an ultrasound 
conducted on a pregnant woman with normal BMI. The fat tissue absorbs and scatters 
the ultrasound waves, causing a negative correlation between the distance of the ul-
trasound probe to the fetus and the image quality. Not even the extensive technical 
improvements of the ultrasound equipment achieved in these last decennia have been 
able to undo these limitations. In clinical practice when mothers are obese, repeated 
sonograms are often needed before a somewhat satisfactory imaging result can be 
obtained.70 Furthermore, obese pregnant women have a higher incidence of fetal 
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malformations. These include mainly neural tube defects (‘spina bifida’), heart defects, 
anal atresia and limb disorders (Table 2).71 The combination of increased suspicion of 
malformations and a poorer imaging, requires particular attention for the clinical care-
takers. Uhden et al. reported that fetal heart defects are more common with overweight 
and obese women (relative risk = 2.04), while the percentage qualitatively incomplete 
studies increased from 6.4% in normal weight women to 17.4% in obese women, at the 
20 weeks ‘morphology’ ultrasound scan.72 Hendler et. al scored the percentage of ‘insuf-
ficient / poor visualisation’ at the 20 weeks ultrasound scan in the obese women. They 
showed that the percentage of poor visualisations in obese women was 37% for cardiac 
structures and 43% for cranio-spinal structures, compared to 19% and 30% respectively 
in normal weight women. A repetition of the ultrasound examination two weeks later 
reduced the proportion of insufficient visualisation of the fetal heart down to 20% in the 
obese women.73 It still demonstrates an inadequate ultrasound examination of the fetal 
heart in 1 out of 5 obese pregnant women. The FaSTER trial, an ultrasound study on the 
identification of Down syndrome, reported that the chance of detecting general fetal 
abnormalities decreased by 30% under the influence of maternal obesity (OR van 0.7; 
95%CI 0.6-0.9; p = 0.001).74  
The limited visualisation and the necessity to repeat the sonographic study in obesity 
is not only stressful for the women, but also forces extra pressure on the organisation 
and economics of the prenatal care system. 
Table 2. Risk of congenital disorders during pregnancy for mothers with obesity compared to normal 
weight. (From: Stothard et al., 2009)71
malformation or (95% Ci) P- Value
neural tube defects 1.87 (1.62-2.15) 0.001
Cardiac defects 1.30 (1.12-1.51) 0.001
anal atresia 1.48 (1.12-1.97) 0.006
limb disorders (-reduction) 1.34 (1.03-1.73) 0.03
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aBsTraCT
The environment in utero and in early neonatal life may induce a permanent response 
in the fetus and the newborn, leading to enhanced susceptibility to later diseases. This 
review concentrates on the role and mechanisms of events during the antenatal and 
immediate postnatal period resulting in later life diseases, concentrating on abnormal 
growth patterns of the fetus.
Fetal overgrowth is related to exposure to a diabetic intra uterine environment, in-
creasing the vulnerability to transgenerational obesity and hence an increased sensitiv-
ity to more diabetic mothers. This effect has been supported by animal data.
Fetal growth restriction is more complex with a role of malnutrition in utero and catch 
up growth due to a high caloric intake and low physical activity in later life. Metabolic 
changes and a transgenerational effect of intra uterine malnutrition have been sup-
ported by animal data.
In recent years the discovery of alterations of the genome due to different influences 
during embryonic life, called epigenetics, has led to the phenomenon of fetal program-
ming resulting in changing transgenerational metabolic effects. 
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inTroDUCTion
It is known that environmental factors influence health and the development of diseases. 
Certainly the environment in utero and in early neonatal life may induce a permanent 
response in the fetus and the newborn, leading to enhanced susceptibility to later 
diseases. These effects can be transgenerational and are probably due to an epigenetic 
transmission mediated by the mother (Aerts and Van Assche, 2006; Poston, 2010).                                
Abnormal environmental factors during pregnancy may lead to increased fetal 
growth, due to increased transplacental nutrients or may lead to fetal growth restric-
tion, due to decreased transplacental transfer. Both extremes of fetal growth can induce 
developmental programming through epigenetic adaptations.
The present review will concentrate on the role and mechanisms of events during the 
antenatal and immediate postnatal period resulting in diseases in later life, concentrat-
ing on abnormal growth patterns in the fetus.
FeTal enVironmenT anD inCreaseD FeTal groWTh
human data
Even before the discovery of insulin, Dubreuil and Anderodias (1920) described gi-
ant islets of Langerhans in the pancreas of a newborn of a diabetic mother. Pedersen 
proposed that increased transplacental transfer of glucose leads to increased insulin 
secretion by the fetus, inducing macrosomia (Pedersen et al, 1954). It was confirmed 
that fetal hyperinsulinism was due to B cell hyperplasia and the hypothesis was put 
forward that hyperactivity of the fetal B cells may result in reduced secretory capacity 
in later life. Furthermore, an intact hypothalamic structure was needed to induce B cell 
hyperplasia, predicting the role of the hypothalamus in perinatal programming (Van 
Assche and Gepts, 1971).
Dörner was among the first to provide evidence that exposure to a diabetic intra-uter-
ine environment increases the risk of developing diabetes in the offspring. Moreover he 
showed a transgenerational effect and the importance of good metabolic control in the 
prevention of long-term consequences (Dörner et al, 1973, 1984). These observations 
were confirmed by several epidemiologic studies and recently summarized: the excess 
of maternal transmission of diabetes is consistent with an epigenetic effect of hypergly-
caemia in pregnancy acting in addition to genetic factors that induce diabetes in next 
generations. Individuals with genetic susceptibilities may be the most vulnerable to the 
in utero influences of maternal diabetes (Mclean et al, 2006; Poston, 2010).
Offspring of diabetic mothers also have an increased risk for obesity related to the 
degree of fetal hyperinsulinism (Silverman et al, 1991). Furthermore impaired glucose 
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tolerance and obesity in adults due to a diabetic intra-uterine environment is indepen-
dent of the genetic background (Clausen et al, 2008; Dabelea et al, 2000; Plagemann et 
al, 1997). 
Maternal obesity has gained an epidemic proportion in Europe and the developed 
world (EU document A6-450/2006). Maternal obesity and increased weight gain during 
pregnancy are associated with increased birth weight independent of genetic factors. It 
is also evident that maternal obesity induces higher transplacental transfer of nutrients 
resulting in fetal hyperinsulinism, increased fetal growth and adiposity (Ludwig and 
Currie, 2010). Maternal obesity therefore has a transgenerational effect inducing obesity 
and diabetes (Dabelea and Crume, 2011).    
animal data
Animal models of diabetes and obesity during pregnancy may unravel the specific ef-
fects of an exposure to an abnormal intra-uterine environment independent of inherited 
trails.  In the rat, mild diabetes during pregnancy can be induced with a low dose of 
streptozotocin, stimulating the insulin producing B cell, hyperinsulinism and increased 
weight of the fetus. (Over-) Stimulation of the B cells in utero leads to a reduced insu-
lin secretion during later life in conditions of increased demands such as obesity and 
pregnancy (Aerts and Van Assche, 1977; Devlieger et al, 2008). In experimental induced 
gestational diabetes a transgenerational effect was demonstrated (Aerts and Van As-
sche, 1979). Moreover, normalization of the maternal glycaemia by islet transplantation 
prevents deleterious effects for the fetus and offspring (Aerts and Van Assche, 1992). It 
seems clear that (over-) stimulation of the fetal B cell reduces the function of this cell in 
the offspring (Aerts and Van Assche, 2006).
However it may be possible that fetal hyperinsulinism itself may induce malpro-
gramming (Plagemann et al, 1998b). Indeed another pathophysiologic mechanism 
may be related to the hypothalamic control of food intake, body weight and glucose 
metabolism (Plagemann et al, 1998a). The ventromedial hypothalamic nucleus (VMN), 
the lateral hypothalamic area (LHA) and the arcuate hypothalamic nucleus (ARC) of the 
medio-basal hypothalamus play an important role in this context. Hyperinsulinism in 
the fetus of pregnant rats with diabetes is associated with increased insulin content in 
the hypothalamus leading to an impaired organization of the VMN, the antagonistic LHA 
being unaltered (Plagemann et al, 1998b). Hypotrophy and hypoplasia of the VMN may 
result in a diminished function of the satiety center, together with a relative overactivity 
of the antagonistic LHA, stimulating appetite and weight gain (Plagemann et al, 2009). 
Neuropeptides in the ARC play an important role in the regulation of food intake, body 
weight and metabolism. In particular neuropeptide Y (NPY) is the most potent orexi-
genic neuropeptide and is regulated via the circulating satiety factors leptin and insulin, 
both suppressing NPY expression (Plagemann et al 1998b). Perinatal hyperinsulinism 
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induces resistance of the NPYergic system against the regulatory signals leptin and in-
sulin, leading to hyperphagia and overweight in adult offspring (Plagemann and Harder, 
2009). Islet transplantation in induced maternal diabetes prevents the effects in VMN 
and ARC (Franke et al, 2005; Harder et al, 2001). Furthermore malprogramming of the 
hypothalamic structures is also operational in the diabetic lactating period, suggesting 
the importance of the milk composition (Fahrenkrog et al, 2004; Plagemann et al, 2002).
Recently, several experimental models in rat and mice of diet induced obesity have 
been reported inducing fetal hyperinsulinism and increased body weight, leading to 
glucose intolerance, insulin resistance, obesity, hyperphagia and hypertension in the 
offspring (Holemans et al, 2004; Nivoit et al, 2009; Samuelsson et al, 2008;). These effects 
are  transgenerational (Holemans et al, 2004). It is clear that diet induced obesity during 
pregnancy in animals show comparable changes in the fetus and the offspring as seen 
in experimental diabetes. Fetal hyperinsulinism is the result of B cell (over-) stimulation 
and induces B cell dysfunction in later life. Hyperleptinaemia in the early neonatal pe-
riod induces overweight, hyperphagia, diabetic tendency and cardiovascular problems 
in later life. Hypothalamic alterations, induced by fetal hyperinsulinism are associated 
with neonatal leptin resistance with long term consequences (Plagemann and Harder, 
2009). The important role of induced leptin resistance is confirmed in maternal obesity: 
young offspring of obese dams are leptin resistant, and remain leptin resistant and 
hyperphagic when adult (Kirk et al, 2009).
Insulin is also known as a potent mitogenic factor, which is another reason to decrease 
fetal hyperinsulinism to lower the risk for cancer in later life (Van Assche et al, 2010).
FeTal enVironmenT anD inTra-UTerine groWTh resTriCTion
human data
The fetus with intra-uterine growth restriction shows a reduced amount of B cells related 
to low insulin and glucose levels (Van Assche et al, 2001). Studies in England and Wales, 
demonstrating the association between low birth weight and adult impairment of 
glucose tolerance, obesity, type 2 diabetes and cardiovascular diseases have led to the 
Barker hypothesis of fetal origin of adult diseases (Barker and Osmond, 1986; Barker et 
al, 1993). Consequent population studies have confirmed the relation between low birth 
weight and adult diseases (Leon et al, 1996). The most vulnerable period in pregnancy is 
shown in studies of the maternal malnutrition during the Dutch hunger winter in 1944. 
This malnutrition resulted in a higher incidence of impaired glucose tolerance, type 2 
diabetes and cardiovascular risks in the offspring especially when deprivation occurred 
in the third trimester (Ravelli et al, 1998).  
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The consequences in later life are also determined by caloric intake. A population 
subjected to poor nutrition in the perinatal period can keep a normal glucose tolerance 
as long as they remain on a low caloric diet. A change to a higher caloric intake and 
low physical activity increases the incidence of impaired glucose tolerance and type 
2 diabetes (Aerts and Van Assche, 2006). In this respect, a high caloric intake in the 
postnatal period inducing catch up growth will aggravate the consequences in later life 
(Gluckman et al, 2008; Hales and Barker, 1992). Breastfeeding may prevent accelerated 
caloric intake in the postnatal period (Rodekamp et al, 2009).
It is accepted that the underdevelopment of the fetal B cells may lead to reduced B cell 
function in later life, certainly in periods of increased demands. Leptin may also play an 
important role. High caloric intake in the newborn after a period of fetal growth restric-
tion may induce a leptin charge. Hyperleptinaemia in the early neonatal period induces 
hyperphagia, overweight, diabetic tendency and cardiovascular problems in later life 
(Plagemann and Harder, 2009), certainly in situations of previous fetal undernutrition 
(Vickers et al, 2008).
animal data
Several animal models mainly in the rat have studied the impact of reduced fetal 
nutrition on long term consequences. Global food restriction by semi starvation or by 
unilateral uterine artery ligation during pregnancy results in underdevelopment of the 
fetal B cells, low insulin levels and intra-uterine growth restriction (De Prins and Van 
Assche, 1982; Garofano et al, 1998). In adult rats, insulin resistance and subtle changes in 
vascular function are found (Holemans et al, 1996, 1999). However hypertension did not 
seem to be a consequence (Holemans et al, 1999; Simmons et al, 2001).  
An isocaloric, but low protein diet has been frequently used for the induction of 
intra-uterine growth restriction. A reduced B cell mass and reduced insulin secretion 
in the fetus was correlated with the occurrence of gestational diabetes in the offspring 
(Dahri et al, 1991; Dahri et al, 1995). Offspring from pregnancies with low protein diet do 
seem to have an increased blood pressure (Langley and Jackson, 1994). Here, also the 
deficiency in the total islet mass and specifically in the B cell mass during fetal life, results 
in a reduced adaptation in adult life leading to gestational diabetes with macrosomic 
fetuses, indicating a transgenerational effect (Blondeau et al, 1999; Boloker et al, 2002).    
Intra-uterine growth restriction as such, does not program the hypothalamus towards 
increased appetite and obesity. However, high caloric intake and increased leptin 
concentration in the neonatal period may induce hyperphagia and obesity in later life 
(Plagemann and Harder, 2009).
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ePigeneTiC aDaPTaTions
Exposure to environmental changes in utero has been investigated as epigenetic 
events resulting in transgenerational effects, such as macrosomia, obesity and diabe-
tes. The alterations on the genome, without changes of the DNA are characterized as 
epigenetics. This is a slow process of changing methyl groups on cytosine bases in DNA 
by methyltransferases. Modifications are identified as de-methylation, histone deacety-
lation and increased histone acetylation, independent from replication (Feng et al 2010). 
Therefore, DNA methylation appears to occur before cellular differentiation, as no de 
novo methyltransferases are present after cellular differentiation. This suggests a role for 
environmental influence, such as excessive nutrition, nutritional restriction or low folic 
acid and vitamin B12 levels, on DNA methylation in early life development (Hanson and 
Gluckman, 2008; McLean et al, 2006).
Especially during periconception and embryonic life the rate of DNA synthesis is 
high and therefore susceptible for alterations in DNA methylation, leading to meta-
bolic imprinting for leptine, SOCS3 and glucose transporter mechanisms for energy 
homeostasis (Dabelea and Crume, 2011). Whether these changes are irreversible is not 
yet clear, although animal studies on developmental programming indicate that an 
obese phenotype is not transmitted to their offspring by mating, but merely by uterine 
environmental influence. This stresses the importance of embryonic environment on 
epigenetic imprinting for metabolic mechanisms on the future generations (Bouchard 
et al, 2010; Dabelea and Crume, 2011; Waterland et al, 2007).
ConClUsions
It seems clear that events in utero induce a response in the fetus and newborn, leading 
to enhanced susceptibility for later diseases.
In maternal diabetes and in maternal obesity increased transplacental nutrient supply 
to the fetus induces B cell hyperactivity, hyperinsulinism and increased fetal growth. Fe-
tal hyperinsulinism is responsible for changes in the hypothalamus resulting in malpro-
gramming of food intake, body weight and glucose metabolism. Insulin is also known 
as a potent mitogenic factor. From the clinical point of view it is therefore evident that 
in maternal diabetes and in maternal obesity fetal hyperinsulinism should be avoided. 
Early detection of gestational diabetes and strict metabolic control are essential. Obesity 
needs to be prevented preferably at adolescence and certainly before pregnancy. 
Intra-uterine growth restriction is associated with a reduced B cell mass and low insu-
lin secretion, the underdeveloped fetal B cell is responsible for a reduced B cell activity 
in later life. Neuroendocrine mechanisms, such as leptin charge, are involved through 
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malprogramming leading to excessive catch up growth. Therefore, efforts should be 
done to prevent intra-uterine growth restriction by early detection and management of 
hypertensive disorders in pregnancy and by optimal nutrition of the pregnant women.
Not every overweight newborn and not every newborn with intra-uterine growth re-
striction will develop problems in later life. It depends on bad or good adaptation and to 
the plasticity of his adaptation later on (Gluckman et al, 2008). This is called epigenetics, 
which means that by different environmental influences, alterations are made during 
early intra-uterine life on gene expressions, leading to aberrant metabolic phenotypes, 
like obesity. More profound understanding of the effect of fetal programming and the 
transference to future generations will be possible with further studies exploring epi-
genetic mechanisms. (Waterland et al, 2007).
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aBsTraCT 
importance: Gender is recognized as a determining factor for differences in outcome in 
adult medicine. Little information is available on fetal gender influence in the prenatal 
period, when development is fastest. 
objective: To develop gender specific fetal growth curves for a low risk population ac-
cording to WHO Multicentre Growth Reference Study Group recommendations and to 
compare immediate birth outcomes between boys and girls.
Design: Population based retrospective longitudinal cohort study.
setting: Academic teaching hospital Leuven, Belgium
Participants: First-, second-, and third trimester fetal ultrasound examinations conduct-
ed `2002-2012. The data was selected using the following criteria: routine examinations 
in uncomplicated singleton pregnancies, Caucasian ethnicity, confirmation of gestation-
al age by a crown rump length (CRL) measurement in the first trimester. Longitudinal 
examinations were only considered if containing all four routine fetal measurements: 
Biparietal Diameter (BPD), Head Circumference (HC), Abdominal Circumference (AC) and 
Femur Length (FL). GAMLSS (Generalized Additive Model Location, Scale and Shape) 
was used to align the timeframes of measurements.
main outcome measures: Gender specific longitudinal growth curves for the four fetal 
measurements BPD, HC, AC, FL from 12 to 40 weeks for boys, girls and the total group; 
estimated fetal weight compared to birth weight; immediate birth outcomes for boys 
and girls.
results: A total of 27680 complete scans were selected from the astraia© ultrasound 
database representing 12368 pregnancies. Fetal growth curves for BPD, HC, AC and 
FL were derived. The HC and BPD were significantly larger in boys compared to girls 
from 20 weeks’ gestation onwards (p<0.001) equating to a 3 day difference at 20-24 
weeks. Boys were significantly heavier, longer and had greater head circumference than 
girls (p<0.001) at birth. The Apgar score at one minute (p=0.01) and arterial cord pH 
(p<0.001) were lower in boys.
Conclusions: These longitudinal fetal growth curves for the first time allow integration 
with neonatal and paediatric WHO gender specific growth curves. Immediate birth 
outcomes are worse in boys than girls, and gender differences in intra uterine growth is 
sufficiently distinct to have a clinically important effect on fetal weight estimation and 
second trimester dating. Gender differences might play a role in obstetric or immediate 
neonatal viability management. 
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inTroDUCTion
Ultrasound has been an indispensable tool for diagnosis in obstetrics and fetal growth 
assessment for at least 4 decades.1-3 Clinical management in pregnancies is increasingly 
based on ultrasound measurements derived in the first trimester and on the recognition 
of pathological fetal growth, which depends on reliable, standardized growth curves.4 
Although it is widely known that boys are slightly larger than girls in the first trimester 
and at birth, there has been no consideration of fetal gender in the development and 
interpretation of fetal growth curves.5-8 This gender dichotomy seems important since 
there is clear evidence that gestation specific neonatal outcomes are worse in boys, 
indicating the vulnerability of the male embryo and fetus. 9,10 
Many charts have been published on fetal growth using different methodologies from 
the early 1990s until early in this decade, after which new (dating-) protocols emerged.11 
Most normal ranges were designed from cross sectional data,12-19 which by their nature 
may represent fetal size at a given point but do not directly infer growth. To derive in-
formation on fetal growth, statistical strategies using repeat measurements are required 
but longitudinal methodologies are utilized more rarely.20,21 Given these complexities 
the World Health Organization (WHO) Multicentre Growth Reference Study Group 
(MGRS) recommended GAMLSS (Generalized Additive Model Location, Scale and Shape) 
for the construction of the WHO Growth Standards.22,23 Most recently growth charts have 
been developed in regions of Europe and the United States and customization based on 
ethnicity reported.11,12,18,19,24
Our aim was to develop gender specific longitudinal first-, second-, and third trimester 
normal growth reference curves within a low-risk Caucasian population with a robust 
WHO endorsed longitudinal statistical methodology. Further, we aimed to test the valid-
ity of these curves by comparing the estimated fetal weights derived from these charts 
to actual birth weight, and determine whether there was a gender specific difference in 
immediate birth outcome.
meThoDs
This was a retrospective longitudinal cohort study of first-, second-, and third trimester 
fetal biometry ultrasound examinations performed during the period  2002-2012 in the 
University Hospital Leuven. The study was approved by the ethics committee of the 
University Hospitals KU Leuven. The data was selected from the astraia© ultrasound da-
tabase with all four routine biometry measurements (BPD, HC, AC and FL) present, with 
the following criteria (figure 1): indication ‘routine fetal growth’ (level 1 and 2 excluded), 
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singleton pregnancy, ethnicity ‘Caucasian’ and gestational age confirmed by a crown 
rump length (CRL) measurement (3-83mm) in the first trimester.25 Only pregnancies 
with at least 2 or maximum 3 scans (first-, second-, and third trimester) were selected, 
representing a routine of care scheme for a low risk-population. The measurements were 
performed with the following ultrasound machines (with time period of usage): Kretz 
Voluson 730 (2002-2006), ESAOTE Technos (2002-2006), Acuson Sequoia (2002-2007), 
General Electric Voluson® 730 Expert (GE healthcare Medical systems, Kretztechnik, 
Zipf, Austria 2007-2012), General Electric Voluson E8 (GE healthcare Medical systems, 
Kretztechnik, Zipf, Austria 2007-2012). The first three devices were equipped with a 4-8 
MHz curved linear array probe. The GE Voluson E730 and GE Voluson E8 used a curved 
 89.933 scans 
(all 4 biometry  
measurements: BPD, 
HC, AC and FL) 
Selected on: 
- Singleton 
- Caucasian 
- Routine scan 
- Confirmed dating 
 
39.724 scans 
27.680 scans 
12.368 pregnancies 
(= 2.24 scans average) 
Selected on: 
- If ≤1 or ≥4 scans 
per pregnancy : 
Exclusion 
 
10.092 scans Girls 
(4.513 pregnancies) 
6.596 scans UK* 
(2.955 pregnancies) 
10.992 scans Boys 
(4.900 pregnancies) 
Selected on: 
- Girls / Boys / UK* 
 
Figure 1. Flowchart on selection procedure for normal routine fetal ultrasound scans between 2002-2012. 
*UK = Unknown gender.
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4-8 MHz volumetric 3D abdominal probe. All growth data were immediately stored in 
an electronic database (astraia© Software Inc., Munich, Germany). Fetal measurements 
were based on the following two-dimensional biometric parameters: Biparietal Diameter 
(BPD), Head Circumference (HC), Abdominal Circumference (AC) and Femur Length (FL), 
as designated in the guidelines descriptions (Supplement, e-text 3.1).26 Only complete 
fetal data-sets (all 4 measurements) were analyzed. Neonatal data from the included 
patients were extracted from their birth-files for gestational age at delivery, gender, 
birth-weight, -length, head-circumference, Apgar scores (AS) for 1st and 5th minute after 
birth, umbilical cord arterial pH and base excess (BE) measurement. Only gender specific 
neonatal data-sets were analyzed. 
statistical analysis
Outliers in BPD, HC, AC or FL were removed from the data. GAMLSS (Generalized Additive 
Models for Location, Scale and Shape, www.gamlss.org) was applied to construct the 
growth curves for all four fetal routine fetal biometry measurements: BPD, HC, AC and 
FL, by use of the R-package GAMLSS.22,23 We assessed several distributions: Box-Cox-t, 
Box-Cox Cole and Green, and Box-Cox Power Exponential. Goodness-of-fit of the models 
was assessed with QQ plots, AIC (Akaike Information Criterium) and worm plots. The 
goodness-of-fit was investigated covering the gestational age 12-40 weeks period, and 
for substrata of this period. GAMLSS smoothed the ante-natal growth curves for BPD, 
HC, AC, FL and EFW.  For the EFW, the Hadlock-3 formula [Log10 EFW = 1.3350.0034(AC)
(FL) + 0.0316(BPD) + 0.0457(AC) + 0.1623(FL)] was used.11 The 5th, 10th, 50th, 90th and 95th 
percentile were plotted with grid lines. The whole analysis was done three times: for all 
pregnancies, for boys and for girls. SAS 9.4 was used for merging the fetal database with 
the neonatal database, and analyzing the neonatal data.
resUlTs 
Between 2002 and 2012 89933 scans were selected. After restricting to a low-risk popu-
lation a total of 27680 scans remained representing 12368 pregnancies (figure 1). The 
mean maternal BMI was 23.8 kg/m² (std. 4.8), 7% of the women smoked. Gender specific 
birth data-sets could be ascertained in 76.1% of the cases and are outlined in table 1. In 
total we had 4900 boys and 4513 girls, representing respectively 10992 and 10092 scans. 
The mean birth-weight, -length and head-circumference was significantly (p<0.001) dif-
ferent for boys (3450g, 50.9cm, 34.9cm) as compared to girls (3329g, 50.1cm, 34.3cm). 
A low one minute AS (≤5) was more common in boys (3.8%) as compared to girls (2.9%) 
(p=0.01) as was a low five minute AS (≤7) for boys (3.2%) compared to girls (2.3%, table 1) 
(p=0.009). The arterial umbilical cord pH was lower in boys compared to girls (p<0.001). 
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There was no difference in asphyxia, defined as a pH<7.10, in boys (0.9%) compared to 
girls (1.0%, p = 0.90) and abnormal BE (<-10mEq/L) was the same for both sexes. There 
was no difference in preterm birth (<37 weeks) for girls (5.7%) and boys (6.5%, table 2) 
(p=0.14) which occurred in 6% of the pregnancies overall. In the pre-term group boys 
were heavier (P=0.003), longer (p=0.005) and had larger head-circumferences (p=0.006). 
The immediate outcome of AS and pH were also differently in boys and girls, although 
not statistically different due to the smaller group (table 2). The term-group is outlined 
separately in the supplement (e-table 3.1). 
GAMLSS longitudinal fetal antenatal growth curves for BPD, HC, AC, FL from 12-40 
weeks were developed for boys, girls and combined (Supplement, e-figures 3.1-3.4). 
For each parameter the 5th, 10th, 50th, 90th and 95th centiles were constructed. Actual 
values for these centiles and grid-curves are also outlined in the supplement (e-tables 
3.3-3.12). Comparing the two gender growth trajectories and their percentiles, for BPD, 
Table 1. Neonatal data for boys, girls and combined in term and preterm pregnancies.
Total
(n= 9413)
Boys
(n= 4900, 52.1%)
girls
(n= 4513, 47.9%)
P-value*
ga at birth (wks,0/7d), mean ± std 39w2/7 ± 1w5d 39w2/7 ± 1w5d 39w3/7 ± 1w5d 0.02
Birth weight (g), mean ± std 3392 ± 512 3450 ± 515 3329 ± 502 <0.001
length (cm), mean ± std 50.5 ± 2.4 50.9 ± 2.4 50.1 ± 2.4 <0.001
hC (cm), mean ± std 34.6 ± 1.6 34.9 ± 1.6 34.3 ± 1.5 <0.001
1 minute as ≤5 3.4% 3.8% 2.9% 0.01
5 minute as ≤7 2.8% 3.2% 2.3% 0.009
ph Umb art, mean ± std 7.27 ± 0.07 7.269 ± 0.072 7.274 ± 0.075 <0.001
ph < 7.10
mean ± std
1.9% (177)
7.04 ± 0.06
0.9% (82)
7.041 ± 0.059
1.0% (95)
7.042 ± 0.062
0.90
Be <-10 meq/l
mean ± std
1.4% (132)
-13.46 ± 4.01
0.8% (71)
-13.8 ± 4.2
0.6% (61)
-13.1 ± 3.7
0.30
Neonatal demographic data available in 9413 (76%) of the selected cases ‘2002-2012. GA = gestational 
age; wks = weeks; d = days; g = gram; cm = centimeter; HC = Head Circumference; AS = Apgar Scores; pH = 
pondus Hydrogenium; Umb Art = Umbilical artery; BE = Base Excess; Std. = Standard Deviation. * P-value 
represents difference Boys vs Girls.
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Table 2. Neonatal data for boys, girls and combined in preterm (<37weeks) pregnancies.
Total
(n= 576)
Boys
(n= 317, 55.0%)
girls
(n= 259, 45.0%)
P-value*
ga at birth (wks,0/7d), mean ± std 34w6/7 ± 2w2/7 35w0/7 ± 2w1/7 34w5/7 ± 2w3/7 0.19
Birth weight (g), mean ± std 2481 ± 637 2553 ± 604 2392 ± 665 0.003
length (cm), mean ± std 46.3 ± 4.2 46.8 ± 4.1 45.7 ± 4.3 0.005
hC (cm), mean ± std 32.5 ± 2.5 32.8 ± 2.4 32.2 ± 2.6 0.006
1 minute as ≤5 8.1% 8.6% 7.4% 0.62
5 minute as ≤7 7.9% 8.9% 6.7% 0.32
ph Umb art, mean ± std 7.29 ± 0.07 7.285 ± 0.070 7.289 ± 0.076 0.50
Neonatal demographic data available in 576 pre-term cases ‘2002-2012. GA = gestational age; wks = 
weeks; d = days; g = gram; cm = centimeter; HC = Head Circumference; AS = Apgar Scores; pH = pondus 
Hydrogenium; Umb Art = Umbilical artery; Std. = Standard Deviation. * P-value represents difference Boys 
vs Girls.
Figure 2. Biparietaldiameter (BPD) in mm for boys and girls from 20-30 weeks of gestation for percentiles 
5, 10, 50, 90 and 95. 
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there was a significant (p<0.001) difference for all percentiles in boys having higher BPD 
measurements (figure 2, table 3). At 24 weeks the 50th percentile BPD for boys (60.4mm) 
is significant higher as compared to girls (58.9mm, p<0.001, e-table 3.8, 3.13). This cor-
responds to a difference of three gestational days. The boys 5th percentile aligns with 
the 10th percentile of the girls, and the 90th percentile aligns with the 95th percentile of 
Table 3. BPD reference values for boys and girls from 12-40weeks. 
ga Boys (BPD) girls (BPD)
C5 C10 C50 C90 C95 C5 C10 C50 C90 C95
12 16,7 17,3 19,4 21,6 22,3 16,5 17,1 19,2 21,3 21,9
13 20,4 21,0 23,2 25,6 26,3 20,1 20,7 22,9 25,1 25,7
14 24,3 25,0 27,3 29,7 30,4 24,0 24,6 26,8 29,1 29,7
15 28,2 28,9 31,3 33,8 34,5 27,8 28,5 30,8 33,1 33,7
16 32,0 32,6 35,1 37,6 38,3 31,4 32,1 34,5 36,8 37,5
17 35,3 36,0 38,5 41,0 41,8 34,7 35,4 37,9 40,3 41,1
18 38,3 39,0 41,6 44,3 45,1 37,8 38,5 41,0 43,6 44,4
19 41,3 42,0 44,7 47,6 48,4 40,5 41,3 44,0 46,7 47,5
20 44,0 44,9 47,8 50,8 51,7 43,1 43,9 46,7 49,6 50,5
21 46,7 47,6 50,7 54,0 55,0 45,7 46,5 49,6 52,6 53,5
22 49,5 50,4 53,8 57,3 58,4 48,4 49,3 52,5 55,8 56,8
23 52,4 53,4 57,0 60,8 61,9 51,2 52,2 55,7 59,2 60,2
24 55,5 56,6 60,4 64,3 65,5 54,2 55,3 58,9 62,7 63,8
25 58,6 59,8 63,8 67,9 69,1 57,3 58,4 62,3 66,2 67,3
26 61,8 63,0 67,1 71,3 72,6 60,4 61,5 65,5 69,6 70,8
27 64,9 66,1 70,2 74,5 75,8 63,4 64,6 68,6 72,8 74,0
28 67,8 69,0 73,2 77,5 78,8 66,3 67,4 71,5 75,8 77,0
29 70,4 71,6 75,8 80,2 81,5 69,0 70,2 74,3 78,5 79,7
30 72,9 74,1 78,4 82,8 84,2 71,6 72,7 76,9 81,1 82,4
31 75,3 76,6 81,0 85,5 86,9 74,0 75,2 79,4 83,6 84,9
32 77,6 78,9 83,3 87,9 89,4 76,2 77,4 81,7 86,0 87,3
33 79,5 80,9 85,4 90,1 91,6 78,1 79,4 83,7 88,2 89,5
34 81,2 82,6 87,3 92,1 93,7 79,8 81,1 85,6 90,2 91,6
35 82,5 84,0 88,9 93,9 95,5 81,3 82,7 87,3 92,1 93,5
36 83,6 85,1 90,3 95,6 97,3 82,7 84,1 88,9 93,9 95,3
37 84,6 86,2 91,7 97,4 99,2 84,1 85,5 90,5 95,6 97,2
38 85,7 87,4 93,2 99,3 101,2 85,5 87,0 92,1 97,4 99,0
39 87,0 88,8 94,9 101,2 103,3 86,9 88,4 93,7 99,3 100,9
40 88,4 90,3 96,6 103,2 105,3 88,2 89,8 95,3 101,1 102,8
Reference values in mm for fetal biparietal diameter (BPD) for boys and girls for each gestational week for 
the median and 5th, 10th, 90th and 95th centiles. GA = gestational age.
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Figure 3. Headcircumference (HC) in mm for boys and girls from 20-30 weeks of gestation for percentiles 
5, 10, 50, 90 and 95.
Table 4. HC reference values for boys and girls from 12-40weeks.
ga Boys (hC) girls (hC)
C5 C10 C50 C90 C95 C5 C10 C50 C90 C95
12 61,3 63,3 70,3 77,4 79,4 61,9 63,6 69,7 76,1 78,1
13 74,4 76,5 83,8 91,1 93,2 74,3 76,1 82,6 89,5 91,6
14 88,2 90,3 97,8 105,3 107,5 87,3 89,2 96,1 103,3 105,4
15 101,9 104,1 111,6 119,2 121,4 100,6 102,6 109,6 117,0 119,2
16 115,2 117,4 124,9 132,6 134,8 113,6 115,6 122,8 130,4 132,6
17 128,0 130,2 137,8 145,6 147,8 126,3 128,3 135,7 143,3 145,6
18 140,3 142,5 150,3 158,2 160,5 138,5 140,7 148,2 156,0 158,3
19 152,2 154,5 162,6 170,7 173,1 150,1 152,3 160,0 168,0 170,4
20 163,4 165,8 174,3 182,9 185,4 160,7 163,0 171,0 179,2 181,6
21 173,9 176,4 185,5 194,6 197,3 171,1 173,4 181,7 190,2 192,8
22 184,2 187,0 196,8 206,6 209,5 181,5 183,9 192,6 201,5 204,2
23 194,8 197,9 208,5 219,1 222,2 191,9 194,5 203,7 213,2 216,0
24 205,6 208,9 220,3 231,6 234,8 202,3 205,1 215,0 225,2 228,3
25 216,2 219,7 231,7 243,6 247,0 212,5 215,5 226,2 237,3 240,6
26 226,8 230,4 242,8 255,0 258,5 222,5 225,8 237,2 249,1 252,7
27 237,4 241,1 253,6 266,0 269,6 232,7 236,1 248,0 260,5 264,2
28 247,7 251,4 264,0 276,5 280,2 243,0 246,4 258,5 271,1 274,8
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the girls. For HC these differences were even more pronounced (p<0.001; e-figure 3.1, 
e-table 3.14). The prenatal difference of HC of boys at the 95th percentile increases to 
+6.5mm at 35 weeks, but it is already present at twenty weeks’ gestation (+3.8mm, fig-
Table 4. HC reference values for boys and girls from 12-40weeks. (continued)
ga Boys (hC) girls (hC)
C5 C10 C50 C90 C95 C5 C10 C50 C90 C95
29 257,1 260,7 273,4 286,2 290,0 252,7 256,1 268,1 280,6 284,3
30 265,3 269,0 282,0 295,1 299,0 261,6 265,0 277,0 289,5 293,2
31 273,0 276,8 290,0 303,7 307,7 269,6 273,1 285,5 298,3 302,1
32 280,2 284,0 297,6 311,9 316,3 276,5 280,2 293,2 306,7 310,8
33 286,5 290,4 304,4 319,4 324,1 282,6 286,4 300,1 314,4 318,7
34 292,1 296,1 310,3 326,0 331,0 288,0 292,0 306,2 321,1 325,5
35 297,7 301,6 315,9 332,2 337,5 292,6 296,7 311,3 326,5 331,0
36 302,9 306,8 321,2 338,2 343,9 296,6 300,7 315,5 330,9 335,5
37 307,3 311,3 326,1 344,1 350,4 301,0 305,2 320,1 335,8 340,4
38 311,9 316,0 331,1 350,4 357,5 306,5 310,7 325,9 341,7 346,4
39 317,3 321,4 336,7 357,1 365,2 312,8 317,1 332,4 348,5 353,3
40 323,5 327,6 342,9 364,2 373,1 319,4 323,7 339,2 355,4 360,2
Reference values in mm for fetal head-circumference (HC) for boys and girls for each gestational week for 
the median and 5th, 10th, 90th and 95th centiles. GA = gestational age.
Figure 4. Abdominal circumference (AC) in mm for boys and girls from 20-30 weeks of gestation for per-
centiles 5, 10, 50, 90 and 95.
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ure 3, table 4). The neonatal head-circumference confirmed this difference of +6mm as 
being significant between boys and girls (p<0.001; table 1). Generally, prenatal AC mea-
surements were significantly higher in boys than in girls, but less demonstrably across 
the total gestational period than for BPD and HC (figure 4, e-table 3.15). For FL there was 
no significant difference between boys and girls in their antenatal growth percentiles 
(figure 5, e-table 3.16). The EFW was different in boys throughout the gestational age at 
different percentiles compared to girls, except for the 40 weeks measurement (table 5, 
e-table 3.17). Girls reach the 500g EFW one day later (22w3/7) as compared to the boys 
(22w2/7, e-table 3.12). At the 50th percentile at 24 weeks boys are estimated 21gram 
heavier compared to girls (p=0.02, e-table 3.12). 
Figure 5. Femur length (FL) in mm for boys and girls from 20-30 weeks of gestation for percentiles 5, 10, 
50, 90 and 95.
Table 5. EFW reference values for boys and girls from 12-40weeks.
ga Boys (eFW) girls (eFW)
C5 C10 C50 C90 C95 C5 C10 C50 C90 C95
12 50 51 57 63 65 49 50 55 61 63
13 60 62 69 78 81 61 62 69 76 79
14 77 80 89 101 105 79 82 90 101 104
15 104 107 120 136 142 103 106 117 131 136
16 131 136 152 172 179 128 132 147 165 171
17 159 165 185 208 216 159 164 183 206 213
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DisCUssion
In this study we have constructed antenatal growth and estimated fetal weight charts, 
with a strict and clearly defined selection protocol in a normal Caucasian population 
and in boys and girls. Boys have significantly larger late-second and third trimester HC, 
BPD and AC measurements than girls. For FL there are no differences. The implication of 
these findings is that a boy and a girl at exactly 24weeks gestation might, based on the 
current late second trimester dating protocols with head measurements, be assigned 
a gestation as much as 3 days different and a EFW difference of 21gram at 24weeks 
favoring the boys. These antenatal differences were confirmed at birth with boys being 
significant heavier, longer and having larger head-circumferences as compared to girls. 
Table 5. EFW reference values for boys and girls from 12-40weeks. (continued)
ga Boys (eFW) girls (eFW)
C5 C10 C50 C90 C95 C5 C10 C50 C90 C95
18 199 205 230 260 269 198 204 229 257 266
19 248 256 287 324 336 242 250 281 316 328
20 298 308 346 391 406 290 299 337 380 394
21 352 364 410 465 482 342 354 398 450 466
22 414 429 486 552 574 402 416 470 531 551
23 488 506 576 658 685 475 493 557 631 655
24 574 596 681 781 813 561 582 660 750 779
25 671 698 799 917 955 658 684 777 884 919
26 779 810 928 1065 1110 765 795 905 1032 1073
27 901 938 1073 1230 1280 883 918 1046 1193 1241
28 1038 1080 1233 1410 1467 1014 1054 1201 1369 1424
29 1188 1235 1407 1605 1669 1158 1204 1369 1558 1620
30 1348 1400 1593 1814 1886 1314 1366 1550 1761 1831
31 1511 1571 1788 2035 2116 1478 1536 1743 1979 2059
32 1672 1739 1985 2265 2357 1638 1704 1937 2206 2298
33 1825 1902 2182 2504 2610 1788 1863 2128 2437 2544
34 1970 2058 2380 2752 2876 1927 2012 2314 2671 2796
35 2108 2209 2577 3007 3152 2060 2156 2500 2912 3059
36 2244 2358 2775 3267 3434 2193 2301 2689 3163 3336
37 2379 2506 2974 3530 3720 2330 2452 2887 3428 3629
38 2513 2655 3174 3795 4009 2475 2610 3095 3707 3940
39 2647 2802 3373 4060 4299 2626 2774 3310 3999 4265
40 2776 2946 3570 4325 4591 2780 2943 3531 4300 4605
Reference values in g for Estimated Fetal Weight (EFW) for boys and girls for each gestational week for the 
median and 5th, 10th, 90th and 95th centiles. GA = gestational age.
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The one and five minute AS and cord pH were lower in boys. The dating and weight 
estimation differences could potentially play an important part in determining prenatal 
and immediate perinatal viability management in terms of timing the administration 
of maternal steroids for fetal lung maturation, decisions for delivery and possible re-
suscitation. Also in the post-term period management, these gender differences could 
influence decisions including the timing for labor-inductions, affecting an even larger 
population and potentially putting girls at risk of stillbirth by assuming that their gesta-
tional maturity to be less than it is, if second trimester dating of the pregnancy has been 
undertaken.27
In one cross-sectional study a difference has been shown between fetal head mea-
surements for both boys and girls, although the curves were constructed with the older 
linear regression models.28 They also confirmed the birth-weight difference, but did not 
report information on neonatal head circumference or other outcomes (AS, cord pH). 
Another unselected multi-ethnic combined cross-sectional and longitudinal population 
study also found differences in fetal head and abdomen measurements using statistical 
methods current at that time, however no birth outcomes were available29.    
Whilst it has been demonstrated that gestation specific neonatal outcomes are 
worse in boys than in girls,9,10 what had not been previously appreciated in a routine 
population is that boys both have lower Apgar scores at both 1 and 5 minutes and 
lower cord pH values at delivery than girls. These results underline  male vulnerability 
in the perinatal period. In a recent published elegant report on neonatal outcome in 
appropriately grown term babies, gender differences were demonstrated in terms of 
lower Apgar scores at 5 minutes and higher rates of instrumental deliveries for failure 
to progress in labor for boys.30 This concerned a multi-ethnic retrospective cohort from 
one center and birth data for specified for both genders. They demonstrated a birth-
weight difference of 135 g at term, comparing closely with the 121 g that we report), 
but their data lacked other anthropometric data (birth-length and head-circumference) 
and ante-natal growth data. It is of course possible that neonatal outcomes are worse 
because immediate birth outcomes are worse. Whether this is an attribute of being 
male per se, or some effect of fetal size on delivery, cannot be explained from their 
results or ours. We can demonstrate that the gender differences in fetal anthropometry 
starting from 20 weeks onwards affect fetal dating and the estimated fetal weight. In 
our preterm sub-analysis the birth weight differences between boys and girls are also 
present in absolute mean differences (∆ birth-weight 161 g, ∆ birth-length 0.8cm, ∆ HC 
0.6cm), and there are noticeable differences between AS and umbilical cord pH (table 
2), although not statistically significant due to smaller numbers. One hypothesis is that 
either the differences in biometry are relatively more important in the (full grown) male 
fetus interacting with maternal pelvic limitations causing more  labor dystocia for boys, 
and hence lower AS. Alternatively, other fetal gender-specific factors can influence the 
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birth process and compromising the immediate birth outcomes. Gender-specific body 
composition at birth has been reported, where the male infant has more fat mass and 
lean body mass than the female infant, especially in well-nourished mothers.31 This phe-
nomenon has been associated with gender different intra-uterine physical adaptations 
to an enhanced nutrient supply from the mother. The male infant body composition has 
been more subject to maternal influences as higher pre-gestational BMI and excessive 
gestational weight gain.32 Lastly, the lung maturation of the male fetus proceeds slower 
than in the female fetus, possibly contributing to a higher rate of low AS in the term 
grown fetus. In animal studies lung fluid secretion is inhibited and the lung fluid absorp-
tion initiated by adrenalin infusions at birth.33 And preterm asphyxiated male infants 
have lower adrenaline levels than female infants, again putting the boys at higher risk.34 
Whether in the term infant this will be similar, is unknown.
strength and weakness
Our antenatal growth curves are unique in that all four fetal growth parameters (BPD, 
HC, AC and FL) were measured in standardized circumstances in accordance with inter-
national guidelines.26 Longitudinal growth charts were constructed for each parameter, 
with the WHO advocated GAMLSS method used.22,23 GAMLSS can combine longitudinal 
data with a cross-sectional component and can construct centiles in a way that they 
are constrained and do not cross. Further, in using the GAMLSS analysis statistics, we 
could by synchronizing the statistical methods of the WHO, align the biometry measure-
ments with the neonatal and pediatric charts.22,23 With the available neonatal data, we 
could discriminate different growth curves for boys and girls for all four fetal growth 
parameters and hence the EFW. Since the introduction of ultrasound in antenatal care, 
many reports on fetal growth curves have been published.11-21 To recognize pathological 
fetal growth depends on reliable, standardized growth curves.35 Discrepancies between 
curves have often been attributed to differences in methodology and population selec-
tion.36 A recent report reviewed fetal growth charts, demonstrating the wide variations 
of methodologies on how these charts have been constructed concluding that there 
were many grounds for bias in the growth curves that are currently used.37 Particularly 
in ‘inclusion/exclusion criteria’, ‘ultrasound quality control measures’ and ‘gestational 
dating protocols’, many ambiguities existed. Standardization of the methodologies with 
a check-list was recommended to define a high quality study.37 When we compare our 
growth charts to the requirements, these would be compliant for the combination of 
a high quality control score, longitudinal design, sample size and the fact that all four 
parameters (BPD, HC, AC and FL) were examined (e-table 3.2). All growth measurements 
were reviewed by certified staff members, judging all scanned images as to whether 
they adhered to the protocol described. We also incorporated a strict protocol on 
pregnancy dating. Only pregnancies that had a first trimester confirmation scan on 
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gestational age were included: Crown Rump Length (CRL) measurement between 3 and 
83mm (gestational age ≥5+0 and <14+0 weeks).4,25 In Belgium in routine obstetrical care 
every pregnant woman will be offered a first, second and third trimester ultrasound 
scan with fetal growth measurements. In many countries the third trimester scan is not 
part of routine care for low-risk pregnancies.38 Also, to measure the four fetal growth 
parameters in the first trimester is not routine care and allowed us to define ‘fetal growth’ 
through serial measurements, instead of ‘fetal size’, as defined through cross-sectional 
measurements.12-19,39 Furthermore we were able to eliminate aberrant fetal growth and 
extreme maternal influences by excluding fetal anomalies (level 1 and 2 indications) and 
including only mothers enrolled to a routine obstetric care scheme.40 Finally a popula-
tion based cohort was generated with a significant sample size over a period of eleven 
years. The description of a routine population could also be supported by our neonatal 
data. Neonatal data was complete for 76% in our cohort. The rate of premature birth 
was 6%, which is consistent with European nationally accepted norms. In our population 
selection we further customized the charts for one maternal and one fetal factor. We 
selected on ethnicity ‘Caucasian’ and the fetal gender. Other ethnicity derived custom-
ized growth curves have arisen in response to the early reference charts from mainly 
Europe and the United States.18,19 Ethnicity seem to have a discriminative influence on 
fetal growth.24,41 Girls and boys both have different neonatal growth curves, assuming 
there is a discriminative effect of the gender on their growth trajectories. In more than 
three quarters of our cohort complete neonatal data was registered, including gender 
registration. Therefore we focused on developing two separate fetal growth charts: both 
for boys and girls. Fetal gender, unlike maternal ethnicity, is not commonly known in the 
first trimester but it is from the 20 weeks’ scan onwards (‘anomaly’ scan). From a clinical 
point of view it seemed therefore relevant to start discriminating these curves from 20 
weeks’ gestation onwards. 
Some limitations on constructing these charts have to be addressed. The study was 
performed in a University teaching Hospital, a large tertiary referral center, not necessar-
ily reflecting a routine setting. This center, on the other hand, also has a regional remit 
for routine obstetric care for low-risk pregnancies. Some maternal characteristics were 
not excluded in the selected cohort, deliberately to prevent ‘super-normalization’ of 
the cohort: smoking (occurred in 7%) and artificial conception was excluded for intra-
cytoplasmatic-sperm-injection, since this is a level-1 indication. Finally, it is expected 
that within this large time-period some women with subsequent pregnancies were 
included more than once for this cohort.
implications for clinical practice 
Our fetal growth curves for the Caucasian population resemble predictive growth 
curves with the gender specified which can discern aberrant from normal fetal growth. 
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The longitudinal aspect and large cohort, covering the full trimesters have not been 
reported before in the Caucasian population. The neonatal data gave us the opportunity 
to customize for the fetal gender. There was a marked difference between fetal boys and 
girls in their growth trajectory for fetal head measurements and to a lesser extent the 
abdominal circumferences. Also for the estimated fetal weight there was a difference. 
This gender differentiation is important in ante-natal and perinatal care. Prenatal ultra-
sound is used not only to define fetal growth, but also gestational age. Both growth and 
fetal age are important in defining the time-point of fetal viability and the optimization 
of the timing of obstetrical interventions: e.g. medical elective birth or administration of 
corticosteroids for fetal lung-maturation in cases of threatened premature birth. Second 
trimester dating depends on fetal growth parameters and particular on the fetal head 
measurement. Our results suggest a gender specific approach in counseling future 
parents on important issues when fetal viability starts and when is the best time point 
to start obstetrical interventions. 
The gender differences are further demonstrated by the immediate birth outcomes 
for males: different anthropometry (heavier, longer and bigger heads) and lower AS and 
lower cord pH. The significant lower AS and umbilical cord pH in boys underline the 
fetal male vulnerability, although in the asphyxia group (pH<7.10) there was no pre-
dominance by males, stating that boys do not have a higher risk of acidemia at birth in 
a routine population. Therefore the clinical importance of the pH findings (and perhaps 
also the AS) in our study can perhaps be considered as not clinically relevant.
In summary, we present fetal growth curves with the latest statistical tools in a large, 
routine pregnant population with state of the art ultrasound technology. The data cov-
ers the pregnancy period from 12 weeks onwards and there were differences between 
boys and girls for the fetal head, fetal abdomen measurements and the estimated fetal 
weight. Also the immediate neonatal outcome demonstrated gender differences favor-
ing the girls. This could give caretakers the opportunity to take into account a gender 
tailored approach in life-decision care both at the margins of viability and post-term. 
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aBsTraCT
objective
Excessive weight gain during pregnancy has an important influence on fetal growth and 
on weight development in future generations.
Design and methods
A prospective cohort study of 325 obese and nonobese Caucasian women with naturally 
conceived, singleton pregnancies. They were followed up until delivery for maternal 
weight gain and for fetal growth with ultrasound-based weight estimations and final 
birth weight. Using cluster analysis distinct profiles of maternal weight gain during 
pregnancy were obtained. Longitudinal regression analysis was performed to investi-
gate the relationship of the maternal weight gain profile and body mass index (BMI) on 
fetal growth and final birth weight. 
results 
Cluster analysis revealed four discernable maternal weight gain profiles: twelve cases 
(3.7%) ended up at their starting weight or decreased in weight (cluster 1), 16 cases 
(4.9%) who slightly increased in weight (maximum 4 kg) as compared to their initial 
weight (cluster 2), 114 cases (35.1%) who gained between 4 and 12 kg in weight (cluster 
3) and 183 cases (56.3%) who showed the largest weight gain: more than 12 kg (cluster 
4).
There were statistically significant differences in fetal growth associated with weight 
gain cluster, which became apparent late in the second trimester and increased toward 
the end of pregnancy. Maternal BMI and maternal weight gain profile were independent 
predictors of fetal growth and birth weight.
Conclusions
Therefore, the conclusion is that cluster analysis permits to discern four gestational 
weight gain (GWG) patterns in obese and nonobese subjects and that both maternal 
BMI and maternal weight gain pattern during pregnancy positively influence fetal 
growth and birth weight. 
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inTroDUCTion
Maternal weight gain shows a wide variation, even in a low-risk homogeneous Cauca-
sian population with normal pregnancy outcome (1). Despite this, the importance of 
adequate gestational weight gain (GWG) is well documented (2,3). 
Excessive weight gain, based on the 2009 IOM guidelines, has an incidence of up to 50% 
in pregnancy and currently represents an important problem in Western populations 
(4-7). It is associated with gestational diabetes mellitus (GDM), an abnormal increase 
in fetal growth, neonatal macrosomia, emergency caesarean section and postpartum 
weight retention (8). This in turn feeds into the pandemic of obese pregnant mothers 
with its resultant deleterious influence on future generations through the effect of fetal 
programming (9-14). 
Besides GWG, preconception body mass index (BMI) also affects fetal growth and 
pregnancy outcome: an abnormally high or low maternal BMI prior to gestation has 
been shown to influence fetal growth in the second and third trimester of pregnancy 
and is associated with a variety of adverse outcomes (15-17). However, maternal BMI 
does not seem to significantly affect growth in embryonic crown rump length (CRL) 
during the first trimester (18).  
BMI groups are defined by the World Health Organization (WHO): BMI ≤ 18.5 kg/m2 
underweight; BMI ranging from 18.5-24.9 kg/m2 normal weight; BMI ranging from 25.0-
29.9 kg/m2 overweight and ≥ 30.0 kg/m2 obese. In recognition of the dual influence on 
fetal growth, current guidelines refer to an appropriate GWG range that is best adhered 
to for each of the BMI groups, with the lowest gain being advised in the obese group 
(7,19).
This is based on epidemiologic data looking at a total maternal weight gain and its 
relationship to healthy pregnancy outcome (8). Few studies, however, have looked 
longitudinally at maternal weight during pregnancy (20-23). Women’s individual weight 
gain pattern, influenced by nutrition and life-style during pregnancy, can be expected 
to have a greater impact on embryonic or fetal growth than preconception BMI (24,25). 
Because maternal weight gain pattern is being monitored at sparse set of time points, 
cluster analysis is particularly useful by using a discriminant function to determine the 
greatest separation between the clusters (26).  
The aim of this study was to investigate whether the maternal weight gain profile in 
pregnancy and preconception BMI independently influence fetal growth. 
62 Chapter 4
Design anD meThoDs
This prospective study was performed at the Department of Obstetrics and Gynecology 
of the University Hospitals Leuven (Belgium), with approval of the Ethics Committee for 
Human Experimentation of the Faculty of Medicine, Katholieke Universiteit Leuven. All 
women signed informed written consent to take part in the study.
Between April 2007 and April 2008, the nutritional intake and GWG in 605 pregnancies 
were prospectively recorded by a single clinician (IG). From this cohort there was a well 
documented subgroup of 373 healthy Caucasian women, who underwent ultrasound 
examinations to measure fetal size in the University Hospital Leuven and delivered in this 
centre. They were recruited before 15 weeks gestation at the time of their first antenatal 
clinic visit and pregestational BMI was documented at this time. All the pregnancies 
were conceived naturally and showed normal evolution at the time of inclusion. 
The endpoint of the pregnancies was the date of delivery, which ranged from 177 to 
291 days gestation, on which the last maternal weight and the actual neonatal weight 
was measured. Exclusion criteria were: inadequate knowledge of the Dutch language, 
multiple pregnancies and underlying or development of significant maternal or fetal 
pathology. The incidence of premature delivery was 21/325 (6,4%), in accordance to 
earlier studies in the general obstetrical population (27).
From the 373 pregnancies initially recruited, 48 pregnancies were excluded because 
of missing complete longitudinal data from either weight measurements of the mother 
or from estimated weight measurements of the fetus. This was because of either drop 
 
Eligible patients
N = 373
Underweight
N = 27
Included for  
analysis
N = 24
Missing data
N = 3
Normal weight
N = 83
Included for 
analysis
N = 71
Missing data
N = 12
Overweight
N = 111
Included for 
analysis
N = 92
Missing data
N = 19
Obese
N = 152
Included for 
analysis
N = 138
Missing data
N = 14
Figure 1. Inclusion flowchart based on preconception BMI groups. Missing longitudinal data 5maternal 
weight measurements or fetal biometry measurements) were excluded. 
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outs (lost to follow-up or migration) or miscarriage, termination of pregnancy, fetal 
death and twins, leaving a total of 325 viable, singleton pregnancies included in the 
final analysis (Figure 1).  
All women underwent  first trimester sonographic  estimation of gestational age  (GA) 
based on crown rump length (CRL) obtained between 7 and 14 weeks of gestation. 
Maternal weight measurements were performed using a calibrated balance (Seca 
Alpha Model 770, Teleflex medical, Belgium), accurate to 0.1 kg in a standardized way 
(without shoes, with indoor clothing). Height was measured with a microtoise to the 
nearest 0.5 cm, all as described earlier in Guelinckx et al (1).  Preconception BMI was cal-
culated using height measurement at the first visit and the self-reported weight prior to 
conception (kg/m2) (1,7). The total GWG was computed using the final weight measured 
on the day of delivery minus the self-reported weight prior to conception. 
Each subject followed routine antenatal care including a minimum of three ultra-
sound examinations (first, second and third trimester) and additional examinations if 
necessary. All scans were performed by experienced ultrasonographers on a high-end 
ultrasound machine (Voluson 730-E or Voluson E-8, General Electric, USA) and they 
measured the bilateral parietal diameter (BPD), the abdominal circumference (AC) and 
the femur length (FL). The estimated fetal weight (EFW) was calculated using Hadlock IV 
curves [log(10) EFW = 1.335 - 0.0034(AC)(FL) + 0.0316(BPD) + 0.0457(AC) + 0.1623(FL)] 
(28). These curves are the same for both male and female fetuses. 
Birth weight was measured one hour after delivery according to the recommenda-
tions of the WHO’s rules on the Baby Friendly Hospital Initiative. The birth weight was 
measured on a standard calibrated neonatal scale (Seca, model 376, 0.1-7.5kg, Teleflex 
medical, Belgium). 
statistical analysis
Firstly, a cluster analysis was performed on the weight gain patterns of all women (Figure 
2) (26). Subsequently the measurements were retrospectively assigned to four different 
clustered groups based on their GWG. Next, the maternal weight gain cluster assignment 
was used as an explanatory variable in a mixed effects longitudinal regression model to 
assess the evolution of the EFW (Hadlock IV curves) over time (29). In this analysis, the 
actual birth weight of the neonate was added to the fetal weight estimates as an extra 
observation per case (Figure 3). Other explanatory variables in the analysis were BMI (in 
kg/m2), (G)DM (yes/no), GA (in days), parity (0-5), maternal age (in years), vitamin use 
(yes/no) and complications (yes/no). This model was further reduced by tests for the 
presence of random effects (GA, GA2 and GA3) and their structure and for the main and 
interaction effects of the explanatory variables. However maternal weight gain profile 
and BMI were forced in the model. Finally, F-tests were performed for comparing the 
evolution of the EFW over time for each pair of weight gain profile with correction for 
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Figure 2. Maternal weight gain profile during gestational age (GA) reduced to four clusters. 
Figure 3. Evolution of estimated fetal weight (EFW) during pregnancy according to gestational weight gain 
(GWG) cluster. Birth weight measurements are presented by red dots. 
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multiple testing being applied using the approach by Hochberg (30). Statistical analyses 
were performed using SAS 9.2 (SAS Institute Inc., Cary, NC, USA) and Matlab 7.4 (The 
MathWorks Inc., Natick, Massachusetts, USA).
resUlTs
study population:
A total of 325 out of 373 prospectively included pregnant women from different precon-
ception BMI subgroups were included in the final analysis: 24 (7.4%) were underweight, 
71 (21.8%) showed normal weight, 92 (28.3%) were overweight and 138 (42.5%) were 
obese (Figure 1). Baseline characteristics of the study population are summarized in 
Table 1.
Cluster analysis:
Individual patients were divided into eight different groups according to their GWG. 
These were reduced to four clusters, as described above, by assigning the lowest GWG 
group as cluster 1, the second group as cluster 2, the following three groups taken 
together as cluster 3 and the subsequent three groups as cluster 4 (Figure 2). There-
fore four different clusters with specific GWG patterns remained: 12 cases (3.7%) that 
ended up at their starting weight or decreased in weight (cluster 1), 16 cases (4.9%), 
that slightly increased in weight (maximum 4 kg) as compared to their initial weight, 
114 cases (35.1%) that gained between 4 and 12 kg in weight (cluster 3) and 183 cases 
(56.3%) that showed the most weight gain, with more than 12 kg (cluster 4). In general 
the weight of women in cluster 1 decreased during the first trimester of pregnancy while 
for example the gestational weight for women in cluster 4 showed the largest increase. 
Table 2 shows the characteristics per cluster.
Table 1. Subjects baseline characteristics after exclusion
BMI category (kg/m²) a
Underweight
< 18.5
N = 24 (7.4%)
normal weight
18.5 – 24.9
N = 71 (21.8%)
overweight
25.0 – 29.9
N =92 (28.3%)
obese
≥ 30.0
N =138 (42.5%)
nulliparous (%) 8 (33.3) 48 (67.6) 48 (52.2) 47 (34.1)
mean age in years (range) 29.38 (21-35) 29.76 (19-41) 28.74 (17-41) 28.90 (20-41)
smoking at inclusion (%) 1 (4.2) 4 (5.6) 4 (4.3) 20 (14.5)
Bariatric surgery (%) 0 (0) 0 (0) 3 (3.3) 2 (1.4)
(N = 325). body mass index (BMI) group (WHO criteria).
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effect of Bmi and Clusters on eFW and birth weight:
The longitudinal regression model showed that the weight gain profile has a statistically 
positive significant effect on fetal growth (p-value < 0.0001) (Figure 3). The following 
p-values were obtained for the pair-wise comparisons: 0.6234 (cluster 1 versus cluster 
Table 2. Subjects (n=325) characteristics per cluster group.
Cluster i Cluster ii Clusters iii Cluster iV 
 
N =12 N =16 N =114 N =183 
age in years a 28.33 (2.35) 26.63 (5.51) 29.37 (3.62) 29.28 (4.28)
ga at birth in days b 273 
(267, 275)
270 
(266, 278)
273 
(267, 280)
274 
(269, 280)
Birth weight in gram c 3265 
(3060, 3565)
3070 
(2923, 3434)
3380 
(3080, 3610)
3550 
(3159, 3818)
Preconception Bmi in kg/m² d 41.27 
(36.82, 45.06)
33.68 
(31.90, 36)
30.17 
(25.31, 33.43)
27.16 
(21.47, 30.61)
a  mean (standard deviation); b Gestational age (GA) at birth: median (first- and third quartile; Q1and Q3); 
c Birth-weight: median (Q1, Q3); d Preconception body mass index (BMI): median (Q1, Q3).
Figure 4. Mean (CI) estimated fetal weight (EFW) at 280 days (term) for the different gestational weight gain 
(GWG) clusters divided per BMI category (under-, normal-, over-weight and obese). 
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2), 0.0895 (cluster 1 versus cluster 3), 0.0007 (cluster 1 versus cluster 4), 0.0022 (cluster 
2 versus cluster 3), 0.0004 (cluster 2 versus cluster 4) and < 0.0001 (cluster 3 versus clus-
ter 4). Based on the multiple comparison method of Hochberg, we found statistically 
significant differences between the clusters’ EFW growth curves, except for fetal growth 
in cluster 1 versus clusters 2 and 3. The relatively large p-value for comparing cluster 1 
and cluster 2 is likely to be due to the relatively small number of observations in these 
clusters. 
The model also shows that pre-conception BMI had an effect on EFW and birth weight, 
with a larger BMI resulting in a correspondingly larger EFW (p-value < 0.0001).
We subsequently compared BMI prior to conception with the different weight gain 
clusters to define their relative influence on birth weight at 280 days. Figure 4 and Table 
3 show the estimated weight gain at 280 days with 95% confidence intervals for the 
four maternal weight gain profiles at BMI levels of 17, 22, 28 and 35 (under-, normal-, 
overweight and obese). 
DisCUssion
This article describes the first cluster analysis of GWG and demonstrates the positive 
influence of increased GWG on fetal growth and birth weight in a predominantly obese 
sample of pregnant women.
During recent decades the prevalence of obesity (>30kg/m2) prior to conception has 
increased to as high as 25% in some developed countries (5,6). Both obesity and exces-
sive GWG increase the risk for pregnancy-related maternal and fetal complications, like 
GDM, hypertension, pre-eclampsia, emergency caesarean section, macrosomia, intra 
uterine growth restriction (IUGR) and fetal demise (10,12,15,17). Additionally excessive 
GWG results in maternal weight retention after pregnancy with increasing risk for obe-
sity and consequently induces a transgenerational effect influencing the metabolic and 
vascular traits in the offspring (8,14). Therefore, it seems essential to focus on maternal 
weight gain during pregnancy as an important modifiable factor to decrease these 
risks (30). In 2009 the Institute Of Medicine (IOM) produced recommendations for total 
weight gain in pregnancy for each BMI category: 12.5-18 kg (underweight women), 
Table 3. Difference of fetal weight in gram at 280 days for different clusters and BMI’s.
Cluster I Cluster II Cluster III Cluster IV BMI 17 BMI 22 BMI 28 BMI 35
Cluster IV BMI 35
Cluster III +173 BMI 28 +130
Cluster II +142 +315 BMI 22 +111 +241
Cluster I +162 +304 +477 BMI 17 +93 +204 +334
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11.5-16 kg (normal weight women), 7.0-11.5 kg (overweight women) and 5.0-9.0 kg 
(obese women) (7). The aim of these recommendations is to avoid the additional burden 
of total excessive GWG, especially in the obese. Previous studies used the preconcep-
tion BMI class and total GWG to examine their influence on pregnancy and pregnancy 
outcome, showing that particularly the pre-conception obese group and the excessive 
total GWG group have an increased risk for fetal overgrowth or macrosomia and early or 
late onset overweight in the offspring (32-35). 
As fetal growth is not linear, but accelerates at mid trimester, it can be hypothesized 
that besides total GWG and preconception BMI, the pattern of weight gain during preg-
nancy also influences fetal growth (1,22-24,28). If so, this could lead to an instrument 
in pregnancy that is easy to monitor and is easier to influence than preconception BMI. 
Additionally, such a methodology could also be of importance for the non-obese group, 
as both normal weight and overweight women can gain significant weight during preg-
nancy and hereby increase the risks to both themselves and their fetus (1,4,6). 
The strengths of the current study are its prospective design and the fact that detailed 
information from a single center on clinical parameters and ultrasound data were avail-
able for analysis in a large cohort of pregnancies including a significant number of well 
categorized obese patients (n=138, 42.5%). It furthermore represents the first study in 
which the pattern of GWG is taken into account by clustering rather than merely the 
resultant total GWG. This knowledge could add important information on understand-
ing normal and abnormal weight gain, especially in the overweight and obese. 
Our results show that patients, who start to gain weight in the first trimester and 
continue doing so during the entire pregnancy, show the largest positive effect on fetal 
(over-)growth (Figure 3). Around 180-200 days gestation (26-28 weeks), the clusters 
start to separate from each other in relation to their effect on EFW. These findings were 
independent of the BMI groups found in these clusters.
When comparing the different BMI groups within each cluster by taking representa-
tives from each group (BMI 17, 22, 28 and 35), we found that preconception BMI remains 
an important determinant of fetal growth and birth weight. Therefore, it seems that 
besides the preconception BMI to select high-risk pregnancies, it is equally important to 
discuss the trajectory of the GWG. Because normal BMI, but excessive maternal weight 
gain and matching higher cluster will lead to fetal overgrowth and consequently have 
an effect on future generations through fetal programming by increasing the risk of 
child obesity. Two different tools to achieve a reduction of this phenomenon is to discuss 
the risks of overweight and obesity in the preconception period and to acquire custom-
ized maternal weight gain curves (Figure 2). The latter can be adjusted if an abnormal 
pattern is observed. 
Ideally, this information could be useful in clinical management and urge the clinician 
to intervene when rapid first trimester weight gain is detected in this high-risk subset. 
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Naturally, pregnancy poses a specific problem as any treatment (surgical or pharmaco-
logical) might have an adverse effect on the fetus and is therefore ethically and medi-
cally not feasible. Much effort has been taken to study the effect on gestational weight 
gain by interventional programs such as diet and/or physical activity advice. They are 
sometimes hard to compare, because of their heterogeneity. The American College of 
Obstetrics and Gynecology (ACOG) guidelines recommend at least 30 minutes activity 
per day for five days per week (36). A recent meta-analysis on interventions appears 
to favor the diet-based advice on physical activity for the effect on maternal weight 
gain and obstetric outcome (37). New techniques to promote lifestyle alterations by 
motivational interviewing are currently under investigation for the obese and high-risk 
subset pregnancies.
Some limitations of our study also need to be discussed. Our cohort was part of a 
larger study group in which nutritional intake was monitored during pregnancy. Pa-
tients included could therefore be more aware of the problem of excessive GWG. This 
knowledge could potentially have influenced GWG in this group. Also, weight prior to 
conception used to calculate BMI was self-reported, which is difficult to avoid as recruit-
ment took place when women were already pregnant. But self-reported weight has 
been studied in the context of pregnancy and does not lead to significant bias (38,39). 
Further studies on more heterogeneous groups will give more insight into the effect of 
GWG using clustering on fetal growth and birth weight. Also, it would be of interest to 
examine the effect on subsequent pregnancies of GWG control in the obese mothers.
We have shown using cluster analysis that GWG in pregnancy has an effect on fetal 
growth and actual birth weight partly irrespective of the women’s preconception BMI. 
This effect has most impact from 180-200 days gestation when there is a separation 
between the different GWG clusters. By identifying this relationship between GWG, 
growth and birth weight we may now have the time potential to influence weight gain 
and so prevent both perinatal complications and possibly improve outcomes in future 
pregnancies and the metabolic and vascular traits in the offspring.
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aBsTraCT 
introduction
Neonatal adiposity is associated with high maternal pre-gestational body mass index 
(BMI), high gestational weight gain (GWG) and an abnormal maternal glucose me-
tabolism. In this prospective cohort study we aimed to detect early fetal predictors of 
neonatal adiposity in normoglycemic mothers.
methods
One hundred sixty-two women from different BMI classes were recruited during the 
first trimester of pregnancy and prospectively followed-up for maternal weight gain, 
fetal biometry and anthropometry. Exclusion criteria included: pre-existing diabetes 
mellitus (DM), development of gestational DM (GDM), premature delivery and missing 
birth outcome. Excessive GWG (e-GWG) was defined according to the revised criteria of 
the Institute of Medicine. Fetal anthropometry was assessed ultrasonographically for 
liver-length (LL), subscapular- and abdominal fat thickness (SFT and AFT) and lean- and 
fat mass calculations from the mid-portion of the fetal humerus and femur. Generalized 
Additive Model Location, Scale and Shape (GAMLSS) was used to align the timeframes 
of measurements.
results
One hundred twenty-six pregnancies in normoglycemic women were included in the 
final analysis: 63/126 (50%) normal weight, 19/126 (15%) overweight and 44/126 (35%) 
obese. Sixty-one women (48%) showed an e-GWG. In the obese group the fetal LL and 
AFT growth trajectory increased significantly more than in the normal weight group 
(p= 0.01 and p= 0.03). E-GWG positively correlated with the growth in fetal abdominal 
circumference (p= 0.03), LL (p= 0.002), SFT (p= 0.01) and AFT (p= 0.006) when compared 
with the non-excessive GWG (ne-GWG) group. Neonatal weight, length and head cir-
cumference were significantly greater in the e-GWG group as compared to the ne-GWG.
Conclusion
Obesity and e-GWG both positively correlate to adiposity during fetal and neonatal life, 
with e-GWG clearly affecting fetal size in general as confirmed by birth anthropometry. 
In this normoglycemic population  fetal trunk measures (LL, SFT, AFT and AC) are poten-
tially useful in the prediction of neonatal adiposity.
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inTroDUCTion
It has been demonstrated that environmental factors influence health and the devel-
opment of diseases. Certainly the in utero and early neonatal life periods may induce 
responses, that lead to a higher susceptibility to develop diseases that occur in adult 
life. This is known as ‘fetal programming’.1,2 Abnormal environmental factors may lead to 
fetal overgrowth due to increased transplacental nutrients or to fetal growth restriction 
due to decreased transplacental transfer. Both effects can be transgenerational and are 
probably due to an epigenetic transmission mediated by the mother.3,4 There is growing 
insight on the influence of maternal BMI, excessive Gestational Weight Gain (e-GWG) 
and abnormal glucose tolerance on fetal nourishment and development.5 It has been 
demonstrated that maternal obesity is associated with fetal overgrowth and subsequent 
perinatal complications, such as  fetal death, shoulder dystocia, operative delivery  and 
neonatal metabolic complications.6 Excessive maternal weight gain occurs in up to 
50% of pregnancies and is on its turn associated with abnormal fetal growth, obstetric 
complications and post-partum weight retention.7,8 Neonatal (‘birth’) data are available, 
but studies on fetal body composition and development in obesity, inappropriate GWG 
and (G)DM during pregnancy are scarce. Anthropometric ultrasound measurements, in-
dicative of fetal body composition of normal fetuses, have shown a unique exponential 
pattern of the growth profile during the second half of gestation, both in lean mass and 
in fat mass.9 This suggests that the measurement of fetal fat could provide a more sensi-
tive and specific marker of abnormal fetal growth (‘fetal adiposity’).10 In this prospective 
cohort study we aimed to detect early signs of fetal adiposity in normoglycemic mothers 
and study the relationships of maternal BMI and gestational weight gain category with 
fetal/neonatal anthropometric parameters.
Design anD meThoDology
This prospective cohort study was performed at the Department of Obstetrics and 
Gynecology of the University Hospitals Leuven (Belgium). Pregnant women of different 
pre-gestational BMI classes were included at their first trimester ante-natal visit between 
January 2012 and August 2014. This sub-study was part of three prospective studies for 
low-risk, obese and non-obese pregnancies monitored for GWG, development of GDM 
and nutrition.11 All studies were approved by the Ethics Committee for Human Experi-
mentation of the Faculty of Medicine, Katholieke Universiteit Leuven (S52172, S54026 
and S55325). All women have signed written informed consent to take part in the study. 
Exclusion criteria were: pre-existing diabetes (DM) or development of GDM, multiple 
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pregnancies, premature delivery (<34 weeks), missing longitudinal data and adverse 
events (major fetal abnormality, fetal death and/or immature birth).
maternal measurements
Pre-pregnancy weight was self-reported and if not available, patients were weighed at 
the first ante-natal visit in the first trimester on a standard weighing scale (SECA Alpha 
model 888 or 877, Teleflex, Belgium) with light, indoor clothes to the nearest 0.1kg. The 
height was measured at the first ante-natal visit with a microtoise to the nearest 0.5cm 
(SECA model 206, Leicester Height Measure, Burmingham, UK) without shoes. Height 
and weight was used to calculate the BMI (kg/m²). The BMI was categorized as normal 
weight (≤24.9 kg/m2), overweight (25-29.9 kg/m2) and obese (>30kg/m2) as defined 
by the WHO guidelines. The total GWG was computed using the final weight measured 
at the last prenatal visit, minus the pre-gestational weight. GWG gain was categorized 
according to the Institute of Medicine (IOM) 2009 revised recommendations: 11.5-16kg 
(normal weight), 7.0-11.5kg (overweight) and 5.0-9.0kg (obese).8 If women crossed the 
upper IOM threshold, they were categorized in the excessive-GWG (e-GWG) group. If 
they had either adequate or insufficient total GWG they were categorized in the non-
excessive GWG group (ne-GWG). If women were considered high risk (history of GDM, 
BMI≥30kg/m²), a fasting glucose measurement <92mg/dL (<5.1mmol/L) at baseline 
was used to exclude pre-existing DM. Another screening was performed at 24-28 weeks 
using a 75g oral glucose tolerance test (OGTT) based on the 2013 World Health Orga-
nization (WHO) criteria.12 The non-obese population underwent an OGTT if the initial 
50g glucose challenge test showed a glycemia ≥140mg/dL (≥7.8mmol/L) at 24-28weeks 
(local protocol).
Fetal measurements
Determination of gestational age (GA) was based on a crown rump length (CRL) mea-
sured between 7 and 14 weeks of gestation in all patients.13 Ultrasound examinations 
were performed at three time-points in gestation: 12-18 weeks, 26-32 weeks and 
between 35-37 weeks of gestation. A proportion (51 participants) was also examined 
between 20-22 weeks of gestation. Fetal measurements included: Head Circumference 
(HC), Abdominal Circumference (AC) and Femur Length (FL). The measurements were 
obtained in accordance to the guidelines of the International Society for Ultrasound in 
Obstetrics and Gynecology (ISUOG, www.isuog.org).14 Additional measurements of fetal 
body composition were obtained, as described earlier.9-11,15-17 At 12-16 weeks the fetal 
liver length (LL) was measured and at all the subsequent visits also the subscapular fat 
thickness (SFT), abdominal fat thickness (AFT) and the lean- and fat mass at the mid-
portion of the humerus and femur were measured (figure 1). All measurements were 
performed by a single operator (SG) on a high resolution real-time B-mode ultrasound 
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system (E6, E8 or 730-Expert Voluson®, General Electric healthcare Medical systems, 
Kretztechnik, Zipf, Austria) with a convex, high frequency, 4-8 MHz volumetric 3D 
abdominal probe. Neonatal measurements (birth weight -BW-, birth length –BL- and 
head-circumference -BHC-) were obtained within 2 hours after birth. The ponderal index 
(PI) was calculated by the weight divided by the cubic root of the length (birthweight/
length³) and can be regarded as a neonatal proportionality index in line with the adult 
BMI.18 The PI was calculated for all BMI and GWG groups. 
statistical analysis
GAMLSS (Generalized Additive Models for Location, Scale and Shape, www.gamlss.org) 
R-package was applied to construct the growth curves for conventional fetal biometry 
measurements: HC, AC and FL.19,20 We assessed several distributions: Box-Cox-t, Box-
Cox Cole and Green, and Box-Cox Power Exponential. Goodness-of-fit of the models 
was assessed with QQ plots, AIC (Akaike Information Criterium) and worm plots. The 
goodness-of-fit was investigated covering the gestational period of 12-40 weeks, and 
for substrata of this period. GAMLSS smoothened the ante-natal growth curves for 
each prenatal measurement. Percentiles (P10, P50 and P90) for each parameter were 
constructed. Only complete fetal data-sets were analyzed. The effect of BMI category 
(normal weight, overweight and obese) and the effect of e-GWG versus ne-GWG were 
Figure 1. Figure 1. Fetal body composition (ultrasound images) at 33weeks gestation. A. Abdominal Fat 
Tissue (AFT); B. Humerus lean- (2) and fat mass ([1-2]) in mm²; C. Subscapular Fat Thickness (SFT); D. Femur 
lean- (2) and fat mass ([1-2]) in mm².
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added to the GAMLSS model. All prenatal and birth data were corrected for gestational 
age and birth measurements (BW, BL, BHC and PI) were correlated to the fetal param-
eters in the GAMLSS model.
resUlTs
From the 162 recruited pregnant women, 22 were excluded based on an abnormal fast-
ing glucose measurement (GDM or pre-existent DM) at baseline or on the development 
of GDM at the 24-28 weeks screening. Seventy-seven percent (17/22) of these were 
obese. Another 14 pregnancies were excluded for various reasons: one early second 
trimester miscarriage, 3 premature births, 4 drop-outs and 6 missing longitudinal data 
(figure 2, flowchart). Therefore, 126 normoglycemic women with pregnancies resulting 
 
162 pregnancies 
recruited 
126 pregnancies 
63 normal weight 
(BMI <24.9kg/m²) 
19 overweight 
(BMI 25.0-29.9kg/m²) 
44 obese 
(BMI ≥30.0kg/m²) 
Exclusion:  
- (G)DM (22) 
- Pre-term delivery (3) 
- Late miscarriage (1)  
- Missing longitudinal 
data (6) 
- Drop-out (4) 
 
Figure 2. Flowchart of study population. (G)DM= Gestational Diabetes Mellitus; BMI= (pre-gestational) 
Body Mass Index.
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in a >34 weeks live birth were included in the final analysis. Of these 63/126 (50%) had 
a normal pre-pregnancy BMI, 19/126 (15%) were overweight and 44/126 (35%) obese. 
Sixty-one women (48%) had an e-GWG, according to the 2009-IOM revised criteria. The 
maternal, fetal and neonatal demographics for the total group are outlined in table 1.
Standard fetal biometry (HC, AC and FL) was measured in all three trimesters (e-figure 
5.1a,b-5.2a). There was no difference in the evolution in these standard fetal biometry 
measurements throughout gestation between the overweight or obese versus the 
normal BMI group (table 2). There was a significant positive correlation (p= 0.03) be-
tween the e-GWG for fetal AC evolution as compared with the ne-GWG group (table 
2; figure 3). The fetal liver-length (LL) and fetal body composition measurements are 
described throughout pregnancy from early in pregnancy and second half to late third 
trimester respectively (e-figure 5.2b-5.7a,b). The increase in fetal liver size was positively 
correlated with high maternal BMI (obesity) and e-GWG (respectively p= 0.01 and p= 
0.002) when compared to the normal BMI and the ne-GWG group (table 2; figure 4a,b). 
Table 2. Longitudinal Fetal Measurements related to maternal BMI and GWG. 
Fetal measurements overweight vs 
normal 
Bmi
obese vs 
normal 
Bmi
obese vs 
overweight&nl 
Bmi
ne-gWg vs 
e-gWg
head Circumference (hC) 0.68 0.94 0.85 0.08
abdominal 
Circumference (aC)
0.82 0.97 0.89 0.03
Femur length (Fl) 0.29 0.13 0.20 0.13
liver length (ll) 0.35 0.01 0.02 0.002
subscapular Fat Tissue 
(sFT)
0.22 0.08 0.14 0.007
abdominal Fat Tissue 
(aFT)
0.06 0.03 0.07 0.005
h-Flma  0.66 0.52 0.60 0.89
h-Flma% 0.28 0.47 0.29 0.69
h-FFma 0.06 0.61 0.39 0.91
h-FFma% 0.26 0.48 0.29 0.67
F-Flma 0.10 0.46 0.77 0.30
F-Flma% 0.48 0.67 0.80 0.93
F-FFma 0.32 0.27 0.39 0.89
F-FFma% 0.46 0.68 0.80 0.86
BMI = body mass index; (n)e-GWG = (non-)excessive gestational weight gain; H-FLMA = humerus fetal 
lean mass area; H-FLMA% = % of total surface of mid-portion transvers section of humerus; H-FFMA = 
humerus fetal fat mass area; H-FFMA% = % of total surface of mid-portion transvers section of humerus; 
F-FLMA =  femur fetal lean mass area; F-FLMA% = % of total surface of mid-portion transvers section of 
femur; F-FFMA =  femur fetal fat mass area; F-FFMA% = % of total surface of mid-portion transvers section 
of femur; Significance is considered if p <0.05
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Figure 3. Fetal Abdominal Circumference (AC) in mm and gestational age (x-axis) in weeks. Percentiles 10, 
50 and 90 for ne-GWG (‘adequate/insufficient’ GWG) and e-GWG (‘excessive’ GWG).
Figure 4.a. Fetal liver length in mm from 12weeks gestational age onwards (x-axis). Percentiles 10, 50 and 
90 for obese and normal BMI (‘non-obese’).
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Figure 4.b. Fetal liver length in mm from 12weeks gestational age onwards (x-axis). Percentiles 10, 50 and 
90 for ne-GWG (‘adequate/insufficient’ GWG) and e-GWG (‘excessive’ GWG). 
Figure 5.a. Fetal abdominal fat tissue (AFT) in mm from 18weeks gestational age onwards (x-axis). Percen-
tiles 10, 50 and 90 for obese and normal BMI (‘non-obese’).
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Figure 5.b. Fetal abdominal fat tissue (AFT) in mm from 18weeks gestational age onwards (x-axis). Percen-
tiles 10, 50 and 90 for ne-GWG (‘adequate/insufficient’ GWG) and e-GWG (‘excessive’ GWG).
Figure 6. Fetal subscapular fat tissue (SFT) in mm from 18weeks gestational age onwards (x-axis). Percen-
tiles 10, 50 and 90 for ne-GWG (‘adequate/insufficient’ GWG) and e-GWG (‘excessive’ GWG). 
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For the peripheral fetal fat- and lean mass measurements of the extremities (humerus 
and femur) there were no differences between the different pre-gestational BMI and 
weight gain groups (table 2). For abdominal fat deposition, AFT positively correlated 
with maternal BMI (table 2; figure 5a). In the e-GWG group the fetal central fat deposi-
tion increased significantly in pregnancy as shown by an increase for both AFT and SFT 
(table 2; figure 5b, 6).
Neonatal weight, -length and head-circumference did not differ significantly between 
the separate BMI groups, but were different between the two GWG groups (table 1). 
The PI on the other hand did not differ between BMI and GWG groups. The obese group 
delivered significant earlier than the normal BMI group (p= 0.03), but the difference can 
be considered clinically irrelevant (39w1d±1w1d versus 39w4d±1w1d respectively). 
DisCUssion
This longitudinal study in normoglycemic women offers interesting new insight in the 
differential effects of maternal obesity and e-GWG on fetal body composition during 
pregnancy. Additionally, we provide information of the evolution in fat content for spe-
cific central and peripheral fetal compartments during pregnancy, and how maternal 
obesity and e-GWG affect these. Fetal (central) adiposity emerged from 22 weeks gesta-
tion onwards.
While maternal obesity specifically promoted the fetal liver size and abdominal sub-
cutaneous fat accumulation, the excessive GWG also affected the fetal abdominal cir-
cumference and subscapular fat thickness. Excessive GWG certainly correlated well with 
an increased fetal size at birth (higher birthweight, -length and headcircumference). The 
ponderal index, a neonatal body proportionality parameter, on the other hand was not 
influenced by the maternal pre-pregnancy weight or weight gain during pregnancy. 
Since both birth-weight and birth-length were increased, leaving the resultant of the 
PI equation  balanced. In contrast, peripheral fat- and lean mass were not influenced by 
pre-gestational BMI or GWG. 
Intrauterine growth is the result of genetic potential, substrate availability and en-
docrine regulation that will determine the growth trajectory during intrauterine life.21 
Most fetal weight is gained during the second half of gestation, when the pattern of 
fetal growth is accompanied by a large and exponential deposition of fat tissue. Fetal 
fat mass growth is previously reported to correlate with the intrauterine environment, 
whereas fat-free mass shows stronger relationships with genetic factors.22,23 Evaluation 
of the nutritional state in utero, by estimating fetal body composition, might improve 
the prediction of short-term perinatal risks (related to fetal adiposity) in conditions of 
under- and overgrowth.10 But the intra-uterine development of the fetus might also af-
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fect long-term outcomes such as cardiovascular diseases.24 Anthropometric ultrasound 
measurements, indicative of fetal body composition of normal fetuses, have shown an 
unique exponential pattern of the growth profile during the second half of gestation, 
both in lean mass and in fat mass.15,16 This suggests that the measurement of fetal fat 
could provide a more sensitive and specific marker of abnormal fetal growth or develop-
ment in different extra-uterine nutritional circumstances like in high maternal BMI, (n)
e-GWG and (G)DM.25,26 
In previous studies it has been demonstrated that obesity, e-GWG and (G)DM are as-
sociated with abnormal fetal growth, birth-weight and perinatal outcome.6,27-30 
Studies on the influence of abnormal maternal glucose metabolism, obesity and GWG 
often report on neonatal outcomes, where birth-weight and neonatal body composition 
is examined as a resultant of fetal growth.31,32 Not so many reports have focussed on the 
fetal period, while this represents the period of fastest growth in life.32 Cross-sectional 
studies focusing at the late third trimester, exist, but longitudinal studies on fetal anthro-
pometry (standard biometry and fat- and lean mass development) in a normal glucose 
tolerance population are scarce or non-existing.10,34,35
Rigano et al report on a measurement of fetal abdominal wall thickness in a small 
group with a normal (n=25) and abnormal (n=45) glucose challenge test, that was 
followed up prospectively.36 The abnormal group received either treatment with diet 
only or in combination with insulin. The fetal abdominal wall thickness at recruitment 
differed between the GDM group and non-GDM group and they suggested that the 
treatment probably reduced the growth rate of the abdominal wall thickness later in 
pregnancy. While we excluded all glucose intolerant women, we still found a sustained 
difference of fetal abdominal fat thickness from recruitment throughout pregnancy 
in higher maternal BMI and GWG. In a cross-sectional study, Larciprete et al. reported 
on fetal subcutaneous fat thickness during pregnancy in a high risk population and a 
GDM group.9 They confirmed the relatively small differences between GDM foetuses 
and controls, as reported by Rigano and colleagues. This could be explained by the fact 
that GDM women are being tightly controlled after the diagnosis of GDM. In an elegant 
study, Parretti et al. studied the role of abnormal glucose tolerance on fetal growth and 
body composition across gestation in a non)obese population.36 Higher fetal fat mea-
surements were found in the abnormal GCT group, while fetal lean mass did not differ. 
Also, they found a positive association between the 1hr postprandial glucose value and 
fetal fat development, suggesting that even in minor glucose alterations fetal develop-
ment changes with higher deposition of fat tissue in the fetus. Unfortunately they did 
not examine an obese population. Although we excluded all glucose intolerant women, 
we included obese women in our study cohort with fetuses who showed increased fetal 
liver size and abdominal fat thickness. Hence we showed the increase of these insulin 
sensitive tissues in the fetuses of obese (and e-GWG) women. This could indicate that 
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even in a normoglycemic population obesity and e-GWG sensitize the fetal insulin sensi-
tive tissues. Obesity and e-GWG are important reflections of maternal nutritious status 
and hence the nutritional supply for the unborn child.38 They may alter the epigenome of 
the fetus and influence the phenotype at birth and subsequently the metabolic profile, 
predisposing them to diseases in later life. Central adiposity is one of the phenotypes 
associated with increased risk of insulin resistance, hypertension and cardio-vascular 
diseases.39 In our study the e-GWG in particular, but also obesity affected central fetal 
adiposity (liver size, abdominal circumference and truncal fat measurements), poten-
tially putting the fetus at risk for an aberrant metabolic phenotype. Although long term 
follow-up was not part of our study. 
Particularly the fetal liver size, since it can be monitored from early gestation onwards 
(late first trimester), could potentially be a useful tool to detect fetal adiposity in an 
altered nutritional environment in utero. This increased fetal liver development could be 
the first in utero sign of a later pediatric non-alcoholic fatty liver disease (NAFLD).40,41 Since 
we lack fetal liver enzymes from cord-serum and liver ultrasonography even in adults 
has poor agreement on NAFLD diagnosis, this remains merely speculative, but warrants 
further studies. The additional effect of e-GWG by enhancing the fetal AC development 
and SFT deposition, together with the distinct birth-outcome for weight and length 
stresses the importance of GWG on fetal growth and body proportions. One explanation 
for the different effect on fetal AC, which in its measurement contains not only liver and 
AFT, but also visceral fat tissue, could be the additional effect of GWG on fetal visceral fat 
deposition. Especially the relation of maternal nutritional intake, GWG and fetal meta-
bolic (fat) tissue development needs further investigation.42
Strengths of our study include the relative large size sample, the longitudinal design 
throughout pregnancy and the fact that measurements were both performed in both 
the mother and the fetus. This allowed us to stratify for pre-gestational BMI and GWG. 
All pregnancies had a first trimester scan, that allowed us to standardize the gestational 
age determination.13 Additionally, all patients had a normal glucose tolerance with a 
clearly defined protocol to exclude pre-gestational DM and the development of GDM. It 
has been demonstrated that fetal hyperinsulinemia results from transplacental passage 
of maternal hyperglycemia and therefore influencing fetal growth and fat accumula-
tion.3,5 Fetal lean- and fat mass measurements, were based on a previously described 
protocol and were validated in other studies.10,37 All measurements were performed 
by a single operator, excluding inter-operator variability. Furthermore, the complexity 
of longitudinal fetal growth is tackled by the GAMLSS analysis, a statistical technique 
advised by the WHO Multicentre Growth Reference Study Group for the construction of 
growth standards.19,20
Some limitations have to be mentioned. The excessive GWG classification is based on 
the revised 2009-IOM criteria.8 In the non-excessive group both adequate and insufficient 
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GWG are included. When insufficient weight gain is present, an increased incidence of 
SGA and decreased neonatal fat mass was reported in overweight and obese women.43 
It is possible that our non-excessive GWG group was influenced by the insufficient GWG 
group, although they only formed  22/126 (17.5%) of our cohort. Still, this may have 
yielded an increased difference of the fetal development in the e-GWG and ne-GWG 
mother. Furthermore, some of the obese participants were involved in a lifestyle inter-
vention study to prevent the development of gestational diabetes.11 This also explains 
the somewhat higher percentage of obese pregnancies, as compared to the general 
population. Consequently, the GWG in the obese pregnancies may be slightly lower 
than expected. The aim of our study was  to examine early fetal discriminants related to 
maternal factors (obesity and GWG) that have the potential to influence fetal develop-
ment and hence birth outcome. Although fetal liver and abdominal circumference can 
be investigated as early as in late first trimester, the other fetal parameters (AFT, SFT and 
humerus and femur fat- and lean mass), can only be reliably examined from 20 weeks 
onwards. This forms a general limitation not specific for our study, although our study 
is the first to our knowledge to examine these parameters from these early gestational 
periods. Further studies to examine the outstanding fetal discriminants (LL, SFT, AFT and 
AC) as predictors for neonatal adiposity are underway. 
Our longitudinal study determined early signs of fetal adiposity associated with 
maternal obesity and particularly e-GWG in normoglycemic women. Maternal high BMI 
correlated with fetal liver size and abdominal fat, where e-GWG additionally correlated 
with increased subscapular fat and abdominal circumference development. Further-
more, fetal adiposity emerged from as early as 20 weeks as a reflection of a nutritious 
environment in utero. Especially the indicators of the fetal trunk (liver-length, AFT, SFT 
and AC) are discriminative and warrant further investigation, as potential early predic-
tors of neonatal adiposity and long-term offspring metabolic risk. 
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aBsTraCT 
introduction
Neonatal adiposity is the result of in utero development, significantly influenced by 
parental constitution, maternal pre-pregnancy weight, gestational weight gain (GWG) 
and glucose metabolism. Our aim was to detect early antenatal predictors for neonatal 
adiposity in normoglycemic women.
methods
One hundred and sixty-two women were recruited in their first trimester and prospec-
tively followed-up for maternal weight gain and fetal-neonatal biometry and anthro-
pometry. Exclusion criteria included: pre-existing diabetes mellitus (DM), development 
of gestational DM, premature delivery and missing birth outcome. Total GWG was 
categorized according to the revised criteria of the Institute of Medicine. Birth outcome 
measurements, obtained within 48hrs, included neonatal anthropometry measurements 
(skinfolds and circumferences of abdomen, lower- and upper extremity), from which 
neonatal fat mass (% NFM) and the ponderal index (PI) were calculated. Generalized 
Additive Model Location, Scale and Shape (GAMLSS) was used to align the timeframes 
of the antenatal measurements and to correlate them with birth outcome parameters 
and NFM.
results
One hundred and twenty-one pregnancies in normoglycemic women were included in 
the final analysis. The mean NFM at birth was 11.0% (SD±3.4%), with a cut-off of 15% for 
the 90th percentile (P90). No association was found between the maternal pre-pregnancy 
body mass index (BMI) and NFM. However, children born to mothers who had an exces-
sive GWG (e-GWG, 59/121=49%) had a significantly higher NFM (11.6%) as compared 
to the non-excessive GWG mothers (10.4%, p=0.045). Fetal measurements were highly 
correlated with neonatal measurements. Fetal abdominal circumference (AC, p=0.04), 
liver length (LL, p=0.03), subscapular- and abdominal fat thickness (p<0.001), humerus 
(p<0.001) and femur fat mass (p<0.001) development correlated significantly with 90th 
NFM percentile. Fetal abdominal fat thickness (AFT) did not (p=0.25) correlate with the 
PI. 
Conclusion
In the normoglycemic women, e-GWG was associated with an increased neonatal adi-
posity (>P90 NFM). The neonatal PI and high adiposity were preceded by an increased 
development of fetal central- and peripheral fat mass parameters. The fetal abdominal 
development (AC, LL), reflecting fetal central adiposity, correlated significantly to the 
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90th percentile of neonatal fat mass, showing their potential role as early predictors for 
neonatal fat deposition. 
inTroDUCTion
In utero development is the fastest growth trajectory a human will ever experience in 
life. It has been demonstrated that the prenatal period is vulnerable to environmental 
factors and parental constitution, both leading to epigenetic effects responsible for 
diseases that occur in later life.1 This is called the developmental origins of health and 
diseases or fetal/developmental programming.2,3 The environmental factors can cause 
fetal overgrowth or growth restriction depending on increased or decreased transpla-
cental nutrients transfer. Pregnancy related factors include maternal pre-gestational 
body mass index (BMI), excessive gestational weight gain (GWG) and abnormal glucose 
tolerance (gestational diabetes mellitus, GDM).4-6 The influence of these three maternal 
determinants, are associated with an 25% increased incidence of higher birth-weight 
and increased perinatal complications like abnormal fetal growth, shoulder dystocia, 
caesarean section rates and fetal death.7-10  
Studies of fat- and lean mass parameters at birth have mostly been performed on glu-
cose intolerant populations to study their association with gestational glucose levels.8 
Antenatal ultrasound studies, focusing on fetal body composition (‘fetal adiposity’), are 
often undertaken cross-sectionally in the third trimester and (again) in GDM popula-
tions.11-14 Longitudinal prenatal adiposity measurements in relation to neonatal body 
composition (‘birth adiposity’) in normal glucose tolerant population sare therefore 
scarce, and if available, they concern mostly single sonographic markers of fetal fat 
deposition.15-17 We suggested in chapter 5 of this thesis after investigating a wide range 
of antenatal fetal body characteristics, that fat features of the trunk and fetal liver size 
could serve as sensitive markers of abnormal fetal adiposity.18 Our aim was to correlate 
these markers in a prospective study in normoglycemic women with neonatal outcome 
measurements in order to detect specific (early) antenatal predictors for neonatal adi-
posity. This could help to elucidate the mechanisms of an aberrant metabolic start in life.
Design anD meThoDology
This prospective study was performed at the Department of Obstetrics and Gynecol-
ogy of the University Hospitals Leuven (Belgium). Pregnant women of different pre-
gestational BMI classes were recruited at their first trimester ante-natal visit between 
January 2012 and August 2014. This sub-study was part of three prospective studies for 
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low-risk, obese and non-obese pregnancies monitored for GWG, development of GDM 
and nutrition.19 All studies were approved by the Ethics Committee for Human Experi-
mentation of the Faculty of Medicine, Katholieke Universiteit Leuven (S52172, S54026 
and S55325). All women have signed written informed consent to take part in the study. 
Exclusion criteria for the sub-study were: pre-existing diabetes (DM) or development of 
GDM, multiple pregnancies, premature delivery (<34 weeks), missing longitudinal data 
and adverse events (major fetal abnormality, fetal death and/or immature birth).
maternal measurements
At their first ante-natal visit, parameters for BMI (height and pre-pregnancy weight) 
were obtained as described elsewhere.18 The BMI was categorized as normal weight 
(≤24.9 kg/m2), overweight (25-29.9 kg/m2) and obese (>30kg/m2) as defined by the WHO 
guidelines. The total GWG gain was computed using the final weight measured at the 
last prenatal visit, minus the pre-gestational weight. GWG was categorized according 
to the Institute of Medicine (IOM) 2009 revised recommendations: 11.5-16kg (normal 
weight), 7.0-11.5kg (overweight) and 5.0-9.0kg (obese).20 If women crossed the upper 
IOM threshold, they were considered excessive-GWG (e-GWG) or non-excessive (ne-
GWG) if they had either adequate or insufficient total GWG. If women were considered 
high risk (history of GDM, BMI≥30kg/m²), a fasting glucose measurement <92mg/dL 
(<5.1mmol/L) at baseline was used to exclude pre-existing DM. Another screening was 
performed at 24-28 weeks using a 75g oral glucose tolerance test (OGTT) based on the 
2013 World Health Organization (WHO) criteria.21 The non-obese population underwent 
an OGTT if the initial 50g glucose challenge test showed a glycemia of ≥140mg/dL 
(≥7.8mmol/L) at 24-28 weeks (local protocol).
Fetal measurements
Determination of gestational age (GA) was based on the crown rump length (CRL) 
measured between 7 and 14 weeks of gestation in all patients.22 Ultrasound examina-
tions were performed at three time-points in gestation: 12-18 weeks, 26-32 weeks and 
between 35-37 weeks of gestation. A proportion (48 participants) was also examined 
between 20-22 weeks of gestation. Fetal measurements (head circumference -HC-, 
abdominal circumference –AC-, and femur length –FL-) were performed in accordance 
to the International Society for Ultrasound in Obstetrics and Gynecology (ISUOG, www.
isuog.org) guidelines as described elsewhere.18,23 Additional measurements of fetal 
body composition (lean- and fat mass) and fetal liver length (LL) were obtained as previ-
ously described.18,24 All fetal measurements were performed by a single operator (SG) on 
a high resolution real-time B-mode ultrasound system (E6, E8 or 730-Expert Voluson®, 
General Electric healthcare Medical systems, Kretztechnik, Zipf, Austria) with a convex, 
high frequency, 4-8 MHz volumetric 3D abdominal probe. 
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neonatal measurements
Neonatal measurements were obtained within 48hrs after birth as described formerly.19 
In summary, the birth measurements consisted of birth-weight (BW), birth-length (BL), 
head circumference (BHC), abdominal circumference (BAC) and skinfold (SF) measure-
ments of the flank (Fl-SF), triceps (Tr-SF), subscapular (S-SF) and thigh (Th-SF) with a 
Harpenden® skinfold calliper. The skinfolds were obtained using a strict protocol and 
measured at least two times and a third measurement was necessary, if there was a 
difference of >0.2mm between the first two performances. The mean of these measure-
ments was recorded.19 The circumferences of the upper arm and -leg and lower arm and 
-leg were also obtained.19 Neonatal body composition measurements were performed 
by the same operator (SG). Different neonatal body composition algorithms were calcu-
lated as an end-point of the prenatal development measures: BW, BL, BHC, BW/BL, BW/
BL2 and the ponderal index (PI). The PI was calculated by the weight divided by the cubic 
root of the length (birthweight/length³) and can be regarded as a neonatal proportion-
ality index in line with the adult BMI.25 The neonatal fat mass (NFM) was calculated using 
the following (validated) equation26: 0.39055 (BW, kg) + 0.0453 (Fl-SF, mm) – 0.03237 (BL, 
cm) + 0.54657. The percent of body fat is fat mass/BWx100. Total BW minus fat mass was 
calculated as lean-mass.
statistical analysis
GAMLSS (Generalized Additive Models for Location, Scale and Shape, www.gamlss.org) 
R-package was applied to construct the growth curves for conventional fetal biometry 
measurements: HC, AC and FL.27,28 We assessed several distributions: Box-Cox-t, Box-
Cox Cole and Green, and Box-Cox Power Exponential. Goodness-of-fit of the models 
was assessed with QQ plots, AIC (Akaike Information Criterium) and worm plots. The 
goodness-of-fit was investigated covering the gestational period of 12-40 weeks, and 
for substrata of this period. GAMLSS smoothened the ante-natal growth curves for all 
prenatal measurements. Percentiles (P10, P50 and P90) for each parameter were con-
structed. Only complete consecutive fetal- and neonatal data-sets were analyzed. The 
effect of BMI (normal weight, overweight and obese) and the effect of e-GWG versus 
ne-GWG were added in the GAMLSS model. The NFM (%) at birth was correlated in the 
GAMLSS model as a continuous variable and at the cut-off points of 10, 12.5 and 15% for 
the development of all prenatal measurements. Also the birth proportionality measure-
ments BW, BL, BHC, BW/BL, BW/BL2 and PI, were correlated in the GAMLSS model for the 
development of all prenatal measurements. All prenatal and birth data were corrected 
for gestational age. 
100 Chapter 6
resUlTs
From the 162 recruited pregnant women, 22 were excluded based on an abnormal 
fasting glucose measurement (pre-existing DM/GDM) at baseline or  the development 
of GDM at the 24-28 weeks screening. Seventy-seven percent (17/22) of the excluded 
women were obese. Another 19 pregnancies were excluded for various reasons: one 
early second trimester miscarriage, 3 premature births, 4 drop-outs and 11 missing 
longitudinal data (figure 1, flowchart). Therefore 121 normoglycemic women with preg-
nancies resulting in a >34 weeks live birth were included in the final analysis. Of these 59 
(49%) had a normal pre-pregnancy BMI, 19 (16%) were overweight and 43 (35%) were 
obese. Sixty women (50%) had an e-GWG, according to the 2009-IOM revised criteria. 
The maternal, fetal and neonatal demographics are outlined in table 1. The fetal growth 
 
162 pregnancies 
recruited 
121 pregnancies 
59 normal weight 
(BMI <24.9kg/m²) 
19 overweight 
(BMI 25.0-29.9kg/m²) 
43 obese 
(BMI ≥30.0kg/m²) 
Exclusion:  
- (G)DM (22) 
- Pre-term delivery (3) 
- Late miscarriage (1)  
- Missing longitudinal    
data: - 6 prenatal 
- 5 neonatal 
- Drop-out (4) 
 
Figure 1. Flowchart of study population. (G)DM= Gestational Diabetes Mellitus; BMI= (pre-gestational) 
Body Mass Index.
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and body composition measurements throughout gestational age are shown in chapter 
5 (e-figures 5.1-5.7, e-tables 5.1-5.6). The birth measurements are shown in e-figures 
6.1-6.7. The mean NFM at birth was 11.0% (SD±3.4%) and mean neonatal lean mass 
was 90% (SD±5.4%). Of the neonates 81/121 (66.9%) had a NFM percentage of >10%, 
41/121 of >12.5% and 14/121 of >15% (figure 2). The fifteen percent NFM represented 
the 90th percentile (P90). Maternal BMI did not correlate with the NFM (p=0.25). A NFM of 
11.1%, 11.0% and 10.8% corresponded to the normal, overweight and obese BMI class, 
respectively. However, children born to mothers who showed an e-GWG (49%) had a 
significantly higher NFM (11.6%) compared to the ne-GWG mothers (10.4%, p=0.045). 
Table 1. Maternal baseline characteristics. 
Total
(N= 121)
maternal age (years), mean ± std 29.7 ± 4.1
nulliparity (%) 67 (55%)
obese Bmi (%) 43 (35%)
overweight Bmi (%) 19 (16%)
normal weight Bmi (%) 59 (49%)
excessive gWg (%) 60 (50%)
ga at birth (wks,0/7d), mean ± std 39w3d ± 1w2d
Birth weight (g), mean ± std 3396 ± 499
Birth length (cm), mean ± std 50.2 ± 2.4
Birth hC (cm), mean ± std 34.3 ± 1.5
Boys (%) 59 (49%)
BMI = body mass index; GWG = gestational weight gain; GA = gestational age; wks = weeks; d = days; g = 
gram; HC = head circumference; std. = standard deviation. 
40/121
40/121
27/121
14/121
Neonatal Fat Mass (NFM)
≤ 10% FM
> 10≤12.5% FM
> 12.5≤15% FM
> 15% FM
Figure 2. Neonatal fat mass (NFM) in % of total birth weight for 121 neonates. Fat mass (FM) ≤10% (40/121), 
>10≤12.5% (81/121), >12.5≤15% (41/121) and >15% (14/121=90th percentile) of total birth weight.
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Vice versa, the lean-mass percentage was lower in e-GWG mothers (89%) versus the 
ne-GWG mothers (90%). 
The development of all fetal parameters (biometry and body composition) correlated 
with the BW, BL, BHC and the proportionality indices BW/BL and BW/BL2 (table 2). The 
development of fetal AC (p=0.04), LL (p=0.03), SFT (p=0.02), humerus fat mass (p=0.002) 
and femur lean- (p<0.001) and fat mass (p<0.001) correlated significantly with the PI 
(table 3). The AFT did not show a correlation with PI (p=0.25). The development of all 
fetal parameters (biometry and body composition) correlated highly with the NFM, as a 
continuous variable (table 3).
Table 2. Longitudinal Fetal Measurements related to neonatal outcome. 
neonatal measurements 
Fetal measurements BW Bl BhC Weight/
length
Weight/
length²
Weight/
length³ (Pi)
head Circumference <0.001 <0.001 <0.001 <0.001 0.002 0.56
abdominal 
Circumference 
<0.001 <0.001 <0.001 <0.001 <0.001 0.04
Femur length <0.001 <0.001 0.005 <0.001 0.01 0.50
liver length <0.001 <0.001 <0.001 <0.001 <0.001 0.03
subscapular Fat Tissue <0.001 <0.001 <0.001 <0.001 <0.001 0.02
abdominal Fat Tissue <0.001 <0.001 <0.001 <0.001 <0.001 0.25
h-Flma  <0.001 <0.001 <0.001 <0.001 <0.001 0.06
h-Flma% 0.008 0.15 0.10 0.001 0.001 0.09
h-FFma <0.001 <0.001 <0.001 <0.001 <0.001 0.002
h-FFma% 0.008 0.15 0.09 0.001 0.001 0.08
F-Flma <0.001 0.02 <0.001 <0.001 <0.001 <0.001
F-Flma% 0.34 0.89 0.47 0.26 0.22 0.25
F-FFma <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
F-FFma% 0.28 0.85 0.44 0.23 0.22 0.29
BW = birth weight; BL = birth length; BHC = birth head circumference; ponderal index = PI; H-FLMA = 
humerus fetal lean mass area; H-FLMA% = % of total surface of mid-portion transvers section of humerus; 
H-FFMA =  humerus fetal fat mass area; H-FFMA% = % of total surface of mid-portion transvers section of 
humerus; F-FLMA =  femur fetal lean mass area; F-FLMA% = % of total surface of mid-portion transvers sec-
tion of femur; F-FFMA =  femur fetal fat mass area; F-FFMA% = % of total surface of mid-portion transvers 
section of femur; Significance is considered if p <0.05
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Figure 3.a. Fetal abdominal circumference (AC) in mm from 12 weeks gestational age onwards (x-axis). 
Percentiles 10, 50 and 90 for neonatal fat mass >15% (P90) and ≤15%.
Figure 3.b. Fetal liver length in mm from 12 weeks gestational age onwards (x-axis). Percentiles 10, 50 and 
90 for neonatal fat mass >15% (P90) and ≤15%.
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Figure 4.a. Fetal subscapular fat thickness (SFT) in mm from 20 weeks gestational age onwards (x-axis). 
Percentiles 10, 50 and 90 for neonatal fat mass >15% (P90) and fat mass ≤15%.
Figure 4.b. Fetal abdominal fat thickness (AFT) in mm from 20 weeks gestational age onwards (x-axis). 
Percentiles 10, 50 and 90 for neonatal fat mass >15% (P90) and fat mass ≤15%. 
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Figure 5.a. Humerus fetal fat mass area (H_FFMA) in mm2 from 20 weeks gestational age onwards (x-axis). 
Percentiles 10, 50 and 90 for neonatal fat mass>15% (P90) and fat mass ≤15%. 
Figure 5.b. Femur fetal fat mass area (F_FFMA) in mm2 from 20 weeks gestational age onwards (x-axis). 
Percentiles 10, 50 and 90 for neonatal fat mass>15% (P90) and fat mass ≤15%. 
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Globally, for the adipose babies (P90 NFM >15%) there were significant correlations 
with the development of the fetal AC (p=0.04), LL (p=0.03), SFT (p<0.001), AFT (p<0.001), 
the humerus fat mass (p<0.001) and both femur lean- and fat mass (P<0.001, table 3). 
More specifically, the fetal abdominal development (fetal AC and fetal LL), showed a 
more linear increase from the end of the first trimester towards the term period (figure 
3a-b). Reference values are displayed in supplement 2. In the adipose babies (NFM>15%, 
P90), the fetal truncal fat measurements, SFT and AFT, showed an increase from 27-29 
weeks gestation (figure 4a-b). Reference values are shown in e-tables 6.1-6.4. For the 
peripheral fetal fat measurements (humerus and femur) the increase started at 30-32 
weeks gestation (figure 5a-b, e-tables 6.5-6.6).
DisCUssion
This longitudinal study in normoglycemic women demonstrates interesting new insights 
in the correlation between maternal obesity, excessive GWG and neonatal adiposity. 
Excessive GWG and the subsequent development of abnormal fetal growth and adipos-
ity, are associated with an increased risk for neonatal adiposity. While fetal fat measure-
ments (SFT, AFT and peripheral fat depositions) show a high degree of correlation for 
neonatal fat mass and ponderal index, the fetal AFT correlates specifically to increased 
adiposity at birth (NFM >P90). The fetal AC and liver size are the first parameters to show 
a different growth trajectory in babies with a higher neonatal fat percentage, from first 
trimester onwards. Hereafter followed by the AFT and SFT in the late second and the 
peripheral (humerus and femur) fat measurements in the early third trimester. High 
maternal pre-pregnancy BMI was recognized by the IOM as a significant risk factor for 
adverse pregnancy outcome.20 Out of that, excessive GWG also has an influence on the 
long-term cardio-metabolic health of the offspring.29 Therefore the IOM advises a maxi-
mum GWG level per BMI class, negatively correlated to the prepregnancy BMI.20 Obesity 
is seen as a pre-diabetic state, with increased insulin resistance, glucose levels and lipids 
in pregnancy. This potentially influences the developing fetus.30,31 Even in the offspring 
of obese mothers, insulin resistance and increased neonatal body fat have been reported 
as short term outcomes.9 Therefore we aimed to examine a normoglycemic population 
by applying a strict glucose screening and monitoring protocol, particularly in the high 
risk obese mother. Our results demonstrate a significantly higher neonatal fat deposi-
tion (NFM) in the mothers that have gained excessive weight irrespective of their BMI. 
Indeed, the BMI was negatively correlated, although not significantly, with neonatal fat 
mass in our selected population. In chapter 5 we demonstrate in a similar population 
that obesity promotes fetal liver size development and abdominal fat deposition, but 
does not affect ponderal index. While excessive GWG additionally, positively, influenced 
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fetal abdominal circumference and fetal subscapular fat thickness, it also affected birth-
weight, birth length and head-circumference, but not ponderal index. 
Birth size is associated with childhood obesity and overweight.32,33 BW, BL and PI have 
also been positively associated with higher BMI during childhood.34 Neonatal body com-
position in the first days of life  has been used  as representative of in utero development 
by several studies.26 While the importance of the early life period is widely acknowl-
edged, the reports on the prenatal period are scarce. Most studies just summarize the in 
utero period by studying ‘birthweight’, which in itself is merely the outcome of fetal life. 
Buhling et al. performed a cross-sectional study in patients with and without GDM using 
late third trimester (>37 weeks) ultrasound. They correlated the fetal thigh and abdo-
men fat thickness measurement to postnatal skinfold measurements.17 O’Connor et al. 
measured thigh and fetal abdominal fat thickness at 28 weeks and 37 weeks to improve 
the birthweight estimation in 328 pregnancies. The fetal thigh fat improved the predic-
tion of birthweight.15 They measured the fat component as follows: cross sectional plane 
of the mid-thigh with longitudinal tissue (subcutaneous fat and bone-muscle) distance. 
We decided to perform the more widely accepted surface area measurements of fat- 
and lean mass of both fetal humerus and femur.13 A prospective longitudinal study was 
performed by the same group in 62 pregnancies using fetal abdominal fat thickness, 
thigh fat and thigh muscle at 28, 33 and 38 weeks and validated with air displacement 
plethysmography (ADP).16 Our study confirms in a larger, normoglycemic cohort that 
fetal fat deposition increases from 26-28 weeks of gestation onwards. Additionally we 
showed that fetal measurements have a high degree of correlation with general birth 
outcome measurements, but are more specific to the profound neonatal adiposity 
indices (ponderal index and fat mass %). Several studies have addressed neonatal body 
composition by ADP, bio-electrical impedance analysis (BIA), anthropometry measure-
ments or skinfold measurements.16,35-37 Currently there are no parameters available in 
routine use, to indicate body proportionality in young children, under the age of two 
years. Body composition indexes as BW/BL, BW/BL2 have been proposed by the WHO 
multicenter growth study group, but still have to prove their value as predictors of 
metabolic changes in later life.35,38 Skinfolds measurements are practical, but require 
additional training, and there have been concerns on the reproducibility. The reported 
coefficients of variation are: 2.91% for suprailiac skinfolds, 2.57% for subscapular skin-
folds and 2.73% for triceps skinfolds.8 Furthermore, skinfolds inform on the distribution 
of neonatal fat (trunk or extremities), a property that is not present in the alternatives 
(ADP or BIA). ADP and BIA give a general, but objective, fat- and lean-mass outcome 
and seems to be the current normative for study purposes, but indeed no information is 
available on the location of the fat depositions.37 We have BIA information on a limited 
group of our study (n=48) for 6 weeks, 6-12-18-24 months postpartum and this is cur-
rently under investigation.
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The strengths of our study included the relative large sample size, longitudinal design 
and the fact that measurements were performed in both the mother and the fetus. All 
pregnancies had a first trimester scan, that allowed us to standardize the gestational 
age determination.22 We did not focus on just one fetal fat index, but performed a whole 
sequence of central and peripheral fat measurements. A strict protocol to exclude (G)
DM was implemented. All prenatal and postnatal measurements were performed by a 
single operator, overcoming the inter-observer variation, for both fetal and neonatal fat 
(skinfold) measurements. A validated algorithm was used to calculate neonatal fat mass 
percentage.26 Furthermore, the complexity of longitudinal fast fetal growth was tackled 
by the GAMLSS analysis, a statistical technique advised by the WHO Multicentre Growth 
Reference Study Group for the construction of growth standards.27,28  
Some limitations have to be mentioned. We categorized total GWG as excessive or 
non-excessive based on the 2009-revised IOM criteria.20 In the non-excessive group both 
adequate and insufficient GWG are grouped. Recently our group showed a reduction in 
perinatal adverse outcome in obese women who lost weight in pregnancy, without an 
increased risk for low birth weight or small for gestational age (SGA) neonates.39 On the 
other hand the group of Catalano et al. reported on a combined cohort of obese and 
overweight mothers, where they found an increased incidence of SGA and decreased 
fat mass at birth, when mother showed an insufficient weight gain.40 Our insufficient 
GWG group formed 19/121 (15.7%) of our cohort. We can only estimate their influence 
on the ne-GWG group, since we did not select them separately, but it may have yielded 
an increased difference between the e-GWG and ne-GWG. Furthermore we did not cor-
relate for the timing of the GWG, while first trimester weight gain profile may be most 
predisposing on the long-term to an aberrant cardio-metabolic outcome.41 Finally, we 
did not collect information on nutritional intake during pregnancy from all included 
participants. A recent study, investigating a single fetal fat measurement (abdominal fat 
thickness) in an adolescent group, reported the AFT to be more affected by sugar intake 
than GWG.42 Unfortunately only 24hrs recalled food-intake and basic birth measure-
ments were collected (BW, BL, BHC and PI). We have 5-7days food-records for a certain 
group of our cohort (n=96), which will be used for future investigation.
In conclusion, this study demonstrated that in normoglycemic women, excessive 
GWG was associated with increased neonatal adiposity. In our cohort the P90 cut-off for 
neonatal fat mass could be set at 15% of the total body-weight. This increased neonatal 
adiposity (>P90) and the ponderal index were preceded by an increased development 
of fetal central- and peripheral fat mass parameters. The fetal fat measurements proved 
a high degree of correlation for neonatal adiposity, with a gestational age specific tim-
ing of first onset of aberrant fetal adiposity development: first (late first trimester) the 
abdominal circumference and fetal liver length, secondly (late second trimester) the 
truncal fat depositions of abdominal- and subscapular fat thickness and lastly (early 
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third trimester) the peripheral fat depositions on the extremities (humerus and femur). 
The fetal abdominal fat development, a marker of fetal central fat deposition, correlated 
specifically to the 90th percentile of neonatal fat mass, for which further studies are 
needed to show its potential role as a more specific predictor for neonatal adiposity.
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Chapter 7
Intima-Media Thickness (IMT) 
measurements in the fetus and 
the mother during pregnancy: a 
feasibility study
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aBsTraCT 
Fetal intima-media thickness (IMT) has been suggested as a marker of pre-clinical ath-
erosclerosis, and maternal IMT could be altered through dynamic circumstances related 
to pregnancy. We investigated the feasibility of measurement of IMT at four pre-defined 
fetal and four pre-defined maternal arterial locations in order to determine vascular 
changes that could be associated with impaired vascular function. IMT was measured 
from first to third trimester (12-34 weeks), in 38 low-risk pregnancies. We imaged a 
10mm region of interest, using a Mindray (Shenzhen, China) high-resolution ultrasound 
machine with automated IMT measurement software.
Fetal abdominal aorta IMT was measurable during the second trimester in 71% and 
during the third trimester in 100% of the cases and the umbilical artery IMT was measur-
able in 50% and in 82% of the cases during the second and third trimester respectively. 
Fetal IMT measurements were not possible during the first trimester. The fetal common 
carotid artery, fetal renal artery and maternal external iliac artery IMT were not often 
feasible to measure (maximal 20% of cases). Maternal common carotid artery, abdomi-
nal aorta and uterine artery IMT were measurable throughout pregnancy. There was a 
significant relation between gestational age and IMT in the umbilical artery (p = 0.03) 
and a significant relation between body mass index and IMT in the maternal common 
carotid artery (p = 0.01). IMT measurements are feasible in some maternal and fetal 
vessels of interest. Further studies are underway to obtain more insight in the vascular 
development during normal and pathologic pregnancies.
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inTroDUCTion
The fetal environment has been shown to be at the origin of conditions that present 
during adulthood. Low birth weight or intra-uterine growth restriction (IUGR) is associ-
ated with cardiovascular disease (CVD), type 2 diabetes mellitus and hypertension in 
adult life (Barker et al. 1989). This ‘fetal origin of adult disease’ theory was also proposed 
by Law et al. (1993). In these studies adults, who were small at birth, showed higher 
blood pressure and increased prevalence of CVD. It has been suggested that relative 
fetal undernourishment causes alterations that involve cardiovascular development, 
especially at the arterial level (Crispi et al. 2012).  
Arteries are composed of three concentric layers. The intima is composed of endo-
thelium; the media is a distinct layered structure of smooth muscle cells, collagen and 
elastic fibers; and the outer part of the vessel is the adventitia, which also comprises 
collagen and elastic fibers. In pathology studies, the intima-media thickness (IMT) in the 
abdominal aorta is reported to be the first site involved in the process of atherosclerosis 
in adults (McHill et al. 2000). Histology of the abdominal aorta wall in an intra-uterine 
growth restricted stillborn infant with a prenatally increased IMT revealed inflammation 
of the thickened intima layer. Lo Vasco et al. (2011) suggested that this is a very early sign 
of future adult lesions. The assessment of preclinical IMT changes may be an important 
predictor for future atherosclerosis and cardiovascular risk. Ultrasonography has the 
potential to detect these vascular changes.
Few studies have measured IMT in fetuses during pregnancy: Cosmi E et al measured 
IMT of the abdominal aorta in 38 fetuses with IUGR and 32 Appropriate-for-Gestational-
Age (AGA) fetuses (Cosmi et al. 2009). The measurements were performed around 33 
weeks of gestational age (range 30-34 weeks). They focused on a single fetal vessel, the 
fetal abdominal aorta, and found the IMT in the IUGR group was increased compared 
with that in the AGA group. Their consecutive studies represent the first on the sole use 
of a sonographic technique to investigate IMT in the fetus (Zanardo et al. 2011; Zanardo 
et al. 2013). IMT in the mother has also been poorly investigated so far. Existing studies 
have been performed on the common carotid artery (CCA) only. Furthermore studies 
were performed only in late pregnancy and compared these values with those of non-
pregnant groups and hypertensive versus non-hypertensive groups. These reports are 
inconsistent on whether the CCA-IMT is increased in pregnancy (Sator et al. 1999). There 
are also some reports suggesting the Intima/Media (I/M) ratio is increased, as a result 
of inflammation and recruitment of inflammatory cells that occur in the atherosclerotic 
process, primarily in the intima layer (Akhter T et al. 2013). It has been hypothesized that 
the pregnancy-related increased hemodynamic load causes adaptations of elastic arter-
ies, which could be gestational age dependent (Yuan LJ et al, 2013). Also, acute changes 
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in IMT in response to acute blood pressure and vascular tone modifications have been 
reported (Thijssen D et al. 2011). 
No direct maternal influences on vascular wall property changes in the fetus have 
been reported yet. One possible factor could be the hyper-estrogenic state of the 
mother, which may affect the fetus through transplacental passage (Sator et al, 1999; 
Crispi et al 2012). Also, the pre-gestational maternal Body Mass Index (BMI) could be an 
identifiable metabolic risk factor (Raitakari OT et al. 2003).
There seems to be a lack of research on other vascular sites and vascular wall proper-
ties in both the fetus and the mother. 
Therefore we aimed to investigate the feasibility of performing IMT measurements 
at predefined vessel locations using automated software in the fetus and the mother 
during pregnancy.  Furthermore, the IMT measurements were investigated in relation to 
gestational age, BMI and distance from the ultrasound probe to the target vessel (depth).
meThoDs
We performed a cross-sectional study between March and August 2011 in pregnant 
women with a low risk of CVD: no known maternal hypercholesterolemia, diabetes, 
pre-existing hypertension, pregnancy induced hypertension or pre-eclampsia. The 
study was performed in the context of the pilot phase of the ‘DALI’ (vitamin D And 
Lifestyle Intervention) study to prevent gestational diabetes, a 7th Framework Program 
of the European Community (FP7, Grant agreement No 242187). Patients, who came 
for their routine ultrasound scans at the prenatal care unit at the University Hospital 
Leuven, were recruited. The scans are planned at about 12, 20 and 30 weeks of gestation 
and gestational age was confirmed during the first trimester. Additional patients were 
included from admissions at the maternal intensive care unit with threatened premature 
birth but in the absence of cardiovascular compromise (hypertension, pre-eclampsia 
or hemolysis, elevated liver enzymes, low platelet count syndrome). Preconception BMI 
(in kg/m2) was calculated using height measurements at the first antenatal visit and the 
self-reported weight before conception. Approval by the medical ethics committee was 
given and informed consent was obtained at inclusion. 
Intima-media thickness was measured by a single experienced operator (S.G.) with 
the M7 high-resolution real-time B-mode ultrasound machine (Mindray, Shenzhen, 
China), equipped with both a 6.0-14.0 MHz, 4.0-7.0 MHz, and a 3.0-7.0 MHz linear array 
transducer and automated and validated IMT measurement software (figure 1 and 2). 
The probe was chosen on the basis of the depth of penetration required. In the majority 
of cases (n=35) we used the high-frequency (3.0-7.0 MHz) probe. In all measurements, 
both fetal and maternal, we used a minimum region of interest (ROI) window of 10mm, 
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Figure 1. Ultrasound coronal view of the fetal lower abdominal region. Intima-media thickness was mea-
sured in the fetal abdominal aorta, below the renal artery and above the iliac bifurcation at gestational age 
of 20 weeks and 2 days with a 3.0-7.0 MHz linear transducer. CCA = Common carotid artery, IMT = Intima 
media thickness, ROI = Region of interest, SD = standard deviation.
Figure 2. Ultrasound measurement of intima-media thickness in the maternal common carotid artery with 
ultrasound, proximal to the carotid bulb (bifurcation of the external-internal carotid artery), at GA of 20 
weeks and 2 days using a 3.0-7.0 MHz linear transducer. CCA = Common carotid artery, IMT = Intima media 
thickness, ROI = Region of interest, SD = standard deviation. 
120 Chapter 7
an angle of insonation of 60º - 90º in a coronal or sagittal view and the vessel in end-
diastolic cardiac phase, as determined on the B-mode image. The IMT was defined as 
the distance between the leading edge of the blood-intima interface, and the leading 
edge of the media-adventitia interface on the far wall of the vessel and was measured 
in micrometres (µm). The automated IMT wall tracking software allowed an online mea-
surement of the target vessel: minimum, maximum and mean IMT values were outlined 
immediately. Hereby a feedback mechanism was available for the relationship of IMT 
vessels lumen properties. If the maximum IMT measurement crossed the anatomic 
delineation of the vessel and hence created a large discrepancy with the minimum IMT 
value, a large Standard Deviation (SD) resulted. For fetal vessels a SD of ≤100 µm and for 
maternal vessels a SD of ≤130 µm was considered as a valid measurement and otherwise 
rejected for recording. These cut-off points were chosen to obtain realistic values for IMT 
as a quality control for the innovative IMT measurements. Vessel depth was measured 
in a straight angle from the centre of the ultrasound probe surface to the far end of the 
target vessel wall.
We aimed to obtain one image per predefined location of the vessel at three con-
secutive time points and analyzed these immediately, bed-side. Maternal measurements 
were performed after completion of the fetal measurements, allowing the mothers to 
reach a state of relative rest. 
Fetal and maternal arteries were measured at predefined locations: 
- Fetal abdominal aorta: below the renal artery junction and above the iliac bifurca-
tion (figure 1).
- Fetal umbilical artery: in a longitudinal plane, a horizontal trajectory part of the ves-
sel.
- Fetal common carotid artery (fetal CCA): on the left or right side (depending on fetal 
position), proximal to the junction of the carotid bulb.
- Fetal renal artery: in the left or right renal artery (depending on position of the fetus).
- Maternal common carotid artery (maternal CCA): patient in supine position, head 
tilted slight left laterally (angle of 45°), probe approximately 6 cm above the clavicle; 
measurement 1-2 cm proximal to the junction of the internal-external carotid artery, 
the carotid artery bulb (figure 2) as described by Willekes et al (1999).
- Maternal abdominal aorta: right lateral tilted position, identification of left kidney 
and renal artery; measurement below the junction of the renal artery and above the 
iliac bifurcation.
- Maternal uterine artery: median of the cross-point of the uterine artery and external 
iliac artery; preferably on the ipsilateral side of the placental location.
- Maternal external iliac artery: probe positioning by movement laterally from the 
uterus and identification of the external iliac artery from the vein by Doppler signal.
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Statistical analysis was performed with SPSS software version 20.1 (IBM, Armonk, NY, 
USA). Categorical values were compared using the Fisher exact test. The relationship 
between BMI and feasibility or non-feasibility of measurement of IMT was tested with 
independent samples t-test because BMI was distributed normally. Repeated measure-
ments were compared with an intra-class correlation coefficient (two-way random 
effects). The relationship between IMT, gestational age and BMI, and also that between 
the coefficient of variation and depth, were tested with Spearman’s bivariate correlation. 
A p-value of <0.05 was considered to indicate significance. All tests were two-tailed.
resUlTs
study population
During the study period, 38 pregnant women were included; there were 36 Caucasians 
and two Africans. Median age was 31±2.3 years (range: 17-38 years). Two women were 
measured at a different gestational age, in one mother both twins were measured re-
sulting in a total of 41 ultrasound examinations. 
Gestational age (GA) ranged from 12 weeks to 33 weeks and 5 days, with a median 
of 29 weeks. Five ultrasound examinations were performed during the first trimester 
(GA <14 weeks), 14 ultrasound examinations during the second trimester (GA >14 and 
<28 weeks) and 22 ultrasound examinations during the third trimester (GA >28 weeks). 
Mean arterial pressure measured after their ultrasound scan was 103,8 ±8,2 mmHg 
(range 85,7-123mmHg).
Pre-pregnancy BMI of the women ranged from 18 to 30 kg/m2 (median 23 kg/m2). 
There were 2 ultrasound examinations in underweight women (BMI <18.5 kg/m2), 27 
ultrasound examinations in normal weight women (BMI >18.5 and <25 kg/m2), 10 ultra-
sound examinations in overweight women (BMI >25 and <30 kg/m2) and 2 ultrasound 
examinations in obese women (BMI ≥30 kg/m2) (WHO classification of body mass index, 
1995, kg/m2). 
Six twin pregnancies were included in the study: 2 ultrasound examinations were per-
formed in dichorionic diamniotic twins, 4 ultrasound examinations in monochorionic 
diamniotic twins and 2 in monochorionic monoamniotic twins. 
Seven women smoked during pregnancy and seven women received medication (1 
tenovir/emtricitabine, lopinavir/ritonavir and levetiracetam; 3 atosiban in combination 
with betamethasone; 1 aspirin cardio; 1 levothyroxine; 1 calcitriol and 1 calcium carbon-
ate). 
The majority of the examinations (n=35), was performed with the high frequency 3.0-
7.0 MHz linear ultrasound transducer. 
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Feasibility of measurement of imT
IMT was measurable in the fetal abdominal aorta (figure 1) in the second (71%) and third 
(100%) trimester of pregnancy. IMT in umbilical artery was measurable in the second 
(50%) and third (82%) trimester of pregnancy, as outlined in table 1. However these 
measurements were not feasible during the first trimester. 
It was not feasible to measure the fetal common carotid artery and fetal renal artery 
in any trimester in our study. The maternal common carotid artery (figure 2) was mea-
surable in all examinations (100%) all trimesters (table 1). Throughout pregnancy the 
maternal abdominal aorta and the uterine artery were measurable in half of the cases 
(40%-60%). For the maternal external iliac artery, IMT measurements were not feasible at 
any gestational age in our study.
effect of gestational age and Bmi on feasibility
The proportion of patients in whom it was feasible to measure IMT at the level of the fe-
tal abdominal aorta, increased significantly with increasing gestational age. It increased 
from 0% in the first trimester, to 71% in the second trimester (p=0.01). It further increased 
from 71% to 100% between the second and third trimester (p=0.02). The feasibility 
of measurement of IMT at the level of the fetal umbilical artery was also significantly 
related to gestational age, with a significant increase between first and third trimester 
(0% to 82%, p=0.002), although the difference between second and third trimester was 
not significant (50% to 82%, p=0.067). The feasibility of measurement of IMT in the fetal 
CCA was not related to gestational age, with an insignificant difference between second 
Table 1. Feasibility of at least one good quality IMT measurement in pre-defined regions of fetal and 
maternal arteries in first, second and third trimester of pregnancy. 
Assessed vessels 1st trim.
(n=5)
2nd trim. 
(n=14)
3rd trim.
(n=22)
Total
(n=41)
Fetal
Abdominal Aorta 0 10 (71%) 22 (100%) 32 (76%)
Umbilical Artery 0 7 (50%) 18 (82%) 25 (61%)
Common Carotid Artery 0 0 4 (18%) 4 (10%)
Renal Artery 0 0 0 0
maternal
Common Carotid Artery (CCA) 4 (100%) 11 (100%) 16 (100%) 31 (100%)*
Abdominal Aorta 2 (40%) 7 (50%) 9 (41%) 18 (44%)
Uterine Artery 2 (40%) 7 (50%) 13 (59%) 22 (54%)
External Iliac Artery 1 (20%) 1 (7%) 0 2 (5%)
* CCA-IMT measurement was examined in respectively 4/5, 11/14 and 16/22 of the women. Trim. = tri-
mester
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and third trimester (18% versus 10% p=0.14). The IMT in the fetal renal artery was never 
measurable (table 1).
The feasibility of measurement of IMT in the maternal arteries studied was indepen-
dent of gestational age. The measurement of IMT in the maternal external iliac artery 
was difficult to measure in all trimesters of pregnancy (table 1).
No relationship was found between maternal BMI and the feasibility of measurement 
of IMT for any fetal or maternal blood vessel studied: fetal abdominal aorta (p=0.18), 
umbilical artery (p=0.19), fetal CCA (p=0.19), maternal CCA (p=0.50), maternal abdomi-
nal aorta (p=0.69), maternal uterine artery (p=0.64) and maternal external iliac artery 
(p=0.51). 
intra-observer agreement
For each blood vessel measured, there was no significant difference between the first 
and second measurement, or between second and third and first and third repeated 
measurement. This was determined with the inter-class correlation coefficient (ICC): 
fetal abdominal aorta (ICC=0.965), fetal umbilical artery (ICC=0.975), maternal CCA 
(ICC=0.946), maternal abdominal aorta (ICC=0.999) and maternal uterine artery 
(ICC=0.747).
range of imT values throughout pregnancy and effect of Bmi and depth
The IMT range and the median are outlined per separate vessel per trimester in table 2. 
In our small population, no relationship was evident between the IMT and gestational 
age in the fetal abdominal aorta (p=0.13), fetal CCA (p=0.20), maternal CCA (p=0.92), 
maternal abdominal aorta (p=0.54) and maternal uterine artery (p=0.77). However, we 
did find a significant relationship between IMT and gestational age in the fetal umbilical 
artery (p=0.03), with a median IMT of 289 µm in second trimester and 301 µm in third 
trimester.
We did not find a significant relationship between the IMT and maternal BMI in the 
fetal abdominal aorta (p=0.18), fetal umbilical artery (p=0.78), fetal CCA (p=0.20), mater-
nal abdominal aorta (p=0.24) and maternal uterine artery (p=0.86). However, there was 
a significant relationship between the IMT and BMI in the maternal CCA (p=0.01), with 
an IMT of 445 µm in one underweight woman, a median of 510 µm in normal weight 
women, 540 µm in overweight women and 507 µm in one obese woman. 
The mean coefficient of variation (SD/mean; SD and mean as reported by the Mindray 
software per measurement) and the mean with 95% confidence interval (CI)of the IMT 
values are reported in µm (table 3). For the dispersion of the range of IMT values, the 
minimum, maximum and median IMT values are also listen in Table 3, as are the mean 
depth and range of depths (in cm) of the vessels (table 3). The coefficient of variation 
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was found to be the lowest for IMT in the fetal umbilical artery and was also low in the 
fetal abdominal aorta, the maternal CCA and the maternal abdominal aorta. 
There was a significant positive relationship between vessel depth and coefficient 
of variation for the IMT value in the maternal CCA (rho=0.27; p=0.019) and maternal 
uterine artery (rho=0.45; p=0.014). However, there was no significant relationship in the 
Table 2. Median and range of IMT measurement (in µm) in pre-defined regions of fetal and maternal 
arteries in first, second and third trimester of pregnancy. 
Assessed vessels 1st trimester 2nd trimester 3rd trimester
median range imT median range
imT
median range
imT
Fetal
Abdominal Aorta - - 330 181-431 342 201-586
Umbilical Artery - - 289 225-572 301 212-417
Common Carotid Artery - - - - 295 185-367
Renal Artery - - - - - -
maternal
Common Carotid Artery 452 400-539 545 440-712 504 378-740
Abdominal Aorta 580 523-616 561 367-680 652 495-735
Uterine Artery 229 163-415 246 195-351 238 160-535
External Iliac Artery - 582 - 601 - -
Table 3. Mean with 95% CI, minimum, median and maximum IMT per measured fetal and maternal artery 
throughout pregnancy in µm. Vessels’ depth (mean and range) to the far end of the vessels’ wall is defined 
in cm. * Data on fetal renal artery too scarce. 
Fetal* maternal
Vessels abdao Umbart CCa CCa abdao Utart extilart
mean 334 314 286 517 575 264 592
95%CI mean 313-354 294-334 165-406 498-537 534-616 231-296 471-712
Minimum 181 212 185 378 367 160 582
Median 335 301 295 511 578 236 592
Maximum 586 572 367 740 735 535 601
CoeffVar. .12 .09 .17 .13 .11 .15 .18
Depth mean 5.8 5.0 5.2 2.2 10.4 3.1 5.9
Depth range 3.9-9.2 3.1-8.4 4.4-6.0 1.5-2.7 7.5-14.2 1.6-4.9 4.7-7.0
AbdAo = Abdominal Aorta; UmbArt = Umbilical Artery; CCA = Common Carotid Artery; UtArt = Uterine 
Artery; ExtIArt = External Iliac Artery. CoeffVar = Coefficient of Variation
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fetal abdominal aorta (p=0.67), fetal umbilical artery (p=0.33), fetal CCA (p=0.60) and 
maternal abdominal aorta (p=0.40).
DisCUssion
This is the first study to investigate the feasibility of arterial IMT measurement in mother 
and fetus throughout pregnancy using ultrasound. We were able to measure IMT in the 
fetal abdominal aorta and the umbilical artery during the second and third trimester. 
Furthermore, we found a positive relationship between values of IMT and gestational 
age in the umbilical artery. No relationship between IMT value and gestational age was 
evident in any of the other fetal and maternal blood vessels. The maternal CCA IMT could 
be measured throughout pregnancy and exhibited a positive association with pre-
gestational BMI. The maternal abdominal aorta and uterine artery IMT measurements 
were feasible, although more difficult than measurement of maternal CCA IMT. 
Cardiovascular disease generally becomes apparent in older patients. However, the 
intra-uterine environment has been postulated as having a crucial role in programming 
the fetus for short term survival in the early postnatal period, but with impaired con-
sequences for cardiovascular function and metabolic changes in latter adult life, when 
intra-uterine life is unfavorable (Barker et al. 1989; Law et al. 1993; Galjaard et al. 2013). 
Pathology and histology studies indicate that IMT thickening is caused by inflammation 
and that the abdominal aorta artery is the first location of increasing IMT as a sign of 
atherosclerosis (McGill et al. 2000; Lo Vasco et al. 2011; Jarvisalo et al. 2001). Therefore 
assessment of pre-clinical IMT changes may be used to predict future atherosclerosis 
and cardiovascular risk. 
In newborns, the association between birthweight, abnormal growth and increased 
IMT in the abdominal aortic artery and development of atherosclerosis later in life is 
supported by several studies (Jarvisalo et al. 2001; Skilton et al. 2005; Koklu et al. 2007; 
Satoru et al. 2012). In early childhood, Crispi et al. reported early signs of cardiovascular 
dysfunction at 3-6 years of age in children with IUGR and Small for Gestational Age (SGA) 
children as compared to Appropriate for Gestational Age (AGA) children. Not only was 
their cardiac function affected, but the CCA IMT was also increased in both children with 
IUGR and SGA childresn (Crispi et al. 2012). In a recent study, Dratva et al. (2013) reported 
an increased CCA IMT at the age of 11 years to be associated with increased birth weight.
Very few studies however, have measured IMT in fetuses and mothers during preg-
nancy. Cosmi et al. (2009) measured IMT in the abdominal aorta in 38 fetuses with IUGR 
and 32 AGA children. They found the IMT to be higher in IUGR fetuses than in AGA fe-
tuses (1.9mm vs 1.15mm, P<.001). The measurements were performed around 33 weeks 
of gestational age (range 30-34 weeks) and this study represents the first sonographic 
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investigation of IMT in fetuses. Sarikabadayi et al. (2012) measured the umbilical wall 
thickness in the third trimester with routine obstetrical ultrasound equipment, but did 
not measure umbilical IMT. IMT in carotid arteries in pregnant women was found to 
differ from IMT in the non-pregnant fertile female population. This was largely related 
to the increase in carotid media and decrease in carotid intima layer, that supposedly 
occurs because of the different oestrogen levels in the two groups (Sator et al. 1999). 
There is lack of research on other vascular sites in pregnant women. Furthermore, 
relationships between IMT development and pre-gestational weight (under-, normal-, 
overweight and obese mothers), excessive gestational weight gain or gestational and 
type I/II diabetes mellitus have not yet been reported during pregnancy. 
Our study employed a clear IMT measurement protocol to study the feasibility in 
relevant maternal and fetal arterial vessels at different gestational ages, using a cross-
sectional design. The automated IMT wall tracking software allowed an instant measure-
ment of the target vessel and therefore immediate feedback on the relationship of IMT 
to vessel lumen properties was available. If the maximum IMT measurement crossed 
the anatomical delineation of the vessel and hence created a large discrepancy with the 
minimum IMT value, a large standard deviation resulted. These cut-off values were used 
to define a successful measurement as a quality control for the innovative IMT measure-
ments. Furthermore, through bedside analysis of three different consecutive images of 
the identical predefined vessel location instead of simply three off-line analyzes of the 
same image, we could take the image acquisition process into account, being a large 
source of intra-observer variability.
The present study revealed several impediments to measurement of IMT in fetal arter-
ies. In the first trimester it was not possible to obtain a ROI window of 10mm for all 
fetal vessels because of their small size. In second and third trimester, because of fetal 
movements, the position and distance of the target vessel from the ultrasound probe 
(‘depth’) could impair a successful IMT measurement. In the umbilical artery, the coiling 
of the cord could prevent acquisition of a straight ROI window of at least 10mm. The 
fetal CCA was often not visualized because of fetal position (anterior flexing of the fetal 
neck) and hence a ROI window of 10mm could not be defined. The main obstacle to 
obtaining reliable IMT measurements in the fetal renal artery was the limited angle of 
insonation (<60º or >90º) at which the vessel could be visualized. 
The impediments to measuring the IMT in maternal arteries generally were limited 
examination time and maternal discomfort, making it sometimes impossible to com-
plete all measurements. Because its trajectory is superficial, the maternal CCA is at each 
attempt reachable for ultrasound examination. During pregnancy it was more difficult 
to reach the abdominal aorta because of the interposition of the fetus and uterus and 
the ‘depth’ sometimes prevented successful measurement. The uterine artery is charac-
terized by a very curly trajectory, making it hard to obtain a ROI window of 10mm in the 
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correct angle of insonation (<60º or >90º). The correct angle was also the main obstacle 
for successful measurement of the maternal external iliac artery IMT in pregnancy.
It is not easy to compare our quantitative IMT data with those of other studies as the 
available information relies mostly on histopathology or postnatal IMT studies, therefore 
including the fetal-to-infancy transition period in IMT development. The median IMT’s 
in the fetal CCA and abdominal aorta in our study were 295 and 335 µm respectively, 
which are comparable to the results obtained by Jarvisalo et al. (2001). They performed 
an ultrasound study in 11 year old children with a high risk (hypercholesterolemia/
diabetes) and a low risk for atherosclerosis. In the control group they obtained an IMT 
value in the CCA and abdominal aorta of 420 and 440 µm, respectively. In the high-risk 
group both carotid IMT and abdominal aorta IMT were increased compared with values 
for the low-risk group. The abdominal aorta IMT was higher than the CCA IMT, indicative 
of the predilection of the abdominal aorta as the first location of IMT changes related to 
atherosclerosis. The small variation with our study could be related to the different time 
frame (fetuses vs. children) in which the IMT was measured by Jarvisalo et al. (2001). But 
generally, the studies support the robustness of our findings (Dratva et al. 2013). 
In preterm neonates the abdominal aorta IMT was found to increase from 316 µm to 
348 µm for children born at respectively 25 and 37 weeks of gestation (Koklu et al. 2007). 
This is very similar to our results (335 µm), although we could not report a significant 
positive relationship between IMT and gestational age in our study, probably because 
of our small study population. Furthermore it is unknown whether birth has an effect 
on vessel properties, for example, as a result of a change in blood pressure and hence a 
different distention of arteries after birth. In their ultrasound study, Cosmi et al. (2009) 
reported an IMT of 1150 µm in third trimester fetuses was found, which can probably 
partly be explained by the fact that the authors studied a growth-restricted population. 
Also, they used different equipment and ultrasound resolution in their elegant studies 
(Zanardo et al. 2011; Zanardo et al. 2012).
The median IMT of the umbilical artery in our study was 301 µm in the third trimester. 
In their histopathology study, Junek et al. (2000) reported an IMT of about 30 µm in 
umbilical cords, measured after birth. They compared the evolution of IMT in umbilical 
arteries and veins after birth from IUGR fetuses (controls) and fetuses born of mothers 
with pre-eclampsia (PE). They found that the total IMT increased with advancing ges-
tational age at birth, because the increase in the intima was larger than the observed 
decrease in the media. Between the two groups the IMT was 15% thicker in the umbilical 
arteries from foetuses of mothers with PE than in the controls. Of course, the umbilical 
cord changes significantly after birth with contraction of Wharton’s jelly, the umbilical 
vein and arteries. We can only speculate if this may explain the difference in IMTs be-
tween our study and that of Junek et al. (2000). Sarikabadayi et al (2012) measured the 
umbilical wall thickness in the third trimester with standard obstetric ultrasound and 
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measured umbilical IMT and wall thickness in postnatal pathology specimens. Although 
there was a positive correlation between prenatal and postnatal findings, the absolute 
values cannot be compared between these two time frames because of the different 
structures examined.
Maternal CCA IMT was, on average, 517 µm in our study. This is comparable to the 
results obtained by Sator et al. (1999) who reported 560 µm in pregnant women. We 
did not find a correlation with gestational age, but our study was designed to study 
feasibility at different time points in gestation and not gestational age-related effects. 
Interestingly, we found a positive relationship between maternal CCA IMT and 
maternal preconception BMI. This is in accordance with the study of Dick et al. (2013) 
who found a positive relationship between IMT and obesity, although their study was 
conducted in male and non-pregnant female subjects. Yuan et al. (2013) found very 
recently, in late third trimester pregnancy, a difference in maternal CCA IMT between 
normotensive and pre-eclamptic pregnancies (351±85 µm vs 459±95 µm).   
Several limitations to our present study have to be addressed. The number of patients 
studied was relatively small and comprised a heterogeneous, although cardiovascular 
low-risk, obstetric population. Our study also compiled some longitudinal data with 
mostly cross-sectional measurements. Although significant relations were observed, the 
study may have been underpowered to show other correlations such as for gestational 
age or smoking. Furthermore, by defining a limitation in restricting the SD range for suc-
cessful fetal and maternal IMT measurements, there is the possibility of underestimating 
the IMT measurements and hence probable first signs of inflammation or atherosclero-
sis. From a methodological point of view, we chose to focus on the arterial vessel wall 
and a ROI of 10mm. Another possibility is to include the lumen diameter of the vessel 
of interest in the measurements. Satoru et al. (2012) combined the lumen diameter of 
the abdominal aorta and IMT to an adjusted IMT (aIMT in mm/mm) measurement in 
newborns. For first trimester measurements, it could be considered to choose a smaller 
ROI window then 10mm to be able to measure fetal IMT or measure IMT in such tortuous 
vessels as the umbilical artery and the uterine artery. Finally, more information on the 
plasticity of the vessel can be acquired when automated software would take into ac-
count the influences of blood pressure, blood velocity and wall velocity from the vessels. 
The shear stress or arterial stiffness could thereby be defined through different cardiac 
cycles (Rossi et al. 2009; Yuan et al. 2013). A longitudinal study would be required to 
observe intra-individual changes in IMT in selected blood vessels during gestation.
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ConClUsion
This is the first study to investigate the possibility of measuring IMT during pregnancy in 
both fetal and maternal blood vessels. The study proves the feasibility of reliably measur-
ing IMT with automated software in the fetal abdominal aorta and the umbilical artery 
in second and third trimester of gestation. Strong correlations between our findings 
on fetal abdominal aorta IMT and those from the study by Koklu et al. on newborns of 
different gestational ages, support the robustness of our findings. Obesity of the mother 
did not hamper measurement of IMT in fetal arteries. The positive relationship between 
maternal CCA IMT and BMI invites further investigation into abnormal pregnancies. 
Furthermore, fetal IMT development in abnormal pregnancy is of interest, as it could 
contribute to elucidating the mechanisms of intra-uterine fetal programming and the 
prediction of the origin of adult metabolic diseases.
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aBsTraCT 
introduction
Pregnancy causes hemodynamic changes in the mother. The aim of our study was to 
detect modifications of the vascular properties in the maternal common carotid artery 
(CCA) with radio-frequency ultrasound in relation to maternal characteristics.
methods
Women with low-risk pregnancies were recruited during the first trimester and pro-
spectively followed-up for intima media thickness (IMT) and elastic properties (arterial 
stiffness) measurements of the right maternal CCA. High resolution radio-frequency (RF) 
ultrasound was performed in early, mid- and late pregnancy. Blood pressure and gesta-
tional weight gain (GWG) were obtained at every visit. Total GWG was categorized ac-
cording to the 2009-revised Institute of Medicine criteria as excessive- or non-excessive 
(e-GWG and ne-GWG). CCA elastic indices were calculated: carotid artery compliance 
(CAC), young elastic modulus (YEM) and stiffness index (SI). Generalized Additive Model 
Location, Scale and Shape (GAMLSS) was used to align the timeframes of the measure-
ments.
results
Eighty women (51% nulliparous, 50% with e-GWG), were included in the final analysis. 
All CCA properties and indices were significantly associated with gestational age in 
terms of decreasing compliance (p<0.001) and increasing arterial stiffness (YEM and 
SI, p<0.001). All indices (CAC, YEM and SI) were also significantly correlated with both 
maternal age and e-GWG, but when corrected for maternal age, the YEM remained 
positively correlated with GWG (p= 0.004). No correlation was found with respect to 
pre-gestational BMI.  
Conclusion
Maternal CCA stiffness increased throughout pregnancy age and was positively cor-
related with higher maternal age, e-GWG, but not with pre-gestational BMI category, 
based on RF ultrasound data in pregnancy. When e-GWG was corrected for maternal 
age, the IMT-independent stiffness index (YEM) remained positively associated with 
e-GWG. Further studies are warranted on the long-term vascular effects of maternal 
weight gain during pregnancy as a risk factor for future cardiovascular disease.
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inTroDUCTion
Hemodynamic changes in normal pregnancy have been well described.1,2 At the vas-
cular level, the changes of elastic properties are regionally distributed. The systemic 
vasculature (aorta and direct aortic branches) shows an increased compliance, while 
the common carotid artery (CCA) compliance decreases in normal pregnancy.3,4 In 
studies with non-pregnant individuals, increased arterial stiffness is  used as a first 
sign of remodelling and inflammation of the arterial wall and therefore as a risk factor 
for the development of atherosclerosis.5 In pregnancy the research focus is mainly on 
hyperdynamic circumstances, pregnancy complications and the risk for later disease. 
Preeclampsia for example can alter arterial wall properties with long term effects on 
vascular stiffening.6-8 Different tools have been used to investigate the vascular struc-
ture in pregnancy, all based on non-invasive imaging methods. The most commonly 
used technique is ultrasound.9-11 Radio-frequency (RF) ultrasound is capable to detect 
small vessel wall properties and functionality.12,13 Recently CCA behaviour in pregnancy 
has been elucidated using radio-frequency ultrasound.14,15 These small studies have 
focussed mainly on the effects of hypertension and pre-eclampsia, although it has been 
demonstrated that other maternal determinants, like (excessive) GWG, maternal BMI and 
an increased insulin resistant state (gestational diabetes mellitus) influence pregnancy 
outcome.16-17 It is therefore possible that these maternal characteristics also influence 
arterial stiffness in pregnancy.5 The aim of our study was to describe vascular properties 
of the CCA in normal pregnancy and to detect modifications of the vascular properties 
(IMT and arterial stiffness) with RF ultrasound in relation to maternal characteristics.
Design anD meThoDs
This prospective cohort study was performed at the Department of Obstetrics and 
Gynecology of the University Hospitals Leuven (Belgium). Pregnant women of differ-
ent pre-gestational BMI classes were included at their first trimester ante-natal visit 
between August 2012 and December 2013. This vascular sub-study was part of three 
prospective studies for low-risk, obese and non-obese pregnancies monitored for GWG, 
development of GDM and nutrition.18 All studies were approved by the Ethics Com-
mittee for Human Experimentation of the Faculty of Medicine, Katholieke Universiteit 
Leuven (S52172, S54026 and S55325). All women have signed written informed consent 
to take part in the study. Exclusion criteria for the sub-study were: pre-existing diabetes 
(DM), pre-existing hypertension, development of pre-eclampsia, multiple pregnancies, 
missing longitudinal data and adverse events (major fetal abnormality, fetal death and/
or immature birth).
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maternal determinants
At their first ante-natal visit, parameters for BMI (height and pre-pregnancy weight) 
were obtained as described elsewhere.19 The BMI was categorized as obese (≥30kg/
m²), overweight (25-29.9kg/m²) or normal weight (≤24.9kg/m²) as defined by the WHO 
guidelines. The total GWG was computed using the final weight measured at the last 
prenatal visit, minus the pre-gestational weight. GWG gain was categorized according 
to the Institute of Medicine (IOM) 2009 revised criteria: 11.5-16kg (normal weight), 
7.0-11.5kg (overweight) and 5.0-9.0kg (obese).20 If women crossed the upper threshold, 
they were considered excessive-GWG (e-GWG) or non-excessive (ne-GWG) if they had 
either adequate or insufficient total GWG.21 If women were considered a high risk (his-
tory of GDM, BMI≥30kg/m²), a fasting glucose measurement <92mg/dL (<5.1mmol/L) 
at baseline was used to exclude pre-existing DM. Another screening was performed at 
24-28 weeks using a 75g oral glucose tolerance test (OGTT) based on the 2013 World 
Health Organization (WHO) criteria.22 The non-obese population underwent an OGTT if 
the initial 50g glucose challenge test showed a glycaemia of ≥140mg/dL (≥7.8mmol/L) 
at 24-28weeks (local protocol).
Vascular measurements and blood pressure
Determination of gestational age (GA) was based on the fetal crown rump length (CRL) 
measured between 7 and 14 weeks of gestation in all patients.23 Ultrasound examina-
tions were performed at three time points in gestation: 12-18 weeks, 26-32 weeks and 
between 35-37 weeks of gestation. A proportion (29 participants) was also examined 
between 18-22 weeks of gestation. First a trans-abdominal obstetrical ultrasound was 
performed, which took at least 25-30 minutes and gave the women the opportunity 
to acquire a resting state. Right maternal CCA was examined as follows: patient lying 
in supine position, head tilted slight left lateral (angle of 45°), probe approximately 6 
cm above the clavicle; measurement 1-2 cm proximal to the junction of the internal-
external carotid artery, the carotid artery bulb over a region of interest (ROI) of the 
vessel of 15mm.12,24 High resolution RF, real-time B-mode ultrasound (ESAOTE, Genua, 
Italy) was used, with integrated applications (QIMT -Quality IMT- and QAS -Quality 
arterial stiffness-) as developed in ART-LAB systems (figure 1). The technique is based 
on an automated arterial wall tracking system, which preserves the authenticity of the 
acoustic wave and therefor the examined tissue.13 For IMT the far-wall measurement 
was taken. The QAS provided the vascular diameter (DIA) between diastolic and systolic 
phases and the arterial distension (DIS). A 3-11 MHz, linear-array ultrasound probe was 
used. All measurements for both QIMT and QAS were performed three times over 6 
consecutive cardiac cycles at every time point by the same operator (SG). An average 
of the three mean values was taken, based on 18 cardiac cycles, compensating for the 
hemodynamic fluctuations characteristic in vascular measurements. Blood pressure was 
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measured concomitantly using an automated blood-pressure machine (OMRON M6 In-
tellisense, Healthcare Co.Ltd, Japan) and a mean arterial pressure (MAP) was calculated 
from systolic blood pressure (SBP) and diastolic blood pressure (DBP) as: (2xDBP)+SBP/3. 
After analysing the RF-data via ART-LAB software, the following CCA elastic indices were 
calculated25,26: 
- Carotid artery compliance (CAC), as the ability of the vessel to expand in response 
to the cardiac pulse pressure: ([systolic diameter-diastolic diameter]/diastolic diam-
eter)/(SBP-DBP) in %/10mmHg. 
- Young elastic modulus (YEM), provides an estimate of the arterial stiffness, but is less 
dependent on IMT (arterial wall characteristic)27: ([SBP-DBP]x diastolic diameter)/
([systolic diameter-diastolic diameter]/IMT in mmHg/mm.
- Stiffness index (SI), an elastic property relatively independent of blood pressure28: 
ln(SBP/DBP)/([systolic diameter-diastolic diameter]/diastolic diameter).
Variability
Since 3 consecutive measurements of at least 6 cardiac cycles at each time point were 
performed, the intra-observer variability could be calculated for IMT, DIA and DIS. The 
three measurements cycles are regarded as separate observations (figure 1, 2 and e-
Figure 1. a,b. Maternal right common carotid artery measurement with radio-frequency ultrasound A. 
Quality intima media thickness (QIMT), far-wall measurement; green line = IMT, orange line = adventitia 
B. Quality arterial stiffness (QAS) measurement; blue line = arterial distension (DIS), orange line = arterial 
diameter (DIA). X-axis, region of interest in mm; Y-axis distance in mm.
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figures 8.1-8.3). The intra-class correlation coefficients for IMT, DIA and DIS were: 0.80-
0.95 and 0.87, respectively.  
statistical analysis
GAMLSS (Generalized Additive Models for Location, Scale and Shape, www.gamlss.
org) R-package was applied to construct the growth-evolution curves for the vascular 
properties IMT, DIA, DIS, CAC, YEM and SI.29,30 We assessed several distributions: Box-
Cox-t, Box-Cox Cole and Green, and Box-Cox Power Exponential. Goodness-of-fit of the 
models was assessed with QQ plots, AIC (Akaike Information Criterium) and worm plots. 
The goodness-of-fit was investigated covering the gestational period of 12-40 weeks. 
GAMLSS smoothed the ante-natal growth curves for IMT, DIA, DIS, CAC, YEM and SI. 
Percentiles (P10, P50 and P90) for each investigated parameter were constructed. 
Only complete vascular data-sets including a minimum of two consecutive time points 
were analyzed. The effect of BMI (normal weight, overweight and obese) and the effect of 
excessive GWG versus non-excessive GWG was assessed by adding these variables into 
the GAMLSS model. The same analysis was performed for maternal age (continuous) and 
parity (nulli-parous versus parous). All vascular data and maternal characteristics were 
 
 
 
 
 
Figure 2. Correlation (scatterplots) of vascular properties in the right common carotid artery with the ges-
tational age (x-axis in weeks). Y-axis: Intima media thickness (IMT) in µm, diameter (DIA) in µm and disten-
sion (DIS) in µm. Percentiles, P10, P50 and P90.
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corrected for gestational age if applicable and introduced as consecutive measurements 
within the GAMLSS model. 
resUlTs
From the 101 recruited pregnant women, 5 were excluded based on an abnormal fast-
ing glucose measurement (pre-existent DM) at baseline. There were 4 drop-outs, one 
late first trimester miscarriage, 4 pre-eclamptic participants and 8 participants were 
excluded because of only a single time-point vascular measurement. This resulted in 80 
participants in the final analysis: 35 (44%) had a normal pre-gestational weight, 15 (19%) 
were overweight and 30 (38%) obese. Forty women (50%) showed e-GWG and 14/80 
(17.5%) had an insufficient GWG. The maternal baseline characteristics are outlined in 
table 1. All CCA properties (IMT, DIA and DIS) were highly dependent on gestational age 
(table 2). The IMT decreased, the DIA increased and the DIS decreased during pregnancy 
(figure 2). An overview of the measurements at different time-points is given in table 
3. Detailed reference values per gestational week are provided in e-table 8.1. Also all 
CCA elasticity indices were significantly dependent on gestational age (table 2). The CAC 
decreased (p<0.001), while the YEM and SI both increased significantly (p<0.001), with 
advancing gestational age (figure 3). The elasticity indices at different time points are 
detailed in table 3. Reference values per gestational week are provided in e-table 8.2. 
Table 1. Maternal baseline characteristics. 
Total
(N= 80)
maternal age (years), mean ± std 29.7 ± 4.0
nulliparity (%) 41 (51%)
obese (%) 30 (38%)
overweight (%) 15 (19%)
normal weight 35 (44%)
excessive gWg (e-gWg) 40 (50%)
ga at birth (wks,0/7d), mean ± std 39w3d ± 1w2d
Birth weight (g), mean ± std 3420 ± 510
smoking 5 (6.3%)
gDm 6 (7.5%)
Pih 10 (12.5%)
GWG = gestational weight gain; GA = gestational age; wks = weeks; d = days; g = gram; GDM= gestational 
diabetes mellitus; PIH = pregnancy induced hypertension; std. = standard deviation. 
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Table 3. Blood pressure, vascular properties and elasticity indexes of the right maternal common carotid 
artery per gestational age. 
gestational age <18w 18-34w >34w
 
number 78 105 73
DBP (in mmhg), mean ± std 125 ± 11 123 ± 10 126 ± 11
sBP (in mmhg), mean ± std 73 ± 9 70 ± 8 74 ± 8
maP (in mmhg), mean ± std 90 ± 8 88 ± 8 92 ± 8
imT (in µm), mean ± std 521 ± 60 515 ± 56 505 ± 60
Dia (in µm), mean ± std 6565 ± 381 6804 ± 449 6880 ± 439
Dis (in µm), mean ± std 469 ± 125 456 ± 132 406 ± 124
CaC (in %/10mmhg), mean ± 
std
2.86 ± 0.86 2.60 ± 0.82 2.35 ± 0.82
yem (in mmhg/mm), mean ± std 200 ± 72 218 ± 74 241 ± 84
si, mean ± std 3.97 ± 1.22 4.53 ± 1.40 4.86 ± 1.48
DBP = diastolic blood pressure; SBP = systolic blood pressure; MAP = mean arterial pressure; IMT = intima 
media thickness; DIA = diameter; DIS = distension; CAC = carotid artery compliance; YEM = young elastic 
modulus; SI = stiffness index.
 
 
 
 
 
 
Figure 3. Correlation (scatterplots) of elasticity indexes for the right common carotid artery and the gesta-
tional age (x-axis in weeks). Y-axis: carotid artery compliance (CAC) in %/10mmHg; young elastic modulus 
(YEM) in mmHg/mm; stiffness index (SI); Percentiles, P10, P50 and P90. 
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Increasing maternal age, as a continuous variable, was associated with decreasing 
distension (p<0.001), higher IMT values (p=0.006) and lower compliance (p<0.001) and 
therefore higher arterial stiffness indices (YEM/SI, both p<0.001) in the CCA throughout 
gestation. In non-corrected analysis, the GWG, excessive versus non-excessive, provided 
an effect on CCA elasticity parameters by lower distension (p= 0.05) and compliance 
(p = 0.03) and higher stiffening for YEM (p<0.001) and SI (p=0.01). When corrected 
for maternal age, a significant effect on the IMT-independent stiffness index, the YEM 
(p=0.004; figure 4) remained. In the e-GWG group the median age was 31 years, versus 
29 years in the ne-GWG group (p<0.001). No effect of obesity as compared to being 
non-obese (normal- or overweight), or overweight in all CCA properties and elasticity 
indices was demonstrated (table 2). Also being overweight did not result in any effect on 
the CCA measurements as compared to normal pre-gestational BMI (data not shown). 
Lastly, parity (being nulliparous or parous) also did not show any effect on the CCA wall 
properties during pregnancy. 
Figure 4. Young elastic modulus (YEM) in the maternal right common carotid artery from 12-38 weeks of 
gestational age for excessive and non-excessive gestational weight gain (GWG). Na-GWG = non appropri-
ate or excessive gestational weight gain (solid lines); a-GWG = appropriate or non-excessive gestational 
weight gain (dotted lines). C10, C50 and C90 = Percentile 10, 50 and 90. X-axis, gestational age in weeks; 
Y-axis, YEM in mmHg/mm.
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DisCUssion
To our knowledge we present the first large longitudinal radio-frequency ultrasound-
study on the vascular remodeling of the maternal carotid artery  during pregnancy in 
low-risk women. Our study offers important new information on the natural develop-
ment of vascular properties and elasticity in the CCA during pregnancy in relation to 
maternal age, weight gain and pre-gestational BMI. We demonstrate that, when cor-
rected for maternal age, increased arterial stiffening during gestation correlates with 
gestational weight gain, as a short term and modifiable variable. 
Pregnancy induces hemodynamic changes in women: predominantly a decreased 
peripheral resistance, increased plasma volume and increases cardiac output are ob-
served. These adaptations are required for a successful pregnancy outcome and hyper-
tensive disorders may occur during pregnancy. These disorders have recently been 
identified as being a risk factor for cardiovascular diseases later in life by decreasing ar-
terial elasticity.31 Pregnancy is therefore considered a ‘hypertensive stress-test’ in wom-
en.32 Many different methodologies have been used to obtain information on vascular 
function. Therefore, in normal pregnancy various results concerning arterial compliance 
are reported. Applanation tonometry (pulse wave velocity analysis) was one of the first 
reported methods used in pregnant women and is therefore commonly used as the 
standard for arterial elasticity research.7,9,11 This method measures the pulse wave veloc-
ity, produced by the central aorta at the level of the peripheral brachial artery, which 
serves as a reflection of the aortic compliance. In normal pregnancies it reveals a nadir 
of arterial stiffness in the second trimester, and a similar level of arterial stiffness in the 
first and third trimester.11 There is some debate over whether these peripheral measure-
ments reflect real elastic artery remodeling.11,14,15 Therefore other studies, like ours, in-
vestigated local vascular elastic alterations in peripheral vessels that are easily accessible 
like the CCA. The Cardiovascular Risk in Young Finns study used high frequency B-mode 
ultrasound scanning combined with biomarkers to investigate atherosclerotic risks fac-
tors in early life in elegant long-term studies. In a cross-sectional study of approximately 
30 pregnant women per different trimester and matched controls, they reported a de-
crease in compliance and an increase in stiffness during pregnancy for the CCA.25 In the 
current study, we confirmed this finding. In contrast to the Finnish study however, we 
found a negative correlation between gestational age and IMT evolution and the mean 
values per trimester we obtained for CAC, YEM and SI were all lower with smaller SD’s. 
Besides our larger sample size and longitudinal design, the differences can probably be 
also explained by the highly sensitive automatic arterial wall tracking system we used 
and the fact that all measurements were performed by a single operator. Intima media 
thickness measurement is traditionally considered the gold standard in detecting ath-
erosclerosis. In pregnancy it appears that the intima/media ratio (I/M ratio) seems to 
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better reflect the wall remodeling than the IMT complex.10 Our methodology did not 
enable us to differentiate the separate IMT-layers, but we were capable of identifying a 
significant decrease in IMT during gestation, reflecting the expected adaptation of the 
vascular wall to an increased CCA diameter due the higher plasma volume throughout 
pregnancy. Hypothetically, the modified estradiol levels in our ‘older’ mothers could 
have contributed to an altered I/M ratio (through an increased intima and decreased 
media) and therefore to a higher IMT complex in our study. Recently the first reports of 
radio-frequency (RF) ultrasound findings in late third trimester pregnancies were pub-
lished.14,15,33 These small studies focused mainly on the hyperdynamic conditions (like 
pre-eclampsia), but included long term follow up. They revealed with this sensitive 
technique persistent vascular wall modifications at eighteen months postpartum in the 
preeclamptic group. The technique used in our study, RF ultrasound, is a highly sensitive 
detection technique for small structures (up to 17µm), respecting the tissue characteris-
tics by preserving the acoustic wave for amplitude and phase. Based on M-mode, even 
small differences in vascular wall remodeling can be detected in variable hemodynamic 
circumstances.13 Also the linked automated wall tracking technique, allows the mea-
surement to include at least six cardiac cycles, allows to compensate for time-frame 
vascular fluctuations and provides a high quality mean result for both vascular morphol-
ogy and functionality. Using this highly precise methodology, we were able to detect a 
decrease in IMT as pregnancy progresses, that, as far as we know, was never described 
before. Based on the 50th percentile at 12 weeks of gestation the IMT decreased at 38 
weeks from 519µm to 500µm (table 1, supplement 2). This even outbalanced the six 
months increase of IMT of 7.4µm (annually 14.7µm), which is the natural  IMT increase 
(‘aging’), as previously reported in healthy men.34 Furthermore, when maternal age was 
added as an explanatory variable in the GAMLSS model, there was a positive correlation 
with IMT development. This suggests that older mothers could be more vulnerable to 
vascular wall remodeling during pregnancy. Whether this effect is transient and revers-
ible, can only be elucidated in long term follow up studies. Possibilities for funding of 
these studies are currently being investigated. The negative effects of excessive GWG on 
the CCA elasticity indices are striking. When corrected for maternal age (the e-GWG 
group had a slight but significant higher maternal age), the YEM remained significant, 
although the CAC and SI still demonstrated a trend. The YEM is a stiffness index unre-
lated to IMT development and therefore less dependent on maternal age. This has not 
been described before and the etiology is also unknown. Pregnancy is a period where 
there is a general insulin insensitivity and hence a greater degree of  glucose intoler-
ance. The glucose intolerance could lead to increased insulin concentrations, purported 
to be associated with arterial stiffening.5 Furthermore, maternal GWG reflects a placental 
transfer of nutrients, glucose and free fatty acids and if there is excessive GWG this ac-
companies a larger fat deposition.35 Together with the higher insulin levels characteristic 
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in pregnancy, this might explain the negative effects on vascular wall remodeling of the 
maternal CCA in women with e-GWG, even in the absence of IMT increase. We can only 
speculate on this issue, and since we only measured insulin in the obese pregnancies, 
further investigations needed to address this issue are currently underway.18 In contrast 
to e-GWG a higher maternal BMI did not affect CCA elasticity and wall property develop-
ment in pregnancy. Previous studies have reported a decreased arterial elasticity possi-
bly mediated through an obesity mediated hyperinsulinemia, although this did not 
concern a pregnant study group.36 We did not observe this BMI effect while our cohort 
contained a large (38%) number of obese patients. This, and the fact that we also closely 
monitored and excluded patients showing an abnormal glucose tolerance, enable us to 
distinguish the effects of maternal adiposity (BMI), nutrient intake and storage (GWG) 
and abnormal glucose tolerance. These three separate contributors play an important 
role in the development of complications in the mother and the fetus, both short and 
long term.37 It is important to distinguish the different contributors and their specific 
effects, especially as GWG is potentially modifiable. Interventions to reduce GWG in 
pregnancy can have benefits for both the mother and the fetus. These interventions of-
ten reflect lifestyle, physical activity or a combination of both. But, although there has 
been a reduction in GWG, the effect on the prevention of the adverse outcomes are 
mixed.38 Strengths of this study include the longitudinal design and the  application of 
well-defined inclusion/exclusion protocols, while not customizing the cohort too tightly. 
This prevented the data from skewing the results and provided real reference charts, 
other than standard charts. Also, the use of RF-ultrasound technique, all performed by a 
single operator, therefore overcoming the inter-observer variability. Finally the statisti-
cal GAMLSS method, as recommended by the WHO Multicentre Growth Reference Study 
Group especially for development and regeneration data.30 Some limitations also need 
to be mentioned: Obese women were slightly overrepresented in our cohort, but this 
did not lead to increasing rates of e-GWG or GDM. Possibly because the obese women 
were enrolled in a lifestyle intervention program and women with  pre-existing GDM 
were excluded.16 There was no data available on the nutrition in the full cohort to explain 
the positive correlation between excessive GWG and decreased vascular elasticity. We 
have 5-7days food records in 61/80 of the cohort and further analysis is currently in 
progress. Our results could not be correlated with vascular biomarkers and no long-term 
follow up was performed. Therefore leaving the question unanswered whether the ob-
served vascular changes are transient and could be reversible or not. 
In summary, our study provides to our knowledge the first longitudinal radio-frequen-
cy vascular data during pregnancy for the common carotid artery in low risk pregnant 
women. It offers interesting new insights on the general behavior of the arterial elasticity 
in relation to gestational age, maternal age, gestational weight gain and pre-pregnancy 
BMI class. We demonstrate a positive correlation of both maternal age and excessive 
146 Chapter 8
GWG with increased arterial stiffness during gestation in CCA. Whether this concerns a 
transient, reversible phenomenon requires further investigation. 
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aBsTraCT 
introduction
Maternal obesity may influence cardiovascular development in the offspring. The 
aim of our study was to detect modifications in the fetal abdominal aorta (fAA) with 
radio-frequency ultrasound in relation to maternal characteristics and fetal growth and 
development.
methods
Mothers with low-risk pregnancies were recruited during the first trimester and pro-
spectively followed-up, gestational weight gain (GWG) was categorized according to 
the 2009-revised Institute of Medicine guidelines. The fetus was monitored for growth 
and vascular development of the fAA intima media thickness (fAA-IMT) and fAA elastic 
properties (arterial stiffness) with high resolution radio-frequency (RF) ultrasound. FAA 
elastic indices were calculated: fetal abdominal aortic compliance (fAAC), young elastic 
modulus (YEM) and stiffness index (SI). Generalized Additive Model Location, Scale and 
Shape (GAMLSS) was used to align the timeframes of the measurements.
results
Seventy-four mothers were included in the final analysis of whom 50% were nul-
liparous and 49% showed excessive GWG (e-GWG). fAA measurements could reliably 
be obtained from 25 weeks onwards. All fAA properties (IMT, diameter (DIA) and disten-
sion (DIS)) showed a positive correlation (p<0.001) with gestational age. FAA elasticity 
indices decreased during pregnancy with decreasing fAAC (p<0.001) and increasing 
arterial stiffness (YEM, p<0.001 and SI p = 0.04). Elasticity indices (fAAC, YEM and SI) 
were also significantly influenced by fetal size. The fAA-IMT and DIS showed a significant 
smaller increase in obese mothers (p = 0.03 and p = 0.009), compared to normal weight 
(≤24.9kg/m2 body mass index (BMI)) mothers, even after correction for fetal size. 
Conclusion
Arterial stiffness in the fAA increases towards the end of gestation, and is more pro-
nounced if fetal growth is fast. FAA-IMT development is negatively associated with 
higher maternal BMI, suggesting a modulation of the fetal vessel-wall in obese and 
overweight mothers.
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inTroDUCTion
In Western populations cardiovascular disease (CVD) is the most important cause of 
mortality.1 While clinical manifestations appear more during adulthood, the process of 
atherosclerosis, as a first sign of CVD, already starts early in life.2,3 This very early expo-
sure to an adverse environment during pregnancy, and the subsequent predisposition 
to disease later in life is referred to as the ‘fetal origin of adult disease’, as proposed by 
Law et al. and is one of the features of the Barker’s hypothesis ‘Developmental origins of 
health and disease (DOHaD)’, or ‘fetal programming’.2,4 
Environmental factors can exert their influence on the metabolic health of the offspring 
during pregnancy by abnormal gestational weight gain (GWG), (gestational) diabetes 
mellitus ((G)DM) and maternal obesity.5,6 These maternal metabolic determinants are 
associated with vascular remodelling in the offspring.7 It has been reported that relative 
fetal undernourishment causes alterations on the arterial level, influencing cardiovas-
cular development,thereby confirming a possible mechanism for the correlation of low 
birth-weight and CVD in adulthood.8 At the other end of the spectrum fetal overnutrition 
and high birth weight predisposes for childhood obesity and increased blood pressure 
in adulthood.9-11 And although studies are still limited, there are data showing that being 
born large for gestational age (LGA) is associated with an increased aortic intima media 
thickness in childhood.12-14 Many studies on cardiovascular risk predictors have been 
performed with imaging of arterial wall layers and properties, mainly focussing on the 
common carotid artery (CCA), as this vessel is easily accessible in children and adults. In 
foetuses and newborns, the AA is a better target to study vascular wall properties. In-
deed histopathology studies reveal that this is the first region of vascular inflammation 
and remodelling preceding future adult lesions.15,16 Furthermore, in a previous feasibility 
study we have found the fetal abdominal aorta (fAA) to be the most accessible fetal ves-
sel during the second and third trimester.17 So far, studies examining the fetal vascular 
development are limited and the two reports  availablefocus on cross-sectional third 
trimester measurements.18,19 With current high standard vessel-wall tracking techniques 
using radio-frequency (RF) ultrasound, it is possible to detect arterial properties and 
elasticity.20,21 The aim of our study was to prospectively detect modifications of the fAA 
during pregnancy using RF ultrasound and to relate these to maternal characteristics 
and fetal growth.
Design anD meThoDology
This prospective cohort study was performed at the Department of Obstetrics and 
Gynecology of the University Hospitals Leuven (Belgium). Pregnant women of different 
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pre-gestational BMI classes were included at their first trimester ante-natal visit between 
August 2012 and December 2013. This vascular sub-study was part of three prospective 
studies for low-risk, obese and non-obese pregnancies monitored for GWG, develop-
ment of GDM and nutrition.22 All studies were approved by the Ethics Committee for 
Human Experimentation of the Faculty of Medicine, Katholieke Universiteit Leuven 
(S52172, S54026 and S55325). All women have signed written informed consent to take 
part in the study. Exclusion criteria for the sub-study were: pre-existing DM, pre-existing 
hypertension, development of pre-eclampsia, multiple pregnancies, missing longitu-
dinal data and adverse events (major fetal abnormality, fetal death and/or immature 
birth).
maternal determinants
At the first ante-natal visit, parameters for BMI (height and pre-pregnancy weight) were 
obtained as described elsewhere.23 The total GWG was computed using the final weight 
measured at the last prenatal visit, minus the pre-gestational weight. GWG gain was 
categorized according to the Institute of Medicine (IOM) 2009 revised criteria: 11.5-16kg 
(normal weight), 7.0-11.5kg (overweight) and 5.0-9.0kg (obese).24 If women crossed 
the upper threshold, they were considered excessive-GWG (e-GWG) or non-excessive 
(ne-GWG) if they had either adequate or insufficient GWG.25 If women were considered 
high risk (history of GDM, BMI≥30kg/m²), a fasting glucose measurement <92mg/dL 
(<5.1mmol/L) at baseline was performed to exclude pre-existing  DM. Another GDM 
screening was performed at 24-28 weeks using a 75g oral glucose tolerance test (OGTT) 
based on the 2013 World Health Organization (WHO) criteria.26 The non-obese popula-
tion underwent an OGTT if an initial 50g glucose challenge test showed a glycaemia of 
≥140mg/dL (≥7.8mmol/L) at 24-28weeks (local protocol).
Vascular and fetal measurements
Determination of gestational age (GA) was based on the fetal crown rump length 
(CRL) measured between 7 and 14 weeks of gestation in all patients.27 Ultrasound 
examinations were performed at three time points in gestation: 12-18 weeks, 26-32 
weeks and between 35-37 weeks of gestation. A proportion (29 participants) was also 
examined between 18-22 weeks of gestation. Fetal measurements included: Biparietal 
Diameter (BPD), Head Circumference (HC), Abdominal Circumference (AC) and Femur 
Length (FL). The measurements were obtained in accordance to the guidelines of 
the International Society for Ultrasound in Obstetrics and Gynecology (ISUOG, www.
isuog.org).28 Estimated fetal weight (EFW) was calculated based on the BPD, HC, AC 
and FL.29 The trans-abdominal obstetrical ultrasound was performed first, and took at 
least 25-30 minutes and gave the women the opportunity to acquire a resting state. 
FAA measurements were obtained with the mothers in a supine position (or in slight 
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lateral tilted position, if necessary when facing aorto-caval compression at advanced 
gestation), trans-abdominal, below the fetal renal artery junction and above the iliac 
bifurcation in a coronal or saggital plane with an angle of insonation of 60°–90° over a 
region of interest (ROI) of the vessel of 15mm (e-figure 9.1). High resolution RF, real-time 
B-mode ultrasound (ESAOTE, Genua, Italy) was used, with integrated applications (QIMT 
-Quality IMT- and QAS -Quality arterial stiffness-) as developed in ART-LAB systems. The 
technique is based on an automated arterial wall tracking system, which preserves the 
authenticity of the acoustic wave and therefore the examined tissue.20 For IMT the far-
wall measurement was taken. The QAS provided the vascular diameter (DIA) between 
diastolic and systolic phases and the arterial distension (DIS). A 3-11 MHz, linear-array 
ultrasound probe was used. All measurements for both QIMT and QAS were performed 
three times over 6 consecutive cardiac cycles at every time point by the same operator 
(SG). This resulted in three mean values for every parameter. An average of the three 
mean (3x6) values was taken, based on 18 cardiac cycles, compensating for the hemo-
dynamic fluctuations characteristic in vascular measurements. Fetal blood pressure was 
calculated using the following algorithm: systolic blood-pressure= 1.06*GA +15.91 and 
diastolic blood-pressure= 0.67*GA+2.47, as previously reported.30 After analysing the 
RF-data via ART-LAB software, the following CCA elastic indices were calculated.31,32 
- Fetal abdominal artery compliandce (fAAC), as the ability of the vessel to expand 
in response to the cardiac pulse pressure: ([systolic diameter-diastolic diameter]/
diastolic diameter)/(SBP-DBP) in %/10mmHg. 
- Young elastic modulus (YEM), provides an estimate of the arterial stiffness, but is less 
dependent on IMT (arterial wall characteristic)33: ([SBP-DBP]x diastolic diameter)/
([systolic diameter-diastolic diameter]/IMT in mmHg/mm.
- Stiffness index (SI), an elastic property relatively independent of blood pressure34: 
ln(SBP/DBP)/([systolic diameter-diastolic diameter]/diastolic diameter).
Birth outcomes (weight and gestational age at birth) were obtained from the elec-
tronic obstetrical records of the individual patients.
Variability
Since multiple measurements were obtained based on at least 6 cardiac cycles at each 
time point, the intra-observer variability could be calculated for IMT, DIA and DIS. The 
three measurements cycles were regarded as separate observations (e-figures 9.2-9.4). 
The intra-class correlation coefficients for IMT, DIA and DIS were: 0.63-0.59 and 0.65, 
respectively.  
statistical analysis
GAMLSS (Generalized Additive Models for Location, Scale and Shape, www.gamlss.
org) R-package was applied to construct the growth-evolution curves for the vascular 
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properties IMT, DIA, DIS, fAAC, YEM, SI and for the fetal growth EFW.35,36 We assessed sev-
eral distributions: Box-Cox-t, Box-Cox Cole and Green, and Box-Cox Power Exponential. 
Goodness-of-fit of the models was assessed with QQ plots, AIC (Akaike Information Cri-
terium) and worm plots. The goodness-of-fit was investigated covering the gestational 
period from 25 to 40 weeks. GAMLSS smoothed the ante-natal growth curves for IMT, 
DIA, DIS, fAAC, YEM, SI and EFW. Percentiles (P10, P50 and P90) for each investigated 
parameter were calculated. 
Only the vascular data-sets including a minimum of two consecutive time points were 
analyzed. The effect of maternal BMI (obese if ≥30kg/m²; overweight if 25-29.9kg/m²; 
normal weight if ≤24.9kg/m²) and the effect of excessive GWG versus non-excessive 
(adequate or insufficient) GWG was assessed by adding these variables to the GAMLSS 
model. The same analysis was performed for maternal age (continuous), parity (nulli-
parous versus parous), birthweight (continuous) and fetal gender. The effect of BMI 
(obese versus normal BMI) was added for EFW, fAA-IMT, fAAC. The effect of exceptionally 
large for gestational age fetuses (EFW>P90) and normal BMI was added to the model 
for DIA. Also the effect of EFW>P90 for all BMI classes, e-GWG and birth-weight was 
added. All fetal growth and vascular data and maternal characteristics were corrected 
for gestational age if applicable and introduced as consecutive measurements in the 
GAMLSS model. 
resUlTs
From the 101 recruited pregnant women, 5 were excluded based on an abnormal fast-
ing glucose measurement (pre-existent DM) at baseline. There were 4 drop-outs, one 
late first trimester miscarriage, 4 pre-eclamptic participants and 14 participants were 
excluded because fewer than two time-points of vascular measurement were available 
for analysis. This resulted in 74 mother-fetus pairs in the final analysis: 34 (46%) had a 
normal pre-gestational weight, 13 (18%) were overweight and 27 (36%) obese. Thirty-six 
women (49%) showed e-GWG and 14/74 (18.9%) had an insufficient GWG. The maternal 
baseline characteristics are outlined in table 1. All fAA properties (IMT, DIA and DIS) were 
highly dependent on gestational age (table 2). The IMT, DIA and the DIS all increased 
during pregnancy (figure 1). An overview of the measurements at each gestational week 
is given in table 3. Detailed reference values per gestational week are provided in e-table 
9.2. Also all CCA elasticity indices changed during gestational age (table 2). The fAAC 
decreased (p<0.001), while the YEM and SI both increased significantly (p<0.001), with 
advancing gestational age (figure 2). The elasticity indices at different time-points are 
detailed in table 3. Reference values per gestational week are provided in e-table 9.3. 
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Figure 1. Correlation (scatterplots) of vascular properties in the fetal abdominal aorta artery with the gesta-
tional age (x-axis in weeks). Y-axis: Intima media thickness (IMT) in µm, diameter (DIA) in µm and distension 
(DIS) in µm. Percentiles, P10, P50 and P90.
Table 1. Study group characteristics.
Total
(N= 74)
maternal age (years), mean ± std 29.8 ± 4.1
nulliparity (%) 37 (50%)
obese (%) 27 (36%)
overweight (%) 13 (18%)
normal weight (%) 34 (46%)
excessive gWg (%) 36 (49%)
ga at birth (wks, 0/7d), mean ± std 39w3d ± 1w1d
Birth weight (g), mean ± std 3425 ± 516
smoking (%) 5 (6.8%)
gDm (%) 6 (8.1%)
Pih (%) 4 (5.4%)
GWG = gestational weight gain; GA = gestational age; wks = weeks; d = days; g = gram; GDM= gestational 
diabetes mellitus; PIH = pregnancy induced hypertension; std. = standard deviation. 
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Figure 2. Correlation (scatterplots) of elasticity indexes for the fetal abdominal aorta artery and the gesta-
tional age (x-axis in weeks). Y-axis: fetal abdominal aorta artery compliance (fAAC) in %/10mmHg; young 
elastic modulus (YEM) in mmHg/mm; stiffness index (SI); Percentiles, P10, P50 and P90.
Table 3. Vascular properties en elasticity measurements of the fetal abdominal aorta artery for each ges-
tational week. Values are displayed for 50th percentile as calculated by the GAMLSS model. 
ga imT (in µm) Dia (in µm) Dis (in µm) faaC (in 
%/10mmhg)
yem (in 
mmhg/mm)
si
26 316 3467 234 5.67 56.0 5.77
27 332 3607 238 5.51 61.8 5.82
28 349 3747 242 5.35 67.6 5.88
29 365 3887 246 5.19 73.4 5.93
30 381 4028 251 5.04 79.2 5.99
31 398 4168 255 4.88 85.0 6.04
32 414 4308 259 4.72 90.8 6.10
33 430 4448 263 4.56 96.6 6.15
34 447 4588 267 4.40 102.4 6.21
35 463 4729 271 4.24 108.2 6.26
36 479 4869 276 4.09 114.0 6.32
37 496 5009 280 3.93 119.8 6.37
38 512 5149 284 3.77 125.6 6.43
GA = gestational age; IMT = intima media thickness; DIA = diameter; DIS = distension; fAAC = fetal ab-
dominal aorta artery compliance; YEM = young elastic modulus; SI = stiffness index.
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Fetal characteristics
Birth weight on a continuous scale positively correlated with the increase in diameter, 
and showed a trend for lower distension increase for the fAA. Birth weight and IMT were 
not significantly correlated, but the elasticity parameters were significantly enhanced 
for the compliance (fAAC) decrease and for the YEM/SI increase (table 2). Since birth 
weight was associated, we corrected for the LGA fetus: EFW>P90 as obtained at every 
time point in the normal BMI group (table 2 and e-table 9.1). If corrected for the LGA 
fetus (EFW>P90), birthweight is significantly associated with a reduced increase in dis-
tension (p= 0.04) and greater decrease in compliance (p= 0.004, table 2). The corrected 
birth weight is significantly correlated with increasing YEM and SI (table 2). Gender did 
not show any association with  vascular development of the fAA (table 2).
maternal characteristics
A higher pre-gestational BMI was associated with a lower increase in fAA-IMT and a 
lower increase in DIS during pregnancy, especially when comparing the obese group 
versus the normal BMI group (p = 0.03 and p = 0.009, respectively). Furthermore, when 
correcting for the LGA fetuses, there still remained a significant correlation of higher BMI 
as compared to normal BMI with the IMT (p = 0.03) and DIS (p = 0.008) evolution in utero 
(table 2). Similarly being overweight had a negative association with the IMT increase (p 
= 0.02) compared to normal weight women, even when corrected for LGA fetuses (p = 
0.02, table 2). When the obese group was compared to the other BMI categories (normal 
and overweight) together, the association with obesity remained significant for the fetal 
aortic distension (p= 0.01), which persisted after correction for LGA fetuses (p = 0.01, 
table 2).
Parity, maternal age and GWG did not show any significant effect on the fAA develop-
ment in utero (e-table 9.1).
DisCUssion
To our knowledge this is the first longitudinal radio-frequency ultrasound study of 
vascular remodeling in the fetal abdominal aorta. Our study offers important new 
information and insight inro the natural development of vascular properties and elastic-
ity in the fAA in relation to gestational age, fetal weight and maternal pre-gestational 
BMI category. We demonstrate that, even when corrected for the LGA fetus (EFW>P90), 
increased arterial stiffening during gestation in the fAA positively correlates with fetal 
growth. Furthermore, maternal pre-gestational BMI category isnegatively associated 
with vessel-wall remodeling of the fAA. 
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Pregnancy induces hemodynamic changes , and is therefore considered a ‘hyperten-
sive stress-test’ in women.37,38 When this adaptive mechanism fails, this may predispose 
to pathologic situations like gestational hypertension, preeclampsia and fetal growth 
restriction. This is most frequent in women with an altered metabolic state.39 Women 
with diabetes, obesity and excessive weight  gainare at higher risk to fail the stress test. 
For the offspring of these women, it is likely that this maladaptation has repercussions 
on fetal growth and long term vascular development. This is suggested by the many 
studies that focus on the relationship of maternal characteristics and birth-outcome on 
long-term cardiovascular effects in the mother and offspring. In contrast, studies includ-
ing the in utero environment and prenatal changes are scarce.40,41 The intima-media 
vessel wall layer has been reported as the first site of atherosclerosis and thickening 
is regarded as an early  pre-clinical sign of future lesions.15,16 Cosmi et al and Crispi et 
al have confirmed increased IMT of the intra uterine growth restricted fetuses and the 
small for gestational age babies.8,18 IMT measurements in school aged children were 
higher in association with higher birthweight.13,14 Most postnatal reports concern the 
common carotid artery, but Koklu et al, reported on the IMT of the abdominal aorta in 
neonates, born at different gestational ages.42 Their IMT results correspond well with 
the ones from our in utero study. One of the reasons forthe limited availability of  data, 
regarding prenatal information on vascular development, is that the parameters (e.g. 
blood pressure) necessary to gain information on the fetal cardiovascular system are 
difficult to obtain. Furthermore, the available research methods require a subject in a 
resting state and require close contact with the subject (applanation tonometry), neither 
of which are feasible in a moving fetus. RF ultrasound offers a non-invasive possibility to 
overcome these limitations.
Recently the first reports of radio-frequency (RF) ultrasound findings in late third 
trimester in the maternal common carotid artery were published.43,44 The technique 
used in our study, RF ultrasound, is a highly sensitive detection technique for small 
structures (up to 17µm), respecting the tissue characteristics by preserving the acoustic 
wave for amplitude and phase. Based on M-mode, even small differences in vascular wall 
remodeling can be detected in variable hemodynamic circumstances.21 Also the linked 
automated wall tracking technique, allows to include at least six cardiac cycles and to 
compensate for time-frame vascular fluctuations and to provide a high quality mean 
result for both vascular morphology and functionality. Using this highly precise meth-
odology, we were able to describe vessel structures and their longitudinal development 
during pregnancy for the first time.
Not surprisingly we found gestational age to have a significant effect on all fetal vessel 
properties (IMT, DIA and DIS). But the progressive arterial stiffening in the fetal aorta (de-
crease of fAAC, increase of YEM and SI) during pregnancy is a novel finding. In addition 
the association between birth weight and fetal growth with the elasticity properties of 
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the fAA in low-risk pregnancy fetus has never been reported before. Most interestingly, 
and also novel, is the finding that maternal obesity was significantly associated with 
altered vascular development in the fetus, shown  by the correlation between maternal 
BMI and  decreased IMT and distension.
We can offer some potential mechanisms for our findings. It has been demonstrated 
that the extracellular matrix (ECM) of the vessel wall develops rapidly during late 
gestation and in the newborn. Elastin which provides elasticity, and collagen, are both 
components of the ECM and contribute to vascular stiffness. It is elastin that accumu-
lates rapidly in late gestation and in the early neonatal period, slowly degrades as the 
individual ages. Collagen on the other hand accommodates increased blood pressure 
and vascular shear stress, and is positively correlated with aging.45 Therefore the ECM 
organization and development strongly relies on intravascular pressure and flow. In 
vitro studies in humans have been performed with umbilical arteries, with an increased 
umbilical IMT in pre-eclamptic versus non-hypertensive subjects.46 An IUGR-induced 
sheep model was used to study the effect of IUGR on carotid vessel compliance with 
pressure-diameter measurements and histo-morphology. They reported a changed 
collagen-to-elastin ratio in the carotid arteries of the IUGR-sheep fetus. They conclude 
that a decreased elastin, due to higher pressure, and increased collagen stiffen the walls 
of the aorta and great arteria, especially in the growth inflicted individual.47 One could 
therefore hypothesize that our observations of increased arterial stiffness in fetal aorta 
are probably due to the rapid vessel development in late gestation, with increasing fetal 
blood flow and hence change in architecture and function of the vessel wall. Based on 
our observations, the DIA increase was much higher than the increase of DIS, which 
might explain the relative stiffening of the  vessel-wall . Whether this observation reflects 
a natural vessel-wall remodeling, as found in the histo-morphology study referred to 
above, is unknown. The finding that a higher maternal BMI is associated with a lesser IMT 
increase, could also reflect a remodeling effect of the arterial vessel layers. This can lead 
to a thinner (and less compliant) fAA. In a previous study we have reported a positive 
association between higher BMI and fetal weight, therefore we corrected for the LGA 
fetus (EFW>P90) in the GAMLSS analysis for the BMI-effect.48 The effect of obesity and 
overweight on the fAA remained even after this correction.
Strengths of this study include the longitudinal design and the application of well-
defined inclusion/exclusion protocol, while not customizing the cohort too tightly. This 
prevented the data from skewing the results and provided real reference charts, rather 
than standard charts. Also, the use of RF-ultrasound technique, all performed by a single 
operator, helped overcoming the inter-observer variability. Finally the statistical GAMLSS 
method used is recommended for development and regeneration data by the WHO 
Multicentre Growth Reference Study Group.36 Some limitations to this study include 
that obese women were slightly overrepresented in our cohort, but this did not lead to 
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increasing rates of e-GWG or GDM. This may have been because the obese women were 
being part of a lifestyle intervention program and therefore tightly controlled for pre-
existing glucose intolerance.22 There was no data available on nutrition in the full cohort 
to explain the positive correlation of BMI and the decreased fAA-IMT development. We 
have 5-7days food records in 57/74 of the cohort and further analysis is currently in 
progress. We had to calculate blood pressure for the fetus, since this was not feasible to 
measure in utero.30 We cannot rule out that individual blood-pressure fluctuations from 
the fetus influenced our results on the elasticity indices. Furthermore, our results could 
not be correlated with vascular biomarkers and no long-term follow up was performed. 
In summary, our study provides the first longitudinal radio-frequency vascular data 
during pregnancy for the fetal abdominal aorta in low risk pregnant women. It offers 
interesting new insights on the general behavior during early life of the fetal arterial 
elasticity in relation to gestational age, fetal growth and pre-pregnancy BMI class. We 
demonstrate a positive correlation of both fetal growth and maternal BMI with increased 
arterial remodeling during gestation in the fetal abdominal aorta. Whether this concerns 
a transient or persistent phenomenon requires further investigation. 
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sUmmary
The effects of maternal adiposity (high body mass index - high BMI -), nutrient intake and 
storage (gestational weight gain - GWG -) and (abnormal) glucose tolerance (gestational 
diabetes - GDM - ) are regarded important cornerstones in metabolic research in preg-
nancy. In Chapter 1, I explained, that they play an important role in the development 
of complications in the mother and the fetus, both short- and long-term. I also reported 
on how the current state of research in pregnancy has evolved and how it can be used 
for detailed studies of the unborn child. In this field of research, the fetal period is often 
conveniently summarized by its resultant birthweight. This outcome parameter is used 
to compare intra-uterine effects on long- and short term complications in epidemiologic 
studies. High and low birth weight have been linked to future increased cardiovascular 
risk profiles, fitting the ‘fetal origin of diseases’ theory. Beside birth weight, more detailed 
information on the neonates’ body composition (fat distribution), in both lean- and fat 
mass might reflect the in utero development better, although fetal predictors for neo-
natal adiposity still have to be developed. Furthermore, there is no generally accepted 
definition of ‘neonatal BMI’ or neonatal adiposity. At present ponderal index or fat-mass 
percentage fill this lacuna. Finally, ultrasound in pregnancy is capable of obtaining in-
formation on the unborn child and uses an estimation for fetal weight. Accuracy for this 
estimate fluctuates around 6-12% of the actual fetal weight. In the obese mother, on the 
other hand, visualization of the fetus is even more limited.
As stated in Chapter 2, the environment in utero and in early neonatal life may induce 
a permanent response in the fetus and the newborn, leading to enhanced susceptibility 
to later diseases. Fetal overgrowth is related to a diabetic intra-uterine environment. 
The increased prevalence of diabetes mellitus (DM) in children of diabetic mothers is 
consistent with an epigenetic effect of hyperglycemia in pregnancy acting in addition 
to genetic factors that induce diabetes in next generations (human and animal data). 
Fetal growth restriction due to malnutrition on the other hand, leads to a higher inci-
dence of CVD and type-2 DM in later life. Particularly when catch-up growth is present 
by high caloric postpartum intake. The third trimester seems to be a vulnerable period 
for the influence of maternal malnutrition, and hence fetal growth restriction (human 
and animal data). The role of environmental influences, such as excessive nutrition, 
nutritional restriction or low folic acid and vitamin B12 levels, on DNA methylation in 
early life development is called epigenetics. The effects of maternal and fetal nutrition 
stresses the importance of the embryonic environment on epigenetic imprinting for 
metabolic mechanisms on the future generations. Not every overweight newborn and 
not every newborn with intra-uterine growth restriction will develop problems in later 
life. Other factors of course influence final outcomes: in general it depends on the extent 
of adaptation and on its plasticity later on.
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In view from the fetus, the intra-uterine period has been associated with gender spe-
cific physical adaptations to a changed nutrient supply from the mother. The male infant 
body composition has been shown to be more sensitive to maternal influences such as 
higher pre-gestational BMI and excessive gestational weight gain. And although gender 
is recognized as a determining factor for differences in outcome in adult medicine, little 
information is available on fetal gender influence in the prenatal period. Given these 
complexities the World Health Organization (WHO) Multicentre Growth Reference Study 
Group (MGRS) recommended GAMLSS (Generalized Additive Model Location, Scale and 
Shape) for the construction of (WHO) Growth Standards. In Chapter 3, we constructed 
fetal growth curves in a Caucasian population (12368 pregnancies) and further custom-
ized for fetal gender. The fetal head measurements were significantly larger in boys com-
pared to girls from 20 weeks’ gestation onwards, equating to a 3 day difference at 20-24 
weeks. Boys were significantly heavier, longer and had greater head circumference than 
girls at birth. The Apgar score at one minute and arterial cord pH were lower in boys. 
These longitudinal fetal growth curves for the first time allow integration with neonatal 
and pediatric WHO gender specific growth curves. Immediate birth outcomes are worse 
in boys than girls, and gender differences in intra uterine growth are sufficiently distinct 
to have a clinically important effect on fetal weight estimation and second trimester 
dating. Gender differences might play a role in obstetric or immediate neonatal viabil-
ity management. The implication of these findings is that a boy and a girl at exactly 
24weeks gestation might, based on the current late second trimester dating protocols 
with head measurements, be assigned a gestation as much as 3 days different and an 
estimated weight difference of 21gram at 24weeks favoring the boys; The term differ-
ence adds to 121gram, favoring the boys. Also the boys’ head circumference is larger 
(+0.6cm) at birth. In conclusion, the boys seem to be more vulnerable around viability 
age (22-24weeks), since they are estimated older than they are in reality. The girls are 
more vulnerable for this erroneous estimate at the later post-term period in pregnancy. 
Because at this stage, decisions on ending the pregnancy are often taken and they are 
older than estimated. But around term, boys do worse for the immediate start (lower 
first minute Apgar Score and cord-pH) compared to girls.
In Chapter 4, a prospective cohort analysis was performed for the influence of mater-
nal GWG and BMI on fetal growth. These factors influence independently fetal growth 
development during pregnancy and birth weight. Cluster analysis discerned four total 
GWG clusters: I: ≤0kg, II: 0-4kg, III: 4-12kg and IV: >12kg. For each cluster there was a 
different fetal weight evolution and also finally, different birth size. When cluster IV was 
compared to cluster I, the additive effect of the cluster difference on birth weight was 
+477g. The maternal BMI class acted independently on the fetal weight evolution. A 
higher BMI class increased fetal growth and hence birth weight. When BMI of 35 was 
compared to a BMI of 17, the additive effect on birth weight was +334g. The total GWG 
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effect had most impact from 180 to 200 days gestation when there was a separation 
between the different GWG clusters. By identifying this relationship between GWG, 
growth and birth weight, we may now have time potential to influence weight gain dur-
ing pregnancy and so possibly prevent perinatal complications, improve the metabolic 
and vascular traits of the infant and possibly improve outcomes in future pregnancies.
Since birthweight is the resultant of the fetal period, the aim of Chapter 5, was to 
increase knowledge on the intra-uterine development with regard to fetal body 
composition. This was prospectively monitored in a highly controlled glucose tolerant 
cohort of 126 mothers. GWG was regarded ‘excessive’ (e-GWG) if the revised-2009 IOM 
upper thresholds were crossed. If not, the GWG was considered non excessive GWG (ne-
GWG). In the prepregnant obese group, the fetal liver size (LL) and the abdominal fat 
thickness (AFT) growth trajectory increased significantly compared to normal weight 
women. E-GWG positively correlated with the growth in fetal abdominal circumfer-
ence , LL, subscapular fat thickness (SFT) and AFT as compared to the ne-GWG group. 
Birth outcomes were significantly different for weight, length and head circumference 
in the e-GWG group as compared to the ne-GWG. Obesity and e-GWG both positively 
affect adiposity during fetal and neonatal life, with e-GWG clearly affecting fetal size in 
general, which was confirmed by birth anthropometry. In the normoglycemic pregnant 
women, determinants of the fetal trunk (LL, SFT, AFT and AC) are potentially useful in the 
prediction of neonatal adiposity. Our longitudinal study determined early signs of fetal 
adiposity associated with maternal obesity and particularly e-GWG in normoglycemic 
women. Maternal high BMI correlated with fetal liver size and abdominal fat, where 
e-GWG additionally correlated with increased subscapular fat and abdominal circumfer-
ence development. Furthermore, fetal adiposity emerged as a reflection of a nutritious 
environment in utero with effects detectable as early as 20 weeks. Especially the indica-
tors of the fetal trunk (liver-length, AFT, SFT and AC) are discriminative of fetal adiposity 
and warrant further investigation as potential early predictors of neonatal adiposity.
Given these results we correlated in Chapter 6 these measurements in 121, highly 
controlled glucose tolerant mothers, prospectively, with neonatal body composition 
indices: neonatal fat mass (NFM), ponderal index (PI) and birthweight. The mean NFM 
at birth was 11.0% (SD±3.4%), with a cut-off of 15% for the 90th percentile (P90). No 
association was found between the maternal body mass index (BMI) and NFM. However, 
children born to mothers who had an e-GWG had a significantly higher NFM (11.6%) 
as compared to the ne-GWG mothers (10.4%). Fetal measures were highly correlated 
with neonatal measurements. Fetal abdominal circumference (AC), liver length (LL), 
subscapular- and abdominal fat thickness, humerus and femur fat mass development 
correlated significantly with 90th NFM percentile. Fetal AFT did not correlate with the PI. 
In the normoglycemic woman, e-GWG was associated with an increased neonatal adi-
posity. The neonatal PI and high adiposity (>P90 NFM) were preceded by an increased 
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development of fetal central- and peripheral fat mass parameters. The fetal abdominal 
tissue development (AC, LL), reflecting fetal central adiposity, correlated highly to the 
90th percentile of neonatal fat mass, showing their potential role as early predictors for 
neonatal fat deposition. In conclusion, the fetal fat measurements showed a high degree 
of correlation for neonatal adiposity, with a gestational age specific timing of first onset 
of aberrant fetal adiposity development: first (late first trimester) the abdominal circum-
ference and fetal liver length, secondly (late second trimester) the truncal fat deposi-
tions of abdominal- and subscapular fat thickness and lastly (early third trimester) the 
peripheral fat depositions on the extremities (humerus and femur). The fetal abdominal 
fat development, a marker of fetal central fat deposition, correlated specifically to the 
90th percentile of neonatal fat mass, for which further studies are needed to show its 
potential role as a more specific predictor for neonatal adiposity.
Fetal developmental programming is influenced by maternal BMI, GWG and glucose 
intolerance. These factors affect the fetal growth and development, often conveniently 
summarized by its resultant ‘birthweight’. Birth weight is used in epidemiological studies 
as a proxy for long- and short term complications. Cardiovascular risks have been linked 
to birth weight, fitting the ‘fetal origin of diseases’ theory. Intima-media thickness (IMT) 
has been suggested as a marker of pre-clinical atherosclerosis. In the mother, IMT can be 
altered through dynamic circumstances related to pregnancy. In 38 low-risk pregnancies 
we investigated in Chapter 7, the feasibility of measurement of IMT at four pre-defined 
fetal and four pre-defined maternal arterial locations to determine vascular changes 
that could be associated with impaired vascular function throughout pregnancy. Fetal 
abdominal aorta IMT was measurable during the second trimester in 71% and during 
the third trimester in 100% of the cases, and umbilical artery IMT was measurable in 
50% and 82% of cases during the second and third trimesters, respectively. Fetal IMT 
measurements were not possible during the first trimester. It was not often feasible to 
measure the IMT of the fetal common carotid artery, fetal renal artery and maternal iliac 
artery (maximal 20% of cases). Maternal common carotid artery, abdominal aorta and 
uterine artery IMTs were measurable throughout pregnancy. There was a  significant 
relation between gestational age and IMT in the umbilical artery and a significant rela-
tion between body mass index and IMT in the maternal common carotid artery. IMT 
measurements are feasible in some maternal and fetal vessels of interest. Furthermore, 
fetal IMT development in abnormal pregnancy is of interest, as it could contribute to 
elucidating the mechanisms of intra-uterine fetal programming and the prediction of 
the origin of adult metabolic diseases.
Pregnancy induces hemodynamic changes in women. The common carotid artery 
(CCA) is an easily accessible artery and is therefore often used in research (but also clini-
cally) as representative for great artery health. Vascular changes in the CCA throughout 
normal pregnancy have not been elucidated before. In Chapter 8, we performed high 
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resolution, radio-frequency (RF) ultrasound measurements of the CCA in 80 low risk 
mothers, prospectively, from first trimester onwards. All CCA properties and indices 
were significantly associated with gestational age in terms of decreasing compliance 
(Carotid Artery Compliance -CAC-) and increasing arterial stiffness (Young Elastic Modu-
lus -YEM- and Stiffness Index -SI-). All indices (CAC, YEM and SI) were also significantly 
influenced by both maternal age and e-GWG, but when corrected for maternal age, the 
YEM remained positively correlated with GWG. Interestingly, no correlation was found 
with respect to pre-gestational BMI. In summary, our study provides to our knowledge 
the first longitudinal radio-frequency vascular data during pregnancy for the common 
carotid artery in low risk pregnant women. Whether the observed changes concern a 
transient, reversible phenomenon or represent a more durable modification with cor-
relates later in life requires further investigation. Particularly the long-term vascular ef-
fects of maternal weight gain during pregnancy as a risk factor for future cardiovascular 
disease.
More challenging - when we look at our feasibility study reported in chapter 7 - is 
the research on the fetal abdominal aorta (fAA) development throughout pregnancy. In 
Chapter 9, we included seventy-four mothers in the final analysis. fAA measurements 
could reliably be obtained prospectively from 25 weeks onwards. All fAA properties (IMT, 
diameter (DIA) and distension (DIS)) showed a positive correlation with gestational age. 
FAA elasticity indices decreased during pregnancy with decreasing fAA Compliance 
(fAAC)  and increasing arterial stiffness (YEM and SI). Elasticity indices (fAAC, YEM and SI) 
were also significantly influenced by fetal size. Interestingly, the fAA-IMT and DIS showed 
a significantly smaller increase in obese mother when compared to normal weight 
(≤24.9kg/m2 BMI) mothers, even after correction for fetal size. In conclusion, arterial 
stiffness in the fAA increases towards the end of gestation, and is more pronounced if 
fetal growth is fast. FAA-IMT development is negatively affected by high maternal BMI, 
suggesting a modulation of the fetal vessel-wall in the obese and overweight mothers. In 
summary, our study provides the first longitudinal radio-frequency vascular data during 
pregnancy for the fetal abdominal aorta in low risk pregnant women. We demonstrate 
a positive correlation of both fetal growth and maternal BMI with increased arterial 
remodeling during gestation in the fetal abdominal aorta. As with the results achieved 
with measures of the maternal CCA, whether this represents a transient or persistent 
phenomenon requires further investigation.
FUTUre PersPeCTiVes
The objective of this thesis was to investigate the effects of pregnancy dynamics (GWG 
and glucose intolerance) on the short term outcomes of infant body and cardiovascular 
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development from the perspective of different pregestational BMI categories. These 
early life developments impact the infants’ start in life and it is thought that this start 
may potentially induce long-term metabolic effects.  
The research conducted for this thesis is unique as it combines: very high quality 
ultrasonic sensing with prospective and longitudinal measurements performed with a 
substantial number of patients under highly controlled conditions. Also, the longitudi-
nal measurements for chapters 5 to 9 were obtained by one single operator, the doctoral 
candidate (SG), hereby overcoming the inter-observer variation bias. This allowed for a 
series of primary studies which advance the current state of knowledge on the dynam-
ics of pregnancy and infant development. The thesis consist of the following chapters. 
Chapter one provides an overall overview and introduction of key history and concepts. 
Chapters two and three reveal general risk factors for adverse fetal growth and the role 
of fetal gender on separate intra-uterine development and (adverse) perinatal outcome. 
Chapter 4 highlights maternal influences on the timing of adverse fetal growth. Chap-
ters 5 and 6 perform a fetal sequencing in order to find early predictors for neonatal 
adiposity. And chapters 7 to 9, discern with novel techniques interesting new informa-
tion on the modulation of maternal and fetal great arteries during pregnancy. This 
thesis certainly opens up new perspectives. And besides the strengths, stated above, 
also shortcomings have to be highlighted, most of them will additionally open up new 
research perspectives, of which most can be managed with the available data enclosed 
in the cohorts from this thesis. 
gestational Weight gain
In chapters 5,6,8 and 9 the GWG has been categorized as ‘excessive’ and ‘non-excessive’ 
according to the 2009-revised IOM criteria. In the non-excessive group, both adequate 
and insufficient GWG has been enclosed. And although the group of insufficient GWG 
was small, there has been some concern of the effect on fetal size (‘birthweight’). There-
fore it is interesting in further studies, to categorize the revealed effects of chapters 5,6,8 
and 9 for this insufficient GWG group. Furthermore, we looked at final GWG (total-GWG). 
There have been reports that ‘timing’ of GWG in pregnancy differentiate the fetal adapta-
tion towards either higher or lower susceptibility for later adverse outcomes. Particularly 
the first trimester weight gain profile seems an important period. As we have followed 
these cohorts prospectively, we measured their weight gain every visit, so we should be 
able to discern GWG profiles per trimester easily. 
nutrition
In chapters 5,6,8 and 9 an effect of maternal GWG and BMI has been demonstrated. 
More in detail it is exciting to look at the different lifestyle factors (nutritional intake and 
physical activity) of these mothers and to correlate them with GWG, BMI and fetal de-
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velopment. For more than two-third of the participants (from ‘DALI’ and ‘MANOE’ study) 
we have 5-7 days food questionnaires and -diaries, providing information on maternal 
nutrition during pregnancy. For the same sub-study groups we will have information 
on physical activity. Analysis is currently being performed. Also, from a small subgroup 
(approx. 50 participants from ‘MANOE’ study) from which we have both maternal and 
fetal-neonatal data, epigenetics analysis is currently being performed in maternal- and 
cord blood.
(g)Dm - (gestational) Diabetes mellitus -
In chapters 5,6,8 and 9, we performed a close control for glucose intolerance and ex-
cluded to our best, the highly glucose intolerant women. Since some of them have been 
excluded at recruitment, we do not have longitudinal information on most of the overt 
diabetic women. For this we have to rely on the multicentre ‘DALI’ study, in which we 
hope to have enclosed a nice cohort of overt DM and GDM. Analyses are currently being 
performed and outcomes (key findings and deliverables) have to be reported at the end 
of 2015.  
Biomarkers
In chapters 5,6,8 and 9 we did not correlate with maternal or fetal/neonatal biomarkers. 
This is a limitation for both the vascular and the fetal-neonatal body composition cor-
relates. We will have the bio-markers for the obese group of women and their off-spring 
(‘DALI’ participants and cord blood), and analysis is currently being performed.
Fetal predictors
In chapters 5 and 6 we aimed to define fetal distinctive body composition measure-
ments in order to predict neonatal adiposity. Although there is no clear definition for 
neonatal adiposity, it seemed that for early antenatal predictors, the fetal abdominal 
circumference and fetal liver size could provide a good estimate for future neonatal 
adiposity. As a predictive model, further investigations are being performed to obtain 
relative risks (RR),  odds ratio’s (OR) and area under the curves (AUC’s). Future research 
in large study samples is needed to obtain a practical and widely accepted definition or 
index for neonatal adiposity, which correlates with future metabolic risk profile.
neonatal adiposity
Continuing this subject, in chapter 5 and 6, we defined neonatal adiposity with an 
algorithm, including skinfolds measured after birth, within the 48hrs. In many research 
settings, a more objective bio-impedance analysis (BIA) or air-displacement plethys-
mography (ADP) is being performed. Although there has been a good correlate between 
skinfold measurements and ADP/BIA, the skinfold measurement technique needs 
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proper training and exercise to overcome inter- and intra-observer variability. Benefit of 
the skinfolds is that they provide more information on fat distribution of the infant. We 
have for as subgroup (‘MANOE’ participants) additional BIA information on mothers, and 
also for infants at 6 weeks, 6, 12, 18 and 24 months post-partum. These measurements 
are still being performed and analyses follow. 
Vascular properties
In chapters 7, 8 and 9 we performed high-technological measurements concerning 
the vascular wall properties of the great arteries of mother (CCA) and fetus (fAA). Since 
these radio-frequency data encloses raw imaging information on tissue characteristics, 
we will be able in the near future to extract even more information on these vessels of 
interest, by outcome parameters for augmentation index and pulse-wave velocities. The 
last parameter being regarded as the golden standard for vascular shear-stress proper-
ties. In highlighting the high-standard technique, we at the same time acknowledge 
the difficulty of repeating these studies in clinical settings. It requires not only skills and 
patience from the investigator (and participant!), but the equipment itself is currently 
only being used in research settings and not in clinical practice. On the other hand, long-
term follow-up is needed to address the vascular changes observed in both mother and 
fetus (e.g. in -preferably the same- children at school age). Funding to embed this high 
technology for long-term follow-up is currently being investigated. 
long term outcomes
In chapters 5,6,8 and 9 only short term outcomes were monitored. Indeed for both fetal 
and neonatal adiposity measurements and vascular measurements long-term follow-up 
is warranted, to estimate the consequences of the findings of the studies. This will hope-
fully provide new insights in the origin of child-hood obesity (a current hot topic) and 
metabolic (aberrant) changes in later life. Together with the DALI consortium currently 
further alternatives to finance these long-term follow studies are being looked at, via 
European, but also via more international resources.  
ConClUsion
In conclusion, this thesis adds:
- Gender-tailored insights in fetal development and outcome consequences, gener-
ally favoring girls above boys, except for the post-term period.
- New sensing techniques to allow for a much more accurate view on fetal body- and 
vascular development in utero. 
- Correlates of fetal development and neonatal adiposity (neonatal fat measurement).
Summary and future perspectives 179
- Measurement approaches in high standard ultrasound technique (RF ultrasound) , 
whichhave been refined for vascular wall property measurements (functional and 
morphology) on the maternal CCA and fAA showing the most promise for reliable 
execution and meaningful insight.
- Measures that show  an overall tendency for increased arterial stiffness during preg-
nancy with some interesting interactions and exceptions.
As these results represent the first studies of this kind to date considerable care needs 
to be taken with the overall interpretation of results. 
It  is clear that high GWG, high BMI and increased glucose intolerance are important 
risk factors for neonatal adiposity. High quality ultrasound measures of vascular devel-
opment could potentially provide clinicians a sensitive tool to detect early the develop-
ment of adiposity. This could allow for targeted interventions to influence GWG and thus 
potentially influence infant adiposity. Whether such an intervention strategy could be 
designed and will prove to be successful is a prime option for future research.
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183Abbreviations
aBBreViaTions
aIMT aortic Intima Media Thickness
AC Abdominal Circumference 
ADP Air Displacement Plethysmography
AFT Abdominal Fat Thickness
AGA appropriate-for-gestational age
AS Apgar Score
BE Base Excess
BHC Birth Head Circumference
BIA bio-electrical impedance analysis
BL Birth Length
BMI Body Mass Index 
BPD BiParietal Diameter
BW Birth Weight
CAC Carotid Artery Compliance
CCA Common Carotid Artery
CRL Crown Rump Length
CVD CardioVascular Disease
DALI Vit D And Lifestyle Intervention on the prevention of GDM
DBP Diastolic Blood Pressure
DIA Diameter
DIS Distension
EFW Estimated Fetal Weight
fAA Fetal Abdominal Aorta
fAAC Fetal Abdominal Artery Compliance
faIMT fetal abdominal aortic Intima Media Thickness
FFMA Fetal Fat Mass Area
FL Femur Length
FLMA Fetal Lean Mass Area
FLDA Functional Linear Discriminant Analysis
GA Gestational Age
GAMLSS Generalized Additive Model Location, Scale and Shape
(G)DM (Gestational) Diabetes Mellitus
(n-e)-GWG  (non-excessive) Gestational Weight Gain
HC Head Circumference
IGF Insulin Growth Factor
IMT Intima-Media Thickness
IOM Institute of Medicine
ISUOG International Society on Ultrasound in Obstetrics and Gynaecology
IUGR Intra-Uterine Growth Restriction
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186 Abbreviations
LGA large-for-gestational age
LL Liver Length
MANOE MAternal Nutrition and Offspring’s Epigenome
MAP Mean Arterial Pressure
MGRS Multicentre Growth Reference Study Group
MHz Mega Hertz
MRI Magnetic Resonance Imaging
NAFLD Non-Alcoholic Fatty Liver Disease
NFM Neonatal Fat Mass
OGTT Oral Glucose Tolerance Test
OR Odds Ratio
PE Pre-Eclampsia
PI Ponderal Index
QAS Quality Arterial Stiffness
QIMT Quality Intima-Media THickness
RF Radio-Frequency
SBP Systolic Blood Pressure
SF (Fl-SF, Tr-SF, S-SF, Th-SF) SkinFold (Flank-, Triceps-, Subscapular-, Thigh-)
SFT Subscapular Fat Thickness
SGA Small-for-Gestational Age
SI Stiffness Index
US UltraSound
Vabulos VAscular and Biometry Ultrasound measurements in LOw risk pregnancy 
Study
YEM Young Elastic Modulus
WHO World Health Organization
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aBsTraCT oF The researCh
Three important cornerstones for metabolic research in pregnancy are maternal adipos-
ity (body mass index -BMI-), nutrient intake and storage (gestational weight gain -GWG-) 
and abnormal glucose tolerance (GDM). These contributors play an important role in the 
intra-uterine development. Beside birth weight, detailed information on the neonates’ 
body composition (fat distribution) in both lean- and fat mass, reflect the in utero de-
velopment better. Accuracy for the estimated fetal growth fluctuates and in the obese 
mother visualization of the fetus is more limited (Chapter 1).
The environment in utero and in early neonatal life may induce a permanent response 
in the fetus and the newborn, leading to enhanced susceptibility to later diseases. Hu-
man and animal data confirm this important early life period. The effects of maternal 
and fetal nutrition stress the importance of the embryonic environment on epigenetic 
imprinting for metabolic mechanisms, but in general it depends on the extent of embry-
onic adaptation and on its plasticity later on (Chapter 2).
The male fetus body composition has been shown to be more sensitive to maternal 
influences and gender is recognized as a determining factor for differences in outcome 
in adult medicine. GAMLSS (WHO) based growth charts for the male and female fetus 
were constructed to align with WHO neonatal and pediatric curves. At birth boys were 
heavier, longer, had greater head circumference with lower first minute Apgar score and 
arterial pH than girls. Second trimester dating estimated boys 3 days ahead to girls. The 
implication is that boys seem to be more vulnerable around viability age (overestimated 
age) and at term (worse birth outcome), although girls are more vulnerable for the 
latter, post-term period in pregnancy, since they are underestimated for their real age 
(Chapter 3).
Maternal GWG and BMI both effect fetal growth and birth weight, independently. 
Cluster analysis discerned four total GWG clusters: I: ≤0kg, II: 0-4kg, III: 4-12kg and IV: 
>12kg. Cluster IV added effect of +477g, when compared to cluster I. A high BMI class 
(35) added +344g, when compared to a low BMI (17). The total GWG effect had most 
impact from 180 to 200 days gestation when there was a separation between the differ-
ent GWG clusters, offering us a time estimate to influence weight gain during pregnancy 
and so possibly prevent perinatal complications, improve the metabolic and vascular 
traits of the infant and possibly improve outcomes in future pregnancies (Chapter 4)
Fetal body composition can be monitored, additional to fetal weight for fetal adiposity 
estimation. The fetal liver size (LL) and the abdominal fat thickness (AFT) growth trajec-
tory increased significantly in the high BMI group. Excessive GWG (above IOM guideline, 
e-GWG) positively correlated with the growth in fetal abdominal circumference , LL, sub-
scapular fat thickness (SFT) and AFT as compared to the non-excessive GWG (ne-GWG) 
group. Birth outcomes were significantly different for weight, length and head circum-
ference in the e-GWG group as compared to the ne-GWG. Interestingly, fetal adiposity 
emerged as a reflection of a nutritious environment in utero with effects detectable 
as early as 20 weeks. Especially the indicators of the fetal trunk (LL, AFT, SFT and AC) 
are discriminative of fetal adiposity and warrant further investigation as potential early 
predictors of neonatal adiposity (Chapter 5), represented by neonatal fat mass (NFM), 
ponderal index (PI) and birthweight. The mean NFM at birth was 11.0% (SD±3.4%), with 
a cut-off of 15% for the 90th percentile (P90). No association was found between the 
maternal BMI and NFM. However, children born to mothers who had an e-GWG had a 
significantly higher NFM (11.6%) as compared to the ne-GWG mothers (10.4%). Fetal 
AC, LL, SFT, humerus and femur fat mass development correlated significantly with 90th 
NFM percentile. Interestingly, fetal fat measurements showed a gestational age specific 
timing of first onset of aberrant fetal adiposity development: first (late first trimester) the 
AC and fetal LL, secondly (late second trimester) the truncal fat depositions of AFT and 
SFT and lastly (early third trimester) the peripheral fat depositions on the extremities 
(humerus and femur). The fetal abdominal fat development (LL, AC and AFT), a marker 
of fetal central fat deposition, correlated to NFM P90 warranting further studies as a 
neonatal adiposity predictor (Chapter 6).
Cardiovascular risks have been linked to birth weight, fitting the ‘fetal origin of 
diseases’ theory. A cross-sectional feasibility study in pregnancy revealed from 4 fetal 
and 4 maternal vessels, that the maternal common carotid artery (CCA) and the fetal 
abdominal artery (fAA) were most feasible to measure during pregnancy (Chapter 7).
Pregnancy induces hemodynamic changes in women. Vascular changes in the CCA 
throughout normal pregnancy have not been elucidated before. This is the first Radio-
frequency (RF) study providing longitudinal vascular data during pregnancy for the CCA 
with novel insights on gestational age and e-GWG correlates. Whether the observed 
changes concern a transient, reversible phenomenon requires further investigation 
(Chapter 8).
More challenging, since less feasible, is fetal abdominal aorta (fAA)  development 
throughout pregnancy with RF ultrasound from 25 weeks onwards. All fAA properties 
(IMT, diameter and distension) showed a positive correlation with gestational age. In 
conclusion, our study provides the first longitudinal radio-frequency vascular data 
during pregnancy for the fetal abdominal aorta in low risk pregnant women. We dem-
onstrate a positive correlation of both fetal growth and maternal BMI with increased 
arterial remodeling during gestation in the fetal abdominal aorta. As with the results 
achieved with measures of the maternal CCA, whether this represents a transient or 
persistent phenomenon requires further investigation (Chapter 9).
Long-term follow up studies are needed to correlate some of the results in this thesis, 
particularly on the transience of the vascular changes and neonatal adiposity definition. 
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Correlates with weight gain patterns, lifestyle patterns, biomarkers and pediatric fat 
deposition are under way.
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191Nederlandse samenvatting
neDerlanDse samenVaTTing
Gewichtstoename in de zwangerschap is voor veel aanstaande mamma’s een belan-
grijk onderwerp. Vooral een teveel, maar soms ook een te weinig toename (of zelfs een 
afname) wordt gevreesd. Die ongerustheid hierover komt voornamelijk voort door de 
zorg over het ongeboren kind en dat is niet geheel onterecht. Het Amerikaanse Institute 
of Medicine (IOM), heeft in 2009 haar richtlijnen voor een gezonde gewichtstoename in 
de zwangerschap (her-)uitgegeven. Zij  koppelt de bandbreedte van de totale gewich-
tstoename in de zwangerschap aan de categorie van de body mass index (BMI), zoals 
die voor de zwangerschap bepaald is. Er geldt een negatieve correlatie: hoe hoger de 
BMI, hoe lager de maximale en minimale gewichtstoename mag zijn. De IOM adviezen 
komen voort uit gegevens die o.a. laten zien dat een excessieve gewichtstoename niet 
alleen leidt tot negatieve effecten voor de mamma, maar ook voor de baby. Een van 
die negatieve effecten is een foetale overgroei, die kan ontstaan wanneer de mamma 
een heel voedingsrijke omgeving aanbiedt aan haar baby tijdens de zwangerschap. 
Dat vervolgens deze baby ook zelf weer een hogere kans heeft om later een hogere 
‘adipositeit’ te ontwikkelen of zelfs obesitas noemen we het ‘transgenerationele’ effect. 
In dit proces worden de moederlijke zwaarlijvigheid, een afwijkende gewichtstoename 
en een afwijkende suikerstofwisseling als drie belangrijke factoren, ook wel ‘de drie 
hoekstenen’ genoemd. Behalve de lichamelijke veranderingen die bij de baby plaats-
vinden, zijn er ook epigenetische veranderingen beschreven. Dat zijn veranderingen 
die het genoom niet veranderen, maar wel een aansturings-effect teweeg brengen, 
waardoor sommige genen kunnen worden ‘aan-’ of ‘uitgezet’. Het lijkt er dus op dat er 
een modulerend effect uitgaat van de invloeden in de baarmoeder voor het ongeboren 
kind. Deze ‘voorprogrammering’ bepaalt de mogelijkheden van de boreling om zich aan 
het buiten-baarmoederlijke leven aan te kunnen passen. Dit wordt ook wel zijn of haar 
plasticiteit genoemd. 
In dit doctoraatsonderzoek hebben we de invloeden van de drie hoekstenen op de 
intra-uteriene ontwikkeling van de foetus onderzocht, zowel met betrekking tot de 
lichaamssamenstelling, als ook tot de vaatontwikkeling. Verder hebben we de geslacht 
specifieke ontwikkeling van de foetus voor de geboorte gekarakteriseerd en gekoppeld 
aan de uitkomsten bij de geboorte. Via nieuwe hoog technologische methoden hebben 
we prospectief zeer gedetailleerd kleine structurele vaatveranderingen, zowel bij de 
moeder als bij de foetus kunnen vastleggen. Ook hebben we de zwangerschapsinvloe-
den (BMI, gewichtsverandering) op zowel vaatfunctie als -morfologie kunnen documen-
teren. Met de informatie over de lichaamssamenstelling en vaatontwikkeling krijgen 
we een goed idee van de foetale metabole voortgang. De informatie kan ons mogelijk 
helpen in de zoektocht naar interventiemogelijkheden in de zwangerschap, opdat de 
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transgenerationele overdracht van aberrante (moederlijke) omgevingsinvloeden naar 
baby tijdig kan worden onderbroken. 
Om de achtergrond te begrijpen van de onderzoeksmethoden die sterk op beeld-
vorming zijn toegespitst, is een voorkennis van de evolutie van de niet invasieve 
technieken (echogeluidsonderzoek) van belang. Dit leg ik uit in hoofdstuk 1. Met dit 
echogeluid onderzoek (‘echo’) kan een zeer gedetailleerd beeld worden verkregen van 
het ongeboren kind. In epidemiologische studies wordt vaak teruggegrepen op het 
geboortegewicht als een afspiegeling van het intra-uteriene traject. Deze uitkomstmaat 
wordt gebruikt om korte en lange termijn effecten te verduidelijken. Zowel hoog als 
laag geboortegewicht wordt in verband gebracht met toekomstig verhoogd cardiovas-
culair risico, wat past in de ‘foetale oorzaak voor latere ziektes’ theorie. Naast het ge-
boortegewicht, zou meer gedetailleerde informatie over de lichaamssamenstelling van 
de pasgeborene, zowel in vetmassa als in vetvrije massa, meer kunnen vertellen over de 
ontwikkeling in de baarmoeder. Er is helaas nog geen algemeen geaccepteerde definitie 
van ‘neonatale BMI’ of van neonatale zwaarlijvigheid voorhanden. Ook moeten foetale 
voorspellers voor neonatale zwaarlijvigheid nog ontwikkeld worden. Momenteel wordt 
de zogenaamde ‘ponderal index’, een soort baby-BMI en ‘percentage vethoeveelheid’ 
gebruikt om deze leemte op te vullen. Prenataal kunnen we een schatting doen van 
het foetale gewicht met een marge van ongeveer tussen 6 en 12% van het werkelijke 
gewicht. Ook is bekend dat bij een obese moeder  de beeldvorming van de foetus meer 
beperkt is.
Zoals hierboven gemeld, zou het milieu binnen de baarmoeder en in het vroege neo-
natale leven, een blijvende reactie kunnen veroorzaken in de foetus en de pasgeborene, 
wat tot een verhoogde vatbaarheid voor latere ziekten kan leiden. In hoofdstuk 2, meld 
ik dat foetale overgroei is gerelateerd aan een diabetisch milieu in de baarmoeder. De 
verhoogde kans op diabetes mellitus (DM) voor kinderen van moeders met diabetes, 
komt overeen met een epigenetisch effect van hyperglycemie in de zwangerschap, na-
ast genetische factoren waaronder diabetes in volgende generaties. Aan de andere kant 
zorgt een foetale groeibeperking veroorzaakt door ondervoeding, juist tot het vaker 
voorkomen van cardio-vasculaire ziekten en type-2 diabetes mellitus het latere leven. 
Vooral, als er sprake is van een inhaalslag voor de beperkt gegroeide foetus, via hoog-
calorische voedselinname na de geboorte.  Het derde trimester lijkt een kwetsbare peri-
ode te zijn voor de invloed van moederlijke ondervoeding, en daaruit voortkomende 
foetale groeiachterstand. Excessieve voeding, een beperkte voedingswaarde of een 
laag foliumzuur en vitamine B12 niveau, zijn omgevingsfactoren die een invloed heb-
ben op DNA-methylatie in de ontwikkeling van het jonge leven, dit wordt ‘Epigenetica’ 
genoemd. 
De effecten van moederlijke en foetale voeding benadrukken het belang van de 
embryonale omgeving op de epigenetische inprenting voor metabole mechanismen 
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op de toekomstige generaties. Niet iedere pasgeborene met overgewicht en niet elke 
pasgeborene met een intra-uteriene groeiachterstand zal later in het leven problemen 
ontwikkelen. Er zijn uiteraard andere factoren die invloed hebben op de uitkomst daar-
van: over het algemeen hangt het af van de mate van aanpassing en de plasticiteit van 
de baby.
Vanuit de foetus gezien, wordt de periode in de baarmoeder geassocieerd met sexe-
afhankelijke fysieke aanpassingen vanwege een veranderde voedingsvoorraad van de 
moeder. De lichaamssamenstelling van een jongen is meer gevoelig gebleken voor 
moederlijke invloeden, zoals een hogere BMI voor de zwangerschap en een excessieve 
gewichtstoename in de zwangerschap. En alhoewel geslacht wordt erkend als een 
bepalende factor voor uitkomstverschillen binnen de geneeskunde voor volwassenen, 
is er nog maar weinig informatie beschikbaar over de invloed van het foetale geslacht 
in de prenatale periode. Vanwege de complexiteit die gepaard gaat met onderzoek 
naar ‘groei’, heeft de Multicentre Growth Reference Study Group (MGRS) van de Wereld 
Gezondheids Organisatie (WHO) het GAMLSS model (Generalized Additive Model Loca-
tion, Scale and Shape) aangeraden voor het ontwikkelen van (WHO) groei standaarden.
In hoofdstuk 3 hebben we groeicurven gemaakt voor de foetus in een Kaukasische 
populatie (12368 zwangerschappen) en deze verder aangepast voor het foetal geslacht. 
Dit leverde interessante bevindingen op. De metingen van het foetale hoofd waren 
significant hoger voor jongens vergeleken met meisjes vanaf 20 weken zwangerschap, 
wat overeen komt met een verschil van 3 dagen op een leeftijd van 20 – 24 weken. 
Jongens waren significant zwaarder, langer en hadden een grotere hoofdomtrek dan 
meisjes bij de geboorte. De Apgar score op 1 minuut en de zuurgraad van het arterieel 
navelstrengbloed waren lager bij jongens. 
Deze longitudinale foetale groeicurves, laten voor de eerste keer een integratie toe 
tussen neonatale en door de WHO gebruikte pediatrische, sekse-specifieke groeicurves. 
De uitkomst direct na de geboorte was voor jongens slechter dan voor meisjes, en het 
verschil tussen de intra-uteriene groei tussen de seksen was voldoende groot om een 
klinisch belangrijk effect te hebben op de schatting van foetaal gewicht (waarbij de 
grootte van het hoofd betrokken is) en tweede trimester zwangerschapsduur bepaling, 
die in veel landen in het tweede trimester op basis van het foetale hoofd wordt bepaalt. 
Daardoor is de implicatie van deze bevindingen dat voor een jongen en een meisje, op 
precies 24 weken zwangerschapsduur, een verschil kan worden toegewezen van wel 3 
dagen en een geschat verschil in gewicht van 21 gram op 24 weken. Dit verschil is in het 
voordeel van de jongens. Het verschil op het eind van de zwangerschap loopt op tot 
121 gram, in het voordeel van de jongens. Daarnaast vonden we de hoofdomtrek van de 
jongens groter (+0.6cm) is bij de geboorte. Samengevat, lijken jongens kwetsbaarder te 
zijn rond de levensvatbare leeftijd  (22 – 24 weken), omdat ze ouder worden geschat dan 
ze in werkelijkheid zijn. Meisjes zijn kwetsbaarder voor deze onjuiste schatting tijdens 
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de latere, post-terme periode in de zwangerschap. In dit stadium worden immers vaak 
beslissingen genomen over het al dan niet beëindigen van een zwangerschap en ze 
zijn al ouder dan geschat. Rond de uitgerekende datum hebben jongens een slechtere 
start (lagere 1 minuut Apgar Score en navelstreng-PH) vergeleken met meisjes, maar of 
dit van voorbijgaande aard is, zonder neveneffecten hebben we door een gebrek aan 
verdere gegevens niet kunnen concluderen.
In hoofdstuk 4 is een prospectieve cohort analyse uitgevoerd voor de invloed van 
moederlijke gewichtstoename in de zwangerschap en BMI op de foetale groei. Deze 
factoren bleken de foetale groei onafhankelijk van elkaar te beïnvloeden. Er konden vier 
verschillende clusters onderscheiden worden voor gewichtstoename in de zwangersc-
hap:  I: ≤0kg, II: 0-4kg, III: 4-12kg and IV: >12kg. In elk cluster was er een andere evolutie 
van het foetale gewicht en ook, uiteindelijk, een verschillend geboortegewicht. Bij het 
vergelijken van cluster IV met cluster I was het toevoegend effect van het cluster verschil 
op het geboortegewicht +477g. De moederlijke BMI had een onafhankelijke invloed op 
de evolutie van foetaal gewicht. Een hogere BMI klasse zorgde voor een toename van 
foetale groei en daardoor een hoger geboortegewicht. Wanneer een BMI van 35 werd 
vergeleken met een BMI van 17, was het toegevoegde effect op het geboortegewicht 
+344g. 
Het totale effect van gewichtstoename in de zwangerschap had de grootste impact 
op 180 tot 200 dagen zwangerschapduur, toen er een scheiding was tussen de verschil-
lende GWG clusters. Door de relatie tussen gewichtstoename in de zwangerschap 
(GWG),  foetale groei en geboortegewicht te identificeren, kunnen we nu mogelijk 
de gewichtstoename beinvloeden tijdens de zwangerschap en mogelijk op die ma-
nier perinatale complicaties voorkomen en op de langere termijn zelfs cardiovasculaire 
risico’s en metabole aandoeningen.
Aangezien het geboortegewicht de uitkomst is van de foetale periode, was het 
doel van hoofdstuk 5 om de kennis te vergroten over de ontwikkeling van de foetale 
lichaamssamenstelling in de baarmoeder.
Dit werd prospectief in een zeer goed gedocumenteerde populatie onderzocht via 
een gecontrolleerde glucose-tolerante groep van 126 moeders. De GWG werd als ‘ex-
cessief’ beschouwd (e-GWG) als de herschreven-2009 IOM bovenste limieten werden 
overstegen. Als deze drempel niet werd gepasseerd, dan werd de gewichtstoename als 
niet-excessief gedocumenteerd (ne-GWG). In de groep obese vrouwen, steeg het groei 
traject van de foetale lever grootte (LL) en de dikte van het buikhuidvet (ATF) significant 
vergeleken met vrouwen van een normaal gewicht. Excessieve-GWG correleert positief 
met de groei van foetale buikomtrek, LL, sub-scapulaire huidplooidikte (SFT) en AFT, 
vergeleken met de ne-GWG groep. Vergeleken met de  ne-GWG waren de uitkomsten 
bij de geboorte in de e-GWG groep significant anders voor gewicht, lengte en hoof-
domtrek. Obesitas en e-GWG hadden beiden een positieve invloed op zwaarlijvigheid 
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tijdens de foetale en neonatale periode, waarbij e-GWG duidelijk de foetale grootte in 
het algemeen beïnvloedde, wat werd bevestigd door metingen na de geboorte. 
Ons longitudinaal onderzoek heeft vroege tekenen van foetale zwaarlijvigheid kun-
nen vaststellen die geassocieerd worden met moederlijke obesitas en vooral bij e-GWG 
in  vrouwen met een normale glucose tolerantie. Een hoge BMI bij de moeder correl-
eerde met de foetale levergrootte en buikvet, waar e-GWG daarbij ook correleerde met 
toegenomen buik-huidplooidikte en de ontwikkeling van de buikomtrek. 
Foetale zwaarlijvigheid komt naar voren als een afspiegeling van een voedzame 
omgeving in de baarmoeder waarvan de effecten al op 20 weken gemeten kunnen 
worden. Vooral de indicatoren van de foetale romp (lever-lengte, AFT, SFT en AC) zijn 
discriminatief voor foetale zwaarlijvigheid en vragen verder onderzoek als potentieel 
vroege voorspellers van neonatale zwaarlijvigheid. 
Naar aanleiding van deze resultaten correleerden we in hoofdstuk 6 deze metingen 
in 121, streng opgevolgde, glucosetolerante moeders, prospectief, met een neonatale 
lichaamssamenstelling (‘adipositas’-) index: neonatale vetmassa (NFM), ponderal index 
(PI) en geboortegewicht. De gemiddelde NFM bij geboorte was 11.0% (SD±3.4%), met 
een cut-off van 15% voor het 90ste percentiel (P90). Er werd geen associatie gevonden 
tussen maternale BMI en NFM. Echter, kinderen die geboren waren bij moeders met een 
e-GWG hadden een significant hoger NFM (11.6%) vergeleken met groep kinderen van 
de ne-GWG moeders (10.4%).
Foetale metingen in het algemeen vertoonden een hoge correlatie met de neonatale 
metingen. Foetale buikomtrek (AC), lever lengte (LL), subscapulaire huidplooi (SFT) en 
buikhuidvet dikte (AFT), humerus en femur vet massa ontwikkeling correleerden signifi-
cant met het 90ste NFM percentiel.  Foetale AFT correleerde niet met PI. Bij de normaal 
glucose tolerante vrouw, werd e-GWG geassocieerd met een verhoogde neonatale 
zwaarlijvigheid. De neonatale PI en hoge adipositeit (>P90 NFM) werden vooraf gegaan 
door een verhoogde ontwikkeling van foetale parameters voor centrale- en perifere vet 
massa.
De ontwikkeling van het foetale buikweefsel (AC, LL), een afspiegeling van foetale 
centrale adipositeit, correleerde sterk met het 90ste percentiel van neonatale vetmassa, 
waarmee hun potentiele rol als vroegtijdige voorspellers voor neonatale vet afzetting 
wordt aangetoond.
Samenvattend, de foetale vetmetingen bewezen een hoge graad van correlatie met 
neonatale adipositas. Verder was er een zwangerschapsduur gerelateerde timing voor 
een eerste aanzet (de eerste tekenen) van een afwijkende foetale vetopstapeling:  als 
eerste, aan het eind van het eerste trimester, de buikomtrek en foetale lever grootte; 
ten tweede, aan het eind van het tweede trimester, de aanzet van lichaamsromp-vet 
5AFT en SFT) en tenslotte, in het begin van het derde trimester, de perifere vetverdel-
ing van de extremiteiten (humerus en femur). De ontwikkeling van het het foetale 
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buikhuidvet, wat een markeerpunt is voor de centrale vetverdeling, correleerde vooral 
met het 90ste percentiel van neonatale vetmassa, waarvoor verder onderzoek nodig is 
om de potentiele rol ervan als meer specifieke voorspeller voor neonatale adipositeit te 
kunnen aantonen. 
Zoals hierboven reeds gemeld, wordt de programmering van foetale ontwikkeling 
beïnvloed door de BMI van de moeder, gewichtsveranderingen glucose-(in-)tolerantie. 
Deze factoren beinvloeden de foetale groei en onwikkeling, vaak gemakshalve  samen-
gevat door de parameter ‘geboortegewicht’. 
Cardiovasculaire risico’s worden in verband gebracht met het geboortegewicht, wat 
past binnen de theorie van ‘foetale oorzaak voor ziektes’. De dikte van de Intima-media 
(IMT) wordt gezien als een markering voor pre-klinische atherosclerose (aderverkalk-
ing). Verder is gekend dat IMT van de moeder kan worden veranderd door dynamische 
omstandigheden gerelateerd aan de zwangerschap. In hoofdstuk 7 beschrijf ik 
het onderzoek dat we hebben gedaan bij 38 laag-risico zwangerschappen, naar de 
haalbaarheid van het meten van de IMT op vier vooraf bepaald foetale en vier vooraf 
bepaalde maternale vaatpunten. Het doel is uiteindelijk om de vasculaire veranderin-
gen te kunnen vaststellen die geassocieerd kunnen worden met veranderde vasculaire 
functies gedurende de zwangerschap. 
De IMT van de foetale abdominale aorta (fAA) was meetbaar tijdens het tweede 
trimester in 71% en tijdens het derde trimester in 100% van de gevallen. De IMT van 
de navelstreng arterie was meetbaar in 50% en respectievelijk 82% van de gevallen 
tijdens het tweede en derde trimester. Foetale metingen van IMT waren niet mogelijk 
tijdens het eerste trimester. Het was vaak niet haalbaar om de IMT te meten van de 
foetale a. carotis communis, de foetale a. renalis en de maternale a iliaca (max. 20% 
van de gevallen).  De IMT van de maternale a. carotis communis (CCA), de abdominale 
aorta en de a. uterina waren meetbaar gedurende de hele zwangerschap. Er was een 
significante relatie tussen de zwangerschapsduur en de IMT in de navelstreng arterie en 
een significante relatie tussen de moederlijke BMI en IMT in de maternale CCA. Kortom, 
IMT metingen zijn haalbaar in sommige maternale en foetale bloedvaten. Verder is de 
foetale ontwikkeling van IMT in abnormale zwangerschappen van belang, omdat dit 
zou kunnen bijdragen aan het verhelderen van de mechanismes van intra-uteriene 
programmering en het voorspellen van de oorsprong van metabole ziekten bij volwas-
senen.
Een zwangerschap veroorzaakt hemodynamische veranderingen bij vrouwen. Van-
wege de makkelijke toegankelijkheid van de a. carotis communis (CCA) wordt deze vaak 
gebruikt in het onderzoek naar de conditie het vaatstelsel als zijnde representatief voor 
de (goede) gezondheid van de vaten. Vasculaire veranderingen in de CCA gedurende 
een normale zwangerschap zijn nog niet eerder opgehelderd. In hoofdstuk 8 heb ik 
hoge-resolutie, radio-frequency (RF) echografische metingen gedaan van de CCA in 
197Nederlandse samenvatting
80 laag-risico moeders, prospectief, vanaf het eerste trimester. Alle CCA eigenschap-
pen en indices waren significant geassocieerd met zwangerschapsduur wat betreft 
een afnemende compliantie (Carotid Artery Compliance -CAC-) en een toenemende 
‘vaatstijfheid’ (Young Elastic Modulus -YEM- and Stiffness Index -SI-).  Alle indices (CAC, 
YEM and SI) werden ook significant beïnvloed door zowel leeftijd van de moeder als e-
GWG, maar na corrective voor de maternale leeftijd, bleef de YEM positief gecorreleerd 
met e-GWG. Interessant was dat er geen correlatie werd gevonden wat betreft de BMI 
voorafgaand aan de zwangerschap. Onze studie levert, voor zover wij weten, eerste 
longitudinale radio-frequency vasculaire gegevens tijdens zwangerschap voor de CCA 
binnen een laag-risico populatie. Vooral de vasculaire lange termijn effecten van mater-
nale gewichtstoename tijdens de zwangerschap is interessant als een risicofactor voor 
toekomstige cardiovasculaire ziekten. Of de waargenomen veranderingen een tijdelijk, 
omkeerbaar fenomeen betreffen, of een meer langdurige aanpassing met gevolgen in 
het toekomstig leven,  vraagt om verder onderzoek.
Een veel grotere uitdaging, wanneer we naar onze haalbaarheidsstudie kijken (hoofd-
stuk 7), is het onderzoek naar de ontwikkeling van de foetale abdominale aorta (fAA) 
tijdens de zwangerschap. In hoofdstuk 9 includeerde ik vierenzeventig moeders in de 
uiteindelijke analyse. Metingen van de fAA konden prospectief betrouwbaar worden 
verkregen vanaf 25 weken zwangerschap.  Alle kenmerken van fAA (IMT, diameter (DIA) 
en uitzetting (DIS)) lieten een positieve correlatie zien met zwangerschapsduur. FAA 
elasticiteits-indices namen af tijdens de zwangerschap. Er was een afnemende fAA com-
pliantie (fAAC) en een toenemende vaatstijfheid (YEM and SI). Elasticiteits-indices (fAAC, 
YEM and SI) werden ook significant beïnvloed door grootte van de foetus. Interessant is 
dat de fAA-IMT en de DIS een significant kleinere toename lieten zien in obese moeders 
als deze worden vergeleken met de moeders met normaal gewicht (≤24.9kg/m2 BMI), 
zelfs na correctie voor foetale grootte.
Samenvattend, de vaatstijfheid in de fAA nam toe naar het einde van de zwangersc-
hap en was meer uitgesproken wanneer de foetale groei ook snel is (derde trimester). De 
fAA-IMT ontwikkeling wordt negatief beinvloed door een hoge BMI bij de moeder, wat 
een aanpassing suggereert van de foetale aderwand in de obese moeder en moeder 
met overgewicht. Onze studie levert de eeste longitudinale radio-frequency vasculaire 
gegevens tijdens de zwangerschap over de foetale abdominale aorta in laag-risico 
zwangere vrouwen. We laten een positieve correlatie zien van zowel foetale groei en 
maternale BMI met een toegenomen arteriële remodellering tijdens de zwangerschap 
in de foetale abdominale aorta. Evenzo als bij de resultaten van de maternale CCA, geldt 
ook hier dat er verder onderzoek nodig is om te zien of dit een tijdelijk of een langdurig 
fenomeen betreft.
Toekomst Perspectieven
Het doel van dit doctoraat was om de dynamische effecten van de zwangerschap (ge-
wichtsverandering en glucose intolerantie) te onderzoeken op de korte termijn uitkom-
sten van foetale en neonatale lichaams-samenstelling en de cardio-vasculaire ontwikkel-
ing, binnen het perspectief van de verschillende BMI categorieën. Deze ontwikkelingen 
van het vroege bestaan, hebben  impact op de begin van het leven van een kind met de 
gedachte dat dit ook lange termijn metabole effecten kan hebben. De uitkomsten zoals 
boven beschreven openen uiteraard nieuwe perspectieven voor verder onderzoek. Kort 
samengevat is er binnen de gewichtstoename per trimester nog verder onderzoek te 
verrichten, aangezien er tekenen zijn dat met name de gewichtsverandering tijdens het 
eerste trimester cardio-vasculaire effecten heeft op de lange termijn. Verder hebben 
we in de longitudinale studies nog veel (verborgen) informatie met betrekking tot de 
lifestyle van de deelnemers. Er zijn fysieke activiteits-rapporten en voedingsdagboeken 
beschikbaar. Verder is het gerapporteerde werk in deze thesis onderdeel van een grote 
multicentrische studie, waaruit nog meer gegevens zullen volgen. In deze zelfde studie 
werden ook veel ‘biomarkers’ bepaald, waaruit niet alleen de Insuline indices kunnen 
worden berekend, maar ook bijvoorbeeld nuchtere lipiden (triglyceriden, LDL, HDL, 
en vrije vetzuren). In hoofdstuk 6 wordt er gesproken over foetale voorspellers voor 
neonatale adipositeit. Het zou een volgende stap zijn om de foetale parameters die 
opvallend geassocieerd zijn, te combineren in een model, waarbij je ook relative risks 
(RR),  odds ratio’s (OR) and area under the curves (AUC’s) zou kunnen geven voor de 
neonatale ‘hoge’ vetstapeling. Met betrekking tot die vetstapeling, is een vergelijking 
met de gouden standaard (bio-impedance analysis (BIA) of air-displacement plethys-
mography (ADP)) een volgende uitdaging. Voor een bepaalde groep kinderen hebben 
we de BIA gegevens van op 6weken, 6, 12, 18 en 24 maanden. Voor de vaatmetingen 
zou een lange-termijnstudie een logisch vervolg zijn op onze studie resultaten. Het zou 
daarmee mogelijk zijn om te zien of er permanente aanpassingen zijn gebeurd onder 
invloed van zwangerschap gerelateerde factoren, voor zowel de moeder als de baby.
Concluderend brengt deze thesis ons verder in:
- Geslacht specifieke nieuwe inzichten in de foetale ontwikkeling en uitkomsten, 
waarbij in het algemeen de meisjes een voordeel hebben ten opzichte van de jon-
gens, behalve in de post-terme tijdsperiode. 
- Nieuwe gevoelige technieken voor een gedetailleerder inzicht in lichaams-samen-
stelling en vasculaire ontwikelling in de baarmoeder. 
- Correlaties van foetale ontwikkeling en neonatale vetstapeling.
- Metingen verricht met radio-frequency ultrasound voor arteriële vaat-karakteris-
tieken (functionaliet en morfologie) van de maternale CCA en de foetale fAA, met 
vooruitzichten op verder onderzoek.
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- Vaatmetingen: er wordt een algemene vaatstijfheid reactie gezien tijdens de 
zwangerschap, zowel voor de moeder als voor de foetus met interessante links naar 
zwangerschap gerelateerde kenmerken.
Opgemerkt dient te worden dat, aangezien veel uitkomsten in dit doctoraat de eerste 
zijn in hun soort, er nog bevestigende studie moeten volgen, vooraleer er definitieve 
conclusies kunnen worden getrokken. 
Het is in ieder geval duidelijk dat hoge gewichtstoename, hoge BMI and een 
togenomen glucose intolerantie belangrijke risico factoren zijn voor neonatale adiposi-
tas. Echo-onderzoek van hoge kwaliteit, kunnen clinici een gevoelig instrument geven 
om vroege verandering en ontwikkeling te detecteren voor vaatfunctie metingen en 
voor vetstapeling. Hiermee kunnen vervolgens doelgerichte interventies worden 
voorzien om de gewichtsveranderingen aan te passen met als doel de vetstapeling te 
beïnvloeden. Of dergelijke interventie strategieën ontwikkeld en ook succesvol toege-
past kunnen worden, moet bevestigd worden in verder onderzoek.
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e-Table 3.10. Reference values for AbdominalCircumference (AC) in mm, Boys & Girls
ga Boys (aC) girls (aC)
C5 C10 C50 C90 C95 C5 C10 C50 C90 C95
12 50,1 51,6 57,0 62,9 64,7 49,4 50,7 55,5 61,0 62,7
13 60,7 62,4 68,6 75,2 77,2 59,8 61,2 66,7 72,9 74,8
14 72,1 73,9 80,8 88,1 90,3 71,1 72,7 78,9 85,7 87,8
15 83,9 86,0 93,4 101,4 103,7 82,9 84,7 91,5 99,0 101,3
16 95,7 97,9 105,9 114,4 116,9 94,5 96,5 103,9 112,0 114,4
17 107,4 109,7 118,1 127,0 129,6 105,9 108,1 116,0 124,6 127,2
18 118,8 121,2 130,0 139,4 142,2 117,1 119,4 127,9 137,0 139,7
19 130,0 132,5 141,8 151,7 154,6 127,9 130,4 139,5 149,1 152,0
20 140,6 143,3 153,1 163,4 166,5 138,1 140,8 150,5 160,7 163,7
21 150,6 153,6 163,9 174,7 178,0 147,7 150,6 160,8 171,6 174,8
22 160,3 163,5 174,5 186,0 189,7 157,3 160,3 171,2 182,6 186,0
23 169,7 173,4 185,2 197,7 202,0 167,2 170,5 182,1 194,1 197,7
24 179,0 183,4 196,3 209,9 214,9 177,3 180,8 193,2 206,0 209,8
25 188,7 193,6 207,4 221,9 227,5 187,5 191,3 204,4 218,0 222,0
26 199,5 204,4 218,6 233,5 239,1 197,8 201,9 215,7 229,9 234,2
27 211,0 215,7 229,8 244,8 250,0 208,5 212,7 227,1 241,8 246,3
28 222,5 226,9 241,2 256,2 261,1 219,3 223,6 238,5 253,6 258,2
29 233,6 237,9 252,5 267,8 272,6 230,1 234,6 249,7 265,2 269,9
30 244,1 248,5 263,5 279,3 284,2 240,7 245,3 260,7 276,7 281,6
31 253,7 258,2 274,0 290,5 295,5 250,6 255,3 271,3 287,8 293,0
32 262,3 267,0 283,7 301,2 306,5 259,4 264,3 281,0 298,5 304,0
33 269,9 274,9 292,8 311,7 317,3 267,1 272,3 290,0 308,7 314,7
34 276,8 282,2 301,7 322,1 328,2 273,8 279,4 298,2 318,5 325,0
35 283,2 289,1 310,2 332,5 339,2 279,9 285,9 306,1 328,0 335,3
36 289,3 295,6 318,5 342,8 350,0 285,9 292,2 313,8 337,7 345,7
37 295,2 302,0 326,7 353,0 360,8 292,0 298,7 321,7 347,7 356,5
38 301,0 308,2 334,8 363,2 371,6 298,4 305,6 330,0 358,0 367,8
39 306,7 314,4 342,9 373,4 382,5 305,1 312,6 338,5 368,8 379,6
40 312,3 320,5 351,0 383,8 393,5 311,9 319,8 347,1 379,8 391,7
Reference values in mm for fetal abdominal circumference (AC) for boys and girls for each gestational week 
for the median and 5th, 10th, 90th and 95th centiles. GA = gestational weeks.
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e-Table 3.11. Reference values for FemurLength (FL) in mm, Boys & Girls
ga Boys (Fl) girls (Fl)
C5 C10 C50 C90 C95 C5 C10 C50 C90 C95
12 4,7 5,0 6,5 8,5 9,3 5,0 5,3 6,6 8,1 8,6
13 7,3 7,7 9,5 11,7 12,5 7,5 8,0 9,5 11,3 11,9
14 10,3 10,8 12,8 15,0 15,8 10,5 11,0 12,7 14,7 15,3
15 13,6 14,1 16,2 18,4 19,2 13,6 14,2 16,1 18,2 18,9
16 17,0 17,6 19,6 21,8 22,5 16,9 17,5 19,5 21,6 22,3
17 20,3 20,9 22,9 25,1 25,8 20,2 20,8 22,8 25,0 25,7
18 23,5 24,1 26,1 28,3 29,0 23,4 24,0 26,1 28,3 29,0
19 26,5 27,1 29,1 31,4 32,1 26,5 27,1 29,2 31,4 32,1
20 29,3 29,9 32,0 34,3 35,0 29,3 29,9 32,1 34,3 35,0
21 31,7 32,4 34,7 37,0 37,7 31,9 32,5 34,7 37,0 37,7
22 34,1 34,8 37,3 39,8 40,5 34,4 35,1 37,3 39,6 40,3
23 36,5 37,4 40,1 42,6 43,3 37,0 37,7 40,1 42,5 43,2
24 38,8 39,9 42,8 45,4 46,2 39,7 40,4 42,9 45,4 46,2
25 41,2 42,3 45,4 48,1 48,9 42,2 43,0 45,6 48,2 49,0
26 43,6 44,7 47,9 50,7 51,5 44,7 45,5 48,1 50,8 51,6
27 46,1 47,1 50,3 53,2 54,1 46,9 47,7 50,4 53,2 54,0
28 48,6 49,6 52,6 55,6 56,5 49,1 50,0 52,7 55,5 56,4
29 51,0 51,9 54,8 57,8 58,8 51,2 52,1 55,0 57,8 58,7
30 53,1 54,0 57,0 60,0 61,0 53,3 54,2 57,1 60,1 60,9
31 55,1 56,0 59,1 62,3 63,3 55,3 56,3 59,3 62,3 63,2
32 57,0 57,9 61,1 64,4 65,5 57,3 58,3 61,4 64,5 65,4
33 58,6 59,6 63,0 66,4 67,6 59,0 60,0 63,3 66,5 67,4
34 60,2 61,2 64,6 68,3 69,5 60,4 61,5 64,9 68,3 69,3
35 61,5 62,6 66,2 70,1 71,4 61,8 62,9 66,6 70,2 71,3
36 62,9 64,0 67,7 71,8 73,2 63,2 64,4 68,4 72,2 73,4
37 64,5 65,6 69,4 73,7 75,1 64,6 65,9 70,0 73,9 75,1
38 66,2 67,4 71,3 75,7 77,1 66,0 67,3 71,4 75,3 76,5
39 68,0 69,2 73,2 77,7 79,2 67,5 68,7 72,7 76,5 77,6
40 69,9 71,1 75,2 79,7 81,3 68,8 70,0 73,8 77,4 78,5
Reference values in mm for fetal femur length (FL) for boys and girls for each gestational week for the me-
dian and 5th, 10th, 90th and 95th centiles. GA = gestational weeks.
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e-Table 3.13. BiParietalDiamater (BPD) for Boys and Girls in mm 
Centiles ga Boys girls se p-value
C5 20 44,0 43,1 0,059 <0,001
25 58,6 57,3 0,4 <0,001
30 72,9 71,6 0,1 <0,001
35 82,5 81,3 0,3 <0,001
40 88,4 88,2 1,1 0,39
C10 20 44,9 43,9 0,059 <0,001
25 59,8 58,4 0,4 <0,001
30 74,1 72,7 0,1 <0,001
35 84,0 82,7 0,3 <0,001
40 90,3 89,8 1,1 0,36
C50 20 47,8 46,7 0,059 <0,001
25 63,8 62,3 0,4 <0,001
30 78,4 76,9 0,1 <0,001
35 88,9 87,3 0,3 <0,001
40 96,6 95,3 1,1 0,21
C90 20 50,8 49,6 0,059 <0,001
25 67,9 66,2 0,4 <0,001
30 82,8 81,1 0,1 <0,001
35 93,9 92,1 0,3 <0,001
40 103,2 101,1 1,1 0,07
C95 20 51,7 50,5 0,059 <0,001
25 69,1 67,3 0,4 <0,001
30 84,2 82,4 0,1 <0,001
35 95,5 93,5 0,3 <0,001
40 105,3 102,8 1,1 0,03
Centiles = C (C5 =P5; C10=P10; C50=P50; C90=P90; C95=P95). GA = Gestational Age in weeks.  SE = Stan-
dard Error
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e-Table 3.14.  HeadCircumference (HC) for Boys and Girls in mm
Centiles ga Boys girls se p-value
C5 20 163,4 160,7 0,177 <0,001
25 216,2 212,5 1,336 0,008
30 265,3 261,6 0,327 <0,001
35 297,7 292,6 1,038 <0,001
40 323,5 319,4 2,696 0,13
C10 20 165,8 163,0 0,177 <0,001
25 219,7 215,5 1,336 0,003
30 269,0 265,0 0,327 <0,001
35 301,6 296,7 1,038 <0,001
40 327,6 323,7 2,696 0,15
C50 20 174,3 171,0 0,177 <0,001
25 231,7 226,2 1,336 <0,001
30 282,0 277,0 0,327 <0,001
35 315,9 311,3 1,038 <0,001
40 342,9 339,2 2,696 0,16
C90 20 182,9 179,2 0,177 <0,001
25 243,6 237,3 1,336 <0,001
30 295,1 289,5 0,327 <0,001
35 332,2 326,5 1,038 <0,001
40 364,2 355,4 2,696 0,002
C95 20 185,4 181,6 0,177 <0,001
25 247,0 240,6 1,336 <0,001
30 299,0 293,2 0,327 <0,001
35 337,5 331,0 1,038 <0,001
40 373,1 360,2 2,696 <0,001
Centiles = C (C5 =P5; C10=P10; C50=P50; C90=P90; C95=P95). GA = Gestational Age in weeks.  SE = Stan-
dard Error
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e-Table 3.15 AbdominalCircumference (AC) for Boys and Girls in mm
Centiles ga Boys girls se p-value
C5 20 140,6 138,1 0,202 <0,001
25 188,7 187,5 1,702 0,32
30 244,1 240,7 0,373 <0,001
35 283,2 279,9 1,538 0,04
40 312,3 311,9 6,380 0,40
C10 20 143,3 140,8 0,202 <0,001
25 193,6 191,3 1,702 0,16
30 248,5 245,3 0,373 <0,001
35 289,1 285,9 1,538 0,05
40 320,5 319,8 6,380 0,40
C50 20 153,1 150,5 0,202 <0,001
25 207,4 204,4 1,702 0,09
30 263,5 260,7 0,373 <0,001
35 310,2 306,1 1,538 0,01
40 351,0 347,1 6,380 0,33
C90 20 163,4 160,7 0,202 <0,001
25 221,9 218,0 1,702 0,03
30 279,3 276,7 0,373 <0,001
35 332,5 328,0 1,538 0,006
40 383,8 379,8 6,380 0,33
C95 20 166,5 163,7 0,202 <0,001
25 227,5 222,0 1,702 0,002
30 284,2 281,6 0,373 <0,001
35 339,2 335,3 1,538 0,02
40 393,5 391,7 6,380 0,38
Centiles = C (C5 =P5; C10=P10; C50=P50; C90=P90; C95=P95). GA = Gestational Age in weeks.  SE = Stan-
dard Error
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e-Table 3.16. Femurlength (FL) for Boys and Girls in mm
Centiles ga Boys girls se p-value
C5 20 29,3 29,3 0,046 0,36
25 41,2 42,2 0,378 0,007
30 53,1 53,3 0,073 0,03
35 61,5 61,8 0,262 0,27
40 69,9 68,8 1,167 0,27
C10 20 29,9 29,9 0,046 0,20
25 42,3 43,0 0,378 0,05
30 54,0 54,2 0,073 0,02
35 62,6 62,9 0,262 0,17
40 71,1 70,0 1,167 0,27
C50 20 32,0 32,1 0,046 0,08
25 45,4 45,6 0,378 0,36
30 57,0 57,1 0,073 0,02
35 66,2 66,6 0,262 0,08
40 75,2 73,8 1,167 0,20
C90 20 34,3 34,3 0,046 0,40
25 48,1 48,2 0,378 0,40
30 60,0 60,1 0,073 0,38
35 70,1 70,2 0,262 0,34
40 79,7 77,4 1,167 0,06
C95 20 35,0 35,0 0,046 0,26
25 48,9 49,0 0,378 0,39
30 61,0 60,9 0,073 0,31
35 71,4 71,3 0,262 0,39
40 81,3 78,5 1,167 0,02
Centiles = C (C5 =P5; C10=P10; C50=P50; C90=P90; C95=P95). GA = Gestational Age in weeks.  SE = Stan-
dard Error
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e-Table 3.17. Estimated Fetal Weight (EFW) for Boys and Girls in g
Centiles ga Boys girls se p-value
C5 20 298,0 289,7 1,201 <0,001
25 670,8 658,3 10,869 0,21
30 1347,7 1314,3 5,163 <0,001
35 2108,1 2059,9 30,165 0,11
40 2776,4 2780,4 140,429 0,40
C10 20 308,1 299,5 1,201 <0,001
25 697,6 683,6 10,869 0,17
30 1400,3 1365,8 5,163 <0,001
35 2208,8 2156,3 30,165 0,09
40 2946,3 2943,0 140,429 0,40
C50 20 346,4 336,7 1,201 <0,001
25 798,6 776,9 10,869 0,06
30 1593,4 1550,2 5,163 <0,001
35 2577,1 2499,6 30,165 0,01
40 3569,6 3531,0 140,429 0,38
C90 20 391,3 379,8 1,201 <0,001
25 916,5 884,1 10,869 0,005
30 1814,1 1761,1 5,163 <0,001
35 3007,5 2911,8 30,165 0,003
40 4325,5 4300,3 140,429 0,39
C95 20 405,9 393,6 1,201 <0,001
25 954,8 918,8 10,869 0,002
30 1885,8 1831,4 5,163 <0,001
35 3151,6 3058,9 30,165 0,004
40 4590,7 4604,5 140,429 0,40
Centiles = C (C5 =P5; C10=P10; C50=P50; C90=P90; C95=P95). GA = Gestational Age in weeks.  SE = Stan-
dard Error
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The figures and some e-tables are not available 
in the printed version of this thesis, but can be 
downloaded from the electronic version of this 
thesis on www.e-pubs.nl
Chapter 3
e-Text 3.1. Ultrasound protocol guidelines
All operators performed the measurements as single observations in accordance to the 
following guidelines, subsequently defined by the International Society for Ultrasound 
in Obstetrics and Gynecology (ISUOG, www.isuog.org).26 The BPD measurement was 
performed in the transverse plane of the skull at the level where the continuous midline 
echo is interrupted anteriorly by the septum cavum pellucidum and centrally by the 
thalami. Ideally, an angle of insonation of 90° on the midline echo is used. Measure-
ments were performed from the proximal edge of the skull closest to the transducer to 
the proximal edge of the deep border (i.e. outer-inner edge of skull) with the calipers. 
The hC measurement was performed in the same plane. If the ultrasound equipment 
had an ellipse measurement capacity, then the HC could be measured directly by 
placing the ellipse around the outer edge of the skull. Alternatively, the HC could be 
calculated from the BPD and the Occipito-Frontal Diameter (OFD) by using the equa-
tion HC=1.62x(BPD+OFD). This formula required the placement of the calipers for BPD 
at leading edges and for OFD middle of the bone echo at forehead and occiput. The 
aC measurement was performed in the transverse plane of the fetal abdomen at the 
level of the stomach, as circular as possible. The umbilical vein should be visible at the 
level of the portal sinus. The kidneys should not be visible. The AC was measured at 
the outer surface of the skin line using ellipse calipers or it could be calculated from 
linear measurements made perpendicular to each other, usually the Anterior-Posterior 
Abdominal Diameter (APAD) and the Transverse Abdominal Diameter (TAD). To measure 
the APAD the calipers were placed at the outer borders of the body outline from the 
posterior aspect (skin covering the spine) to the anterior abdominal wall. To measure 
the TAD the calipers were placed on the outer borders of the body outline, across the 
abdomen at the widest point. The AC was calculated by a direct ellipse measurement or 
using the formula AC=1.57(APAD+TAD). The Fl was optimally imaged with both ends 
of the ossified metaphyses clearly visualized. The longest axis of the ossified diaphysis 
was measured. An angle of 45-90° between the insonating ultrasound beam and the 
femur were aimed for. The calipers were placed at the ends of the ossified diaphysis if 
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it is visible avoiding the artificial triangle spurs that appear to extend the length of the 
femoral ends.
references
 26. ISUOG Prenatal Ultrasound Screening Taskforce. Practice guidelines for performance of the 
routine mid-trimester fetal ultrasound scan. http: //www.isuog.org/NR/rdonlyres/EA865840-
6CA3-45AC-9E99-FBAF775119A9/0/PrenatalUS_GL_Final.pdf
211Supplement
reFerenCes
e-table 5.1. Fetal abdominal circumference in e-GWG and ne-GWG women
ga
(in weeks)
e-gWg ne-gWg
C10 C50 C90 C10 C50 C90
12 51,8 55,9 60,3 50,5 54,6 58,8
13 62,6 67,6 72,9 61,5 66,4 71,5
14 73,4 79,4 85,5 72,4 78,2 84,3
15 84,4 91,2 98,3 83,4 90,1 97,1
16 95,4 103,1 111,1 94,5 102,0 109,9
17 106,3 114,9 123,8 105,5 113,9 122,7
18 117,2 126,6 136,4 116,5 125,8 135,5
19 127,9 138,2 149,0 127,3 137,5 148,2
20 138,6 149,8 161,4 138,1 149,1 160,6
21 149,2 161,2 173,7 148,6 160,5 172,9
22 159,7 172,6 186,0 159,0 171,8 185,1
23 170,1 183,9 198,1 169,3 182,9 197,0
24 180,5 195,0 210,2 179,4 193,8 208,8
25 190,7 206,1 222,1 189,4 204,5 220,3
26 200,8 217,0 233,8 199,2 215,1 231,8
27 210,8 227,8 245,5 208,9 225,6 243,0
28 220,8 238,6 257,1 218,4 235,9 254,2
29 230,6 249,3 268,6 227,9 246,1 265,2
30 240,5 259,9 280,1 237,3 256,2 276,1
31 250,3 270,5 291,5 246,5 266,3 286,9
32 260,1 281,1 302,9 255,8 276,3 297,6
33 269,9 291,7 314,3 265,0 286,2 308,4
34 279,6 302,2 325,7 274,2 296,2 319,1
35 289,4 312,7 337,0 283,4 306,1 329,8
36 299,1 323,2 348,3 292,7 316,1 340,5
37 308,8 333,7 359,6 301,9 326,1 351,3
38 318,5 344,2 370,9 311,2 336,1 362,1
39 328,2 354,7 382,2 320,4 346,1 372,8
40 337,9 365,2 393,6 329,7 356,1 383,6
Fetal Abdominal Circumference (AC) reference values in mm and gestational age (GA) in weeks. Percentiles 
10, 50 and 90 for ne-GWG (non-excessive GWG) and e-GWG (excessive GWG).
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e-Table 5.2. Fetal liver length in obese and non-obese women
ga
(in weeks)
oBese normal Bmi
C10 C50 C90 C10 C50 C90
12 7,6 8,8 10,2 7,1 8,3 9,6
13 9,2 10,6 12,3 8,7 10,1 11,6
14 10,8 12,5 14,5 10,2 11,9 13,7
15 12,4 14,3 16,6 11,8 13,7 15,8
16 14,0 16,2 18,8 13,3 15,6 17,9
17 15,6 18,0 20,9 14,9 17,4 19,9
18 17,2 19,8 23,1 16,4 19,2 22,0
19 18,8 21,7 25,2 18,0 21,0 24,1
20 20,4 23,5 27,4 19,5 22,8 26,1
21 22,0 25,4 29,5 21,1 24,6 28,2
22 23,6 27,2 31,6 22,6 26,4 30,3
23 25,2 29,1 33,8 24,1 28,2 32,4
24 26,7 30,9 35,9 25,7 30,0 34,4
25 28,3 32,8 38,1 27,2 31,8 36,5
26 29,9 34,6 40,2 28,8 33,6 38,6
27 31,5 36,5 42,4 30,3 35,4 40,7
28 33,1 38,3 44,5 31,9 37,2 42,7
29 34,7 40,1 46,7 33,4 39,1 44,8
30 36,3 42,0 48,8 35,0 40,9 46,9
31 37,9 43,8 50,9 36,5 42,7 49,0
32 39,5 45,7 53,1 38,1 44,5 51,0
33 41,1 47,5 55,2 39,6 46,3 53,1
34 42,7 49,4 57,4 41,2 48,1 55,2
35 44,3 51,2 59,5 42,7 49,9 57,3
36 45,9 53,1 61,7 44,3 51,7 59,3
37 47,5 54,9 63,8 45,8 53,5 61,4
38 49,1 56,8 66,0 47,4 55,3 63,5
39 50,7 58,6 68,1 48,9 57,1 65,6
40 52,3 60,4 70,2 50,5 58,9 67,6
Fetal Liver length reference values in mm from 12 weeks gestational age (GA) onwards. Percentiles 10, 50 
and 90 for obese and normal BMI (‘non-obese’).
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e-Table 5.3. Fetal liver length in e-GWG and ne-GWG women
ga
(in weeks)
e-gWg ne-gWg
C10 C50 C90 C10 C50 C90
12 7,2 8,4 9,7 7,3 8,5 9,7
13 8,8 10,2 11,9 8,8 10,3 11,8
14 10,5 12,1 14,1 10,3 12,1 13,8
15 12,1 13,9 16,2 11,8 13,9 15,8
16 13,7 15,8 18,4 13,3 15,6 17,9
17 15,3 17,6 20,6 14,9 17,4 19,9
18 16,9 19,5 22,8 16,4 19,2 21,9
19 18,5 21,4 24,9 17,9 21,0 23,9
20 20,1 23,2 27,1 19,4 22,8 26,0
21 21,8 25,1 29,3 20,9 24,5 28,0
22 23,4 27,0 31,5 22,5 26,3 30,0
23 25,0 28,9 33,7 24,0 28,1 32,1
24 26,6 30,7 35,8 25,5 29,9 34,1
25 28,2 32,6 38,0 27,0 31,6 36,1
26 29,9 34,5 40,2 28,5 33,4 38,2
27 31,5 36,4 42,4 30,0 35,2 40,2
28 33,1 38,2 44,6 31,6 37,0 42,2
29 34,8 40,1 46,8 33,1 38,8 44,2
30 36,4 42,0 49,0 34,6 40,5 46,3
31 38,0 43,9 51,2 36,1 42,3 48,3
32 39,6 45,7 53,4 37,6 44,1 50,3
33 41,3 47,6 55,6 39,1 45,9 52,4
34 42,9 49,5 57,8 40,7 47,6 54,4
35 44,5 51,4 60,0 42,2 49,4 56,4
36 46,1 53,3 62,1 43,7 51,2 58,5
37 47,8 55,1 64,3 45,2 53,0 60,5
38 49,4 57,0 66,5 46,7 54,8 62,5
39 51,0 58,9 68,7 48,2 56,5 64,5
40 52,7 60,8 70,9 49,8 58,3 66,6
Fetal Liver length reference values in mm from 12 weeks gestational age (GA) onwards. Percentiles 10, 50 
and 90 for ne-GWG (non-excessive GWG) and e-GWG (excessive GWG).
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e-Table 5.4. Fetal abdominal fat tissue in obese and normal BMI women
ga
(in weeks)
oBese normal Bmi
C10 C50 C90 C10 C50 C90
18 0,79 1,06 1,36 0,95 1,20 1,54
19 0,93 1,23 1,59 1,07 1,35 1,73
20 1,06 1,41 1,81 1,19 1,50 1,92
21 1,19 1,59 2,04 1,30 1,64 2,11
22 1,33 1,77 2,27 1,42 1,79 2,30
23 1,46 1,95 2,50 1,53 1,94 2,49
24 1,60 2,13 2,73 1,65 2,08 2,67
25 1,73 2,31 2,96 1,76 2,22 2,85
26 1,87 2,49 3,20 1,88 2,37 3,04
27 2,00 2,67 3,43 1,99 2,51 3,23
28 2,14 2,85 3,67 2,11 2,66 3,42
29 2,28 3,04 3,91 2,23 2,82 3,62
30 2,43 3,23 4,15 2,36 2,97 3,82
31 2,57 3,42 4,40 2,49 3,14 4,03
32 2,71 3,61 4,64 2,62 3,31 4,25
33 2,86 3,81 4,89 2,76 3,49 4,48
34 3,00 4,00 5,14 2,91 3,67 4,72
35 3,15 4,20 5,39 3,06 3,86 4,96
36 3,30 4,39 5,65 3,21 4,05 5,20
37 3,45 4,59 5,90 3,36 4,24 5,45
38 3,59 4,78 6,15 3,51 4,43 5,69
39 3,74 4,98 6,40 3,66 4,62 5,94
40 3,89 5,17 6,65 3,82 4,82 6,19
Fetal abdominal fat tissue (AFT) reference values in mm from 18 weeks gestational age (GA) onwards. Per-
centiles 10, 50 and 90 for obese and normal BMI (‘non-obese’).
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e-Table 5.5. Fetal abdominal fat tissue in e-GWG and ne-GWG women
ga
(in weeks)
e-gWg ne-gWg
C10 C50 C90 C10 C50 C90
18 0,90 1,14 1,45 0,93 1,20 1,55
19 1,03 1,30 1,66 1,04 1,34 1,74
20 1,16 1,47 1,87 1,16 1,49 1,93
21 1,29 1,63 2,07 1,27 1,63 2,12
22 1,42 1,79 2,28 1,38 1,78 2,31
23 1,55 1,95 2,49 1,49 1,92 2,49
24 1,68 2,11 2,69 1,61 2,07 2,68
25 1,80 2,27 2,89 1,72 2,21 2,87
26 1,93 2,43 3,09 1,83 2,36 3,06
27 2,06 2,60 3,30 1,95 2,50 3,25
28 2,19 2,77 3,52 2,06 2,65 3,44
29 2,34 2,95 3,75 2,18 2,80 3,64
30 2,49 3,14 3,99 2,30 2,96 3,84
31 2,65 3,34 4,25 2,42 3,11 4,04
32 2,81 3,54 4,51 2,55 3,27 4,25
33 2,98 3,76 4,78 2,67 3,43 4,46
34 3,15 3,98 5,06 2,80 3,60 4,67
35 3,33 4,20 5,34 2,93 3,76 4,89
36 3,50 4,42 5,62 3,06 3,93 5,11
37 3,68 4,64 5,91 3,19 4,10 5,33
38 3,86 4,87 6,19 3,32 4,27 5,55
39 4,03 5,09 6,47 3,45 4,44 5,77
40 4,21 5,31 6,76 3,59 4,61 5,99
Fetal abdominal fat tissue (AFT) reference values in mm from 18 weeks gestational age (GA) onwards. Per-
centiles 10, 50 and 90 for ne-GWG (non-excessive GWG) and e-GWG (excessive GWG).
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e-Table 5.6. Fetal subscapular fat tissue in the e-GWG and ne-GWG women
ga
(in weeks)
e-gWg ne-gWg
C10 C50 C90 C10 C50 C90
18 0,88 1,07 1,36 0,96 1,22 1,60
19 1,03 1,26 1,60 1,07 1,36 1,78
20 1,19 1,45 1,84 1,18 1,50 1,97
21 1,34 1,64 2,08 1,29 1,64 2,15
22 1,50 1,83 2,32 1,40 1,78 2,33
23 1,65 2,01 2,55 1,51 1,92 2,52
24 1,80 2,20 2,78 1,62 2,06 2,70
25 1,94 2,38 3,01 1,74 2,20 2,89
26 2,09 2,56 3,24 1,85 2,35 3,08
27 2,24 2,74 3,47 1,97 2,51 3,28
28 2,40 2,93 3,71 2,10 2,67 3,50
29 2,56 3,13 3,97 2,24 2,85 3,73
30 2,73 3,34 4,23 2,39 3,03 3,97
31 2,90 3,55 4,50 2,54 3,22 4,22
32 3,08 3,77 4,77 2,69 3,42 4,48
33 3,26 3,99 5,05 2,85 3,62 4,74
34 3,44 4,21 5,33 3,02 3,83 5,01
35 3,63 4,44 5,62 3,18 4,04 5,29
36 3,81 4,66 5,90 3,35 4,25 5,57
37 4,00 4,89 6,19 3,52 4,47 5,85
38 4,18 5,12 6,48 3,69 4,69 6,14
39 4,37 5,34 6,76 3,86 4,90 6,42
40 4,55 5,57 7,05 4,04 5,12 6,71
Fetal subscapular fat tissue (SFT) reference values in mm from 18 weeks gestational age (GA) onwards. 
Percentiles 10, 50 and 90 for ne-GWG (non-excessive GWG) and e-GWG (excessive GWG).
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gridcurves & scatterplots for Total group and Boys & girls
Reference values (gridlines) for outstanding fetal anthropometry measurements for 
neonatal fat mass (NFM) >15% (P90) and fat mass ≤15%.
e-Table 6.1. Fetal abdominal circumference for neonatal fat mass (NFM) >15% (P90) and NFM ≤15% 
ga
(in weeks)
Fat>15% Fat≤15%
C10 C50 C90 C10 C50 C90
12 50,68 55,33 58,09 50,88 54,73 59,19
13 62,49 68,22 71,63 61,62 66,29 71,69
14 74,28 81,09 85,14 72,55 78,05 84,40
15 85,98 93,87 98,56 83,68 90,02 97,35
16 97,56 106,51 111,83 94,91 102,11 110,42
17 108,96 118,95 124,90 106,12 114,16 123,45
18 120,15 131,17 137,73 117,19 126,07 136,34
19 131,17 143,19 150,35 128,11 137,82 149,04
20 142,04 155,07 162,82 138,87 149,39 161,55
21 152,84 166,85 175,19 149,46 160,79 173,88
22 163,58 178,58 187,50 159,91 172,03 186,03
23 174,27 190,26 199,76 170,22 183,11 198,02
24 184,92 201,87 211,96 180,36 194,02 209,82
25 195,48 213,41 224,07 190,33 204,75 221,42
26 205,96 224,85 236,09 200,12 215,28 232,81
27 216,33 236,17 247,97 209,78 225,67 244,05
28 226,57 247,35 259,71 219,34 235,96 255,17
29 236,70 258,41 271,32 228,85 246,19 266,23
30 246,74 269,37 282,83 238,32 256,38 277,25
31 256,72 280,25 294,26 247,77 266,55 288,25
32 266,64 291,09 305,64 257,23 276,72 299,24
33 276,53 301,89 316,98 266,69 286,90 310,25
34 286,38 312,65 328,27 276,16 297,08 321,27
35 296,20 323,36 339,52 285,65 307,29 332,30
36 305,97 334,03 350,72 295,14 317,51 343,36
37 315,72 344,67 361,90 304,66 327,74 354,42
38 325,46 355,31 373,06 314,18 337,98 365,50
Fetal Abdominal Circumference (AC) reference values in mm and gestational age (GA) in weeks. Percentiles 
10, 50 and 90 for neonatal fat mass >15% (P90) and fat mass ≤15%.
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e-Figure 3.1. Grid reference curve and scatterplot for BiParietalDiameter (BPD) in mm for total group from 
12-40 weeks of gestation. Percentiles 5, 10, 50, 90 and 95.
e-Table 6.2. Fetal liver length for neonatal fat mass (NFM) >15% (P90) and NFM ≤15%
ga
(in weeks)
Fat>15% Fat≤15%
C10 C50 C90 C10 C50 C90
12 7,50 8,83 10,07 7,32 8,49 9,77
13 9,07 10,68 12,17 8,87 10,29 11,85
14 10,64 12,52 14,27 10,43 12,10 13,93
15 12,21 14,37 16,38 11,99 13,90 16,00
16 13,78 16,22 18,49 13,54 15,71 18,08
17 15,36 18,07 20,60 15,10 17,51 20,16
18 16,94 19,94 22,73 16,66 19,32 22,24
19 18,53 21,81 24,86 18,21 21,12 24,32
20 20,13 23,70 27,01 19,77 22,93 26,40
21 21,75 25,59 29,17 21,33 24,73 28,47
22 23,37 27,51 31,35 22,88 26,54 30,55
23 25,01 29,43 33,55 24,44 28,35 32,63
24 26,66 31,37 35,76 26,00 30,15 34,71
25 28,32 33,33 37,99 27,55 31,96 36,79
26 29,98 35,29 40,22 29,11 33,76 38,87
27 31,66 37,26 42,47 30,67 35,57 40,94
28 33,34 39,24 44,73 32,22 37,37 43,02
29 35,03 41,23 46,99 33,78 39,18 45,10
30 36,72 43,22 49,26 35,33 40,98 47,18
31 38,41 45,21 51,53 36,89 42,79 49,26
32 40,10 47,20 53,80 38,45 44,59 51,34
33 41,79 49,19 56,07 40,00 46,40 53,41
34 43,49 51,18 58,34 41,56 48,20 55,49
35 45,18 53,17 60,61 43,12 50,01 57,57
36 46,87 55,16 62,87 44,67 51,82 59,65
37 48,56 57,15 65,14 46,23 53,62 61,73
38 50,25 59,14 67,41 47,79 55,43 63,81
Fetal Liver length reference values in mm from 12weeks gestational age (GA) onwards. Percentiles 10, 50 
and 90 for neonatal fat mass >15% (P90) and fat mass ≤15%.
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e-Table 6.3. Fetal subscapular fat thickness for neonatal fat mass (NFM) >15% (P90) and NFM ≤15%
ga
(in weeks)
Fat>15% Fat≤15%
C10 C50 C90 C10 C50 C90
20 0,91 1,02 1,24 1,22 1,53 1,97
21 1,21 1,36 1,65 1,34 1,69 2,17
22 1,48 1,67 2,02 1,46 1,84 2,36
23 1,71 1,93 2,33 1,58 1,99 2,56
24 1,90 2,14 2,59 1,70 2,14 2,75
25 2,06 2,33 2,81 1,82 2,29 2,94
26 2,21 2,49 3,01 1,94 2,44 3,13
27 2,35 2,66 3,21 2,06 2,59 3,33
28 2,53 2,85 3,45 2,19 2,75 3,54
29 2,75 3,11 3,76 2,33 2,92 3,76
30 3,04 3,44 4,15 2,47 3,11 3,99
31 3,37 3,81 4,60 2,62 3,30 4,23
32 3,73 4,21 5,09 2,78 3,49 4,49
33 4,10 4,63 5,59 2,94 3,69 4,75
34 4,46 5,03 6,08 3,10 3,90 5,01
35 4,80 5,42 6,54 3,27 4,11 5,28
36 5,11 5,77 6,97 3,44 4,32 5,55
37 5,40 6,10 7,37 3,61 4,53 5,82
38 5,69 6,42 7,76 3,78 4,74 6,09
Fetal subscapular fat thickness (SFT) reference values in mm from 20 weeks gestational age (GA) onwards. 
Percentiles 10, 50 and 90 for neonatal fat mass >15% (P90) and fat mass ≤15%.
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e-Table 6.4. Fetal abdominal fat thickness for neonatal fat mass (NFM) >15% (P90) and NFM ≤15%
ga
(in weeks)
Fat>15% Fat≤15%
C10 C50 C90 C10 C50 C90
20 1,12 1,39 1,72 1,13 1,46 1,89
21 1,26 1,57 1,94 1,29 1,66 2,15
22 1,41 1,74 2,16 1,45 1,86 2,41
23 1,55 1,92 2,38 1,59 2,04 2,64
24 1,69 2,10 2,60 1,71 2,20 2,84
25 1,84 2,28 2,83 1,82 2,33 3,02
26 1,99 2,48 3,07 1,90 2,44 3,16
27 2,16 2,68 3,32 1,98 2,54 3,28
28 2,33 2,89 3,58 2,05 2,63 3,41
29 2,51 3,11 3,86 2,14 2,75 3,56
30 2,70 3,35 4,14 2,25 2,89 3,74
31 2,89 3,59 4,44 2,37 3,05 3,94
32 3,09 3,84 4,75 2,52 3,23 4,18
33 3,30 4,09 5,07 2,67 3,43 4,44
34 3,51 4,36 5,40 2,84 3,65 4,72
35 3,73 4,62 5,73 3,02 3,88 5,02
36 3,94 4,89 6,06 3,21 4,13 5,34
37 4,16 5,16 6,40 3,41 4,38 5,66
38 4,38 5,43 6,73 3,61 4,63 5,99
Fetal abdominal fat thickness (AFT) reference values in mm from 20 weeks gestational age (GA) onwards. 
Percentiles 10, 50 and 90 for neonatal fat mass >15% (P90) and fat mass ≤15%.
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e-Figure 3.2. Grid reference curve and scatterplot for HeadCircumference (HC) in mm for total group from 
12-40 weeks of gestation. Percentiles 5, 10, 50, 90 and 95.
e-Figure 3.3. Grid reference curve and scatterplot for Abdominal Circumference (AC) in mm for total group 
from 12-40 weeks of gestation. Percentiles 5, 10, 50, 90 and 95.
e-Figure 3.4. Grid reference curve and scatterplot for Femur Length (FL) in mm for total group from 
12-40weeks of gestation. Percentiles 5, 10, 50, 90 and 95.
e-Figure 3.5. Grid reference curve and scatterplot for Estimated Fetal Weight (EFW) in g for total group 
from 12-40 weeks of gestation. Percentiles 5, 10, 50, 90 and 95.
e-Figure 3.6. Grid reference curves and scatterplots for BiParietalDiameter (BPD) in mm for Boys (upper 
right) and Girls (lower right) from 12-40 weeks of gestation. Percentiles 5, 10, 50, 90 and 95.
e-Figure 3.7.a,b. Grid reference curves for BiParietalDiameter (BPD) in mm for Boys and Girls: a) from 20-30 
weeks of gestation (upper); b) from 30-40 weeks of gestation (down). Percentiles 5, 10, 50, 90 and 95.
e-Figure 3.8. Grid reference curves and scatterplot for HeadCircumference (HC) in mm for Boys (upper 
right) and Girls (lower right) from 12-40 weeks of gestation. Percentiles 5, 10, 50, 90 and 95.
e-Figure 3.9.a,b. Grid reference curves for HeadCircumference (HC) in mm for Boys and Girls: a) from 20-30 
weeks of gestation (upper); b) from 30-40 weeks of gestation (down). Percentiles 5, 10, 50, 90 and 95.
e-Figure 3.10. Grid reference curves and scatterplot for Abdominal Circumference (AC) in mm for Boys (up-
per right) and Girls (lower right) from 12-40 weeks of gestation. Percentiles 5, 10, 50, 90 and 95.
e-Figure 3.11.a,b. Grid reference curves for Abdominal Circumference (AC) in mm for Boys and Girls: a) 
from 20-30 weeks (upper); b) from 30-40 weeks of gestation (down). Percentiles 5, 10, 50, 90 and 95.
e-Figure 3.12. Grid reference curves and scatterplot for Femur Length (FL) in mm for Boys (upper right) and 
Girls (lower right) from 12-40 weeks of gestation. Percentiles 5, 10, 50, 90 and 95.
e-Figure 3.13.a,b. Grid reference curves for Femur Length (FL) in mm for Boys and Girls: a) from 20-30 
weeks of gestation (upper); b) from 30-40 weeks of gestation (down). Percentiles 5, 10, 50, 90 and 95.
e-Figure 3.14. Grid reference curves and scatterplot for Estimated Fetal Weight (EFW) in g for Boys (upper 
right) and Girls (lower right) from 12-40 weeks of gestation. Percentiles 5, 10, 50, 90 and 95.
e-Figure 3.15.a,b. Grid reference curves for Estimated Fetal Weight (EFW) in g for Boys and Girls: a) from 
20-30 weeks of gestation (upper); b) from 30-40 weeks of gestation (down). Percentiles 5, 10, 50, 90 and 95.
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Chapter 5
scatterplots fetal measurements
e-Figure 5.1.a,b. Scatterplots for Fetal Head Circumference (HC) in mm (upper) and for Fetal Abdominal 
Circumference (AC) in mm (down) during gestation (x-axis) in weeks. Percentiles 10, 50 and 90 using Box 
Cox Transformation (BCT).
e-Table 8.1. Percentile grids of IMT, DIA and DIS per gestational week
ga imT Dia Dis
P10 P50 P90 P10 P50 P90 P10 P50 P90
12 451,392 519,3619 602,1823 6050,135 6569,734 7106,3 320,6322 470,3141 672,2
13 450,7456 518,6181 601,3198 6062,539 6583,203 7120,869 318,6048 467,3401 667,9495
14 450,0991 517,8742 600,4574 6074,943 6596,673 7135,439 316,5773 464,3662 663,699
15 449,4526 517,1304 599,5949 6087,347 6610,142 7150,008 314,5499 461,3923 659,4485
16 448,8061 516,3866 598,7325 6099,751 6623,611 7164,578 312,5224 458,4183 655,1979
17 448,1596 515,6427 597,87 6112,155 6637,081 7179,147 310,495 455,4444 650,9474
18 447,5131 514,8989 597,0076 6124,559 6650,55 7193,716 308,4675 452,4705 646,6969
19 446,8666 514,1551 596,1451 6136,963 6664,019 7208,285 306,4401 449,4965 642,4464
20 446,2201 513,4112 595,2827 6149,367 6677,488 7222,854 304,4126 446,5226 638,1959
21 445,5737 512,6674 594,4202 6161,77 6690,956 7237,423 302,3851 443,5487 633,9454
22 444,9272 511,9236 593,5578 6174,173 6704,425 7251,992 300,3577 440,5747 629,6948
23 444,2807 511,1797 592,6953 6186,577 6717,894 7266,56 298,3302 437,6008 625,4443
24 443,6342 510,4359 591,8329 6198,98 6731,362 7281,128 296,3028 434,6269 621,1938
25 442,9877 509,6921 590,9704 6211,383 6744,83 7295,697 294,2753 431,6529 616,9433
26 442,3412 508,9482 590,108 6223,786 6758,298 7310,265 292,2479 428,679 612,6928
27 441,6947 508,2044 589,2455 6236,189 6771,766 7324,833 290,2204 425,7051 608,4422
28 441,0483 507,4606 588,3831 6248,592 6785,234 7339,401 288,193 422,7311 604,1917
29 440,4018 506,7167 587,5206 6260,994 6798,702 7353,969 286,1655 419,7572 599,9412
30 439,7553 505,9729 586,6582 6273,397 6812,17 7368,537 284,1381 416,7833 595,6907
31 439,1088 505,2291 585,7957 6285,8 6825,638 7383,105 282,1106 413,8093 591,4402
32 438,4623 504,4852 584,9333 6298,203 6839,106 7397,673 280,0832 410,8354 587,1897
33 437,8158 503,7414 584,0709 6310,605 6852,574 7412,24 278,0557 407,8615 582,9391
34 437,1693 502,9976 583,2084 6323,008 6866,042 7426,808 276,0283 404,8875 578,6886
35 436,5228 502,2537 582,346 6335,411 6879,51 7441,376 274,0008 401,9136 574,4381
36 435,8764 501,5099 581,4835 6347,814 6892,978 7455,944 271,9734 398,9397 570,1876
37 435,2299 500,7661 580,6211 6360,216 6906,446 7470,512 269,9459 395,9657 565,9371
38 434,5834 500,0222 579,7586 6372,619 6919,913 7485,079 267,9185 392,9918 561,6865
Percentile grids for IMT = intima media thickness in µm; DIA = diameter in µm; DIS = distension in µm; GA = 
gestational age. P10 = 10th percentile; P50 = 50th percentile; P90 = 90th percentile.
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e-Table 8.2. Percentile grids of CAC, YEM and SI per gestational week
ga CaC yem si
P10 P50 P90 P10 P50 P90 P10 P50 P90
12 1,868591 2,79078 4,179133 120,6843 185,1391 287,2175 2,49731 3,789062 5,520322
13 1,852908 2,767357 4,144057 121,7242 186,7343 289,6922 2,522861 3,82783 5,576804
14 1,837225 2,743934 4,108981 122,764 188,3295 292,167 2,548412 3,866598 5,633285
15 1,821541 2,720511 4,073906 123,8039 189,9247 294,6417 2,573964 3,905366 5,689766
16 1,805858 2,697088 4,03883 124,8437 191,5199 297,1165 2,599515 3,944133 5,746247
17 1,790175 2,673664 4,003754 125,8836 193,1151 299,5912 2,625065 3,9829 5,802727
18 1,774492 2,650241 3,968678 126,9234 194,7103 302,0659 2,650616 4,021667 5,859206
19 1,758808 2,626818 3,933603 127,9633 196,3055 304,5407 2,676166 4,060432 5,915684
20 1,743125 2,603395 3,898527 129,0031 197,9007 307,0154 2,701715 4,099198 5,972162
21 1,727442 2,579971 3,863451 130,043 199,4959 309,4902 2,727264 4,137963 6,028639
22 1,711759 2,556548 3,828375 131,0828 201,0911 311,9649 2,752813 4,176727 6,085115
23 1,696076 2,533125 3,7933 132,1227 202,6863 314,4396 2,778362 4,215491 6,14159
24 1,680392 2,509702 3,758224 133,1625 204,2815 316,9144 2,80391 4,254254 6,198065
25 1,664709 2,486279 3,723148 134,2024 205,8768 319,3891 2,829458 4,293017 6,254539
26 1,649026 2,462855 3,688072 135,2422 207,472 321,8639 2,855006 4,33178 6,311014
27 1,633343 2,439432 3,652997 136,2821 209,0672 324,3386 2,880554 4,370543 6,367488
28 1,61766 2,416009 3,617921 137,3219 210,6624 326,8134 2,906103 4,409306 6,423962
29 1,601976 2,392586 3,582845 138,3618 212,2576 329,2881 2,931651 4,448069 6,480436
30 1,586293 2,369163 3,547769 139,4016 213,8528 331,7628 2,957199 4,486832 6,53691
31 1,57061 2,345739 3,512694 140,4414 215,448 334,2376 2,982747 4,525595 6,593384
32 1,554927 2,322316 3,477618 141,4813 217,0432 336,7123 3,008295 4,564358 6,649858
33 1,539243 2,298893 3,442542 142,5211 218,6384 339,1871 3,033842 4,60312 6,706332
34 1,52356 2,27547 3,407466 143,561 220,2336 341,6618 3,05939 4,641883 6,762805
35 1,507877 2,252046 3,372391 144,6008 221,8288 344,1366 3,084938 4,680645 6,819278
36 1,492194 2,228623 3,337315 145,6407 223,424 346,6113 3,110485 4,719407 6,875751
37 1,476511 2,2052 3,302239 146,6805 225,0192 349,086 3,136033 4,75817 6,932224
38 1,460827 2,181777 3,267163 147,7204 226,6144 351,5608 3,16158 4,796932 6,988697
Percentile grids for CAC = carotid artery compliance in %/10mmHg; YEM = young elastic modulus in 
mmHg/mm; SI = stiffness index. GA = gestational age. P10 = 10th percentile; P50 = 50th percentile; P90 = 
90th percentile.
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e-Figure 5.2.a,b. Scatterplots for Fetal Femur Length (FL) in mm (upper) and Fetal Liver Length (LL) in mm 
(down) during gestation (x-axis) in weeks. Percentiles 10, 50 and 90 using Box Cox Transformation (BCT).
e-Figure 5.3.a,b. Scatterplots for Fetal Subscapular Fat Tissue (SFT) in mm (upper) and Fetal Abdominal 
Fat Tissue (AFT) in mm (down) during gestation (x-axis) in weeks. Percentiles 10, 50 and 90 using Box Cox 
Transformation (BCT).
e-Figure 5.4.a,b. Scatterplots for Humerus Fetal Lean Mass Area (H-FLMA) in mm² (upper) and in % (down) 
of total surface of mid-portion transvers section of humerus during gestation (x-axis) in weeks. Percentiles 
10, 50 and 90 using Box Cox Transformation (BCT).
e-Figure 5.5.a,b. Scatterplots for Humerus Fetal Fat Mass Area (H-FFMA) in mm² (upper) and in % (down) 
of total surface of mid-portion transvers section of humerus during gestation (x-axis) in weeks. Percentiles 
10, 50 and 90 using Box Cox Transformation (BCT). 
e-Figure 5.6.a,b. Scatterplots for Femur Fetal Lean Mass Area (F-FLMA) in mm² (upper) and in % (down) of 
total surface of mid-portion transvers section of femur during gestation (x-axis) in weeks. Percentiles 10, 50 
and 90 using Box Cox Transformation (BCT).
e-Figure 5.7.a,b. Scatterplots for Femur Fetal Fat Mass Area (F-FFMA) in mm² (upper) and in % (down) of 
total surface of mid-portion transvers section of femur during gestation (x-axis) in weeks. Percentiles 10, 50 
and 90 using Box Cox Transformation (BCT).
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e-Table 9.2. Percentile grids of IMT, DIA and DIS per gestational week
ga imT Dia Dis
P10 P50 P90 P10 P50 P90 P10 P50 P90
26 269,6516 315,8827 382,863 3102,313 3466,738 3862,983 171,6476 233,8431 316,1935
27 283,6074 332,2311 402,6779 3227,78 3606,943 4019,214 174,7107 238,0161 321,836
28 297,5631 348,5795 422,4929 3353,247 3747,149 4175,444 177,7738 242,189 327,4786
29 311,5189 364,9279 442,3078 3478,714 3887,354 4331,675 180,8369 246,362 333,1211
30 325,4746 381,2763 462,1228 3604,181 4027,56 4487,906 183,9 250,535 338,7636
31 339,4303 397,6247 481,9378 3729,648 4167,765 4644,137 186,9631 254,708 344,4062
32 353,3861 413,9731 501,7527 3855,115 4307,971 4800,368 190,0262 258,881 350,0487
33 367,3418 430,3216 521,5677 3980,582 4448,176 4956,599 193,0893 263,0539 355,6913
34 381,2976 446,67 541,3826 4106,049 4588,381 5112,829 196,1523 267,2269 361,3338
35 395,2533 463,0184 561,1976 4231,516 4728,587 5269,06 199,2154 271,3999 366,9763
36 409,209 479,3668 581,0125 4356,983 4868,792 5425,291 202,2785 275,5729 372,6189
37 423,1648 495,7152 600,8275 4482,45 5008,998 5581,522 205,3416 279,7459 378,2614
38 437,1205 512,0636 620,6425 4607,917 5149,203 5737,753 208,4047 283,9188 383,904
Percentile grids for IMT = intima media thickness in µm; DIA = diameter in µm; DIS = distension in µm; GA = 
gestational age. P10 = 10th percentile; P50 = 50th percentile; P90 = 90th percentile.
e-Table 9.3. Percentile grids of fAAC, YEM and SI per gestational week
ga faaC yem si
P10 P50 P90 P10 P50 P90 P10 P50 P90
26 4,033462 5,669164 7,92108 38,08719 56,00549 82,01378 4,062464 5,769922 7,955559
27 3,920861 5,510901 7,69995 42,03019 61,8035 90,5043 4,101144 5,824859 8,031307
28 3,808261 5,352637 7,478821 45,97319 67,6015 98,99483 4,139824 5,879796 8,107054
29 3,69566 5,194373 7,257691 49,91619 73,3995 107,4854 4,178504 5,934733 8,182802
30 3,58306 5,036109 7,036561 53,85918 79,1975 115,9759 4,217184 5,989671 8,258549
31 3,470459 4,877845 6,815431 57,80218 84,9955 124,4664 4,255864 6,044608 8,334297
32 3,357858 4,719581 6,594302 61,74518 90,7935 132,9569 4,294544 6,099545 8,410044
33 3,245258 4,561317 6,373172 65,68818 96,59151 141,4475 4,333224 6,154483 8,485791
34 3,132657 4,403053 6,152042 69,63118 102,3895 149,938 4,371904 6,20942 8,561539
35 3,020057 4,24479 5,930913 73,57418 108,1875 158,4285 4,410584 6,264357 8,637286
36 2,907456 4,086526 5,709783 77,51718 113,9855 166,919 4,449264 6,319295 8,713034
37 2,794855 3,928262 5,488653 81,46018 119,7835 175,4096 4,487944 6,374232 8,788781
38 2,682255 3,769998 5,267523 85,40317 125,5815 183,9001 4,526624 6,429169 8,864529
Percentile grids for fAAC = fetal abdominal aorta artery compliance in %/10mmHg; YEM = young elastic 
modulus in mmHg/mm; SI = stiffness index. GA = gestational age. P10 = 10th percentile; P50 = 50th percen-
tile; P90 = 90th percentile.
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scatterplots neonatal / birth measurements
e-Figure 6.1.a,b. Scatterplots for Birth Head Circumference (BHC) in mm (upper) and Birth Abdominal Cir-
cumference (BAC) in mm (down) at birth in gestational weeks (x-axis). Percentiles 10, 50 and 90 using Box 
Cox Transformation (BCT).
e-Figure 6.2.a,b. Scatterplots for Birth Weight (BW) in g (upper) and Birth Length (BL) in cm (down) at birth 
in gestational weeks (x-axis). Percentiles 10, 50 and 90 using Box Cox Transformation (BCT).
e-Figure 6.3.a,b. Scatterplots for Birth upper arm circumference (Uparm) in mm (upper) and Birth lower 
arm circumference (Loarm) in mm (down) at birth in gestational weeks (x-axis). Percentiles 10, 50 and 90 
using Box Cox Transformation (BCT).
e-Figure 6.4.a,b. Scatterplots for Birth upper leg (Upleg) in mm (upper) and Birth lower leg (Loleg) in mm 
(down) at birth in gestational weeks (x-axis). Percentiles 10, 50 and 90 using Box Cox Transformation (BCT).
e-Figure 6.5.a,b. Scatterplots for Birth Triceps Skinfold (Tr-SF) in mm (upper) and Birth Subscapular Skin-
fold (S-SF) in mm (down) at birth in gestational weeks (x-axis). Percentiles 10, 50 and 90 using Box Cox 
Transformation (BCT).
e-Figure 6.6.a,b. Scatterplots for Birth Flank Skinfold (Fl-SF) in mm (upper) and Birth Thigh Skinfold (Th-SF) 
in mm (down) at birth in gestational weeks (x-axis). Percentiles 10, 50 and 90 using Box Cox Transformation 
(BCT).
e-Figure 6.7.a,b. Scatterplots for Birth fat percentage (‘neonatal adiposity’) in % of total BW at birth in 
gestational weeks (x-axis). Percentiles 10, 50 and 90 using Box Cox Transformation (BCT).
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intra-class correlation coefficient (iCC) of imT, Dia and Dis
e-Figure 8.1. Maternal right common carotid artery measurement with radio-frequency US. Measure-
ments of IMT. First, second and third mean values for each time-point. IMT1 = measurement 1; IMT2 = 
measurement 2; IMT3 = measurement 3; X/Y-axis, IMT values in µm.
e-Figure 8.2. Maternal right common carotid artery measurement with radio-frequency US. Measure-
ments of DIA. First, second and third mean values for each time-point. DIA1 = measurement 1; DIA2 = 
measurement 2; DIA3 = measurement 3; X/Y-axis, DIA values in µm.
e-Figure 8.3. Maternal right common carotid artery measurement with radio-frequency US. Measure-
ments of DIS. First, second and third mean values for each time-point. DIS1 = measurement 1; DIS2 = mea-
surement 2; DIS3 = measurement 3; X/Y-axis, DIS values in µm.
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e-Figure 9.1. Fetal abdominal aorta artery measurement with radio-frequency US. Quality arterial stiffness 
(QAS) measurement; fast-b-mode image; blue line = arterial distension (DIS), orange line = arterial diameter 
(DIA). X-axis, region of interest in mm; Y-axis distance in mm.
e-Figure 9.2. Fetal abdominal aorta artery measurement with radio-frequency US. Measurements of IMT. 
First, second and third mean values for each time-point. IMT1 = measurement 1; IMT2 = measurement 2; 
IMT3 = measurement 3; X/Y-axis, IMT values in µm.
e-Figure 9.3. Fetal abdominal aorta artery measurement artery measurement with radio-frequency US. 
Measurements of DIA. First, second and third mean values for each time-point. DIA1 = measurement 1; 
DIA2 = measurement 2; DIA3 = measurement 3; X/Y-axis, DIA values in µm.
e-Figure 9.4. Fetal abdominal aorta artery measurement artery measurement with radio-frequency US. 
Measurements of DIS. First, second and third mean values for each time-point. DIS1 = measurement 1; DIS2 
= measurement 2; DIS3 = measurement 3; X/Y-axis, DIS values in µm.
e-Figure 9.5. Correlation estimated fetal weight (EFW) >P90 in normal BMI group women versus EFW<P90 
in the same normal BMI group for fetal abdominal aorta diameter (fAA DIA) from 26 weeks onwards. 
EFW>P90 and EFW<P90 were introduced as explanatory variables in the GAMLSS model; p <0.07. X-axis: 
gestational age in weeks; Y-axis: abdominal aortic diameter in µm.
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hierdoor een bepaalde anciëniteit van je onderzoekers, waarvan mijn voorgangers, 
die bij jou hun doctoraat hebben afgerond, ook een afspiegeling zijn. Deze houding 
kenmerkt jou niet alleen op onderzoeksgebied, maar ook in de klinische setting, zowel 
in de algemene verloskunde als voor de foetale chirurgie. Dit valt voor vooral de junior-
assistenten soms wat zwaar. Ik heb er veel van geleerd. Ook was er nooit een onvertogen 
woord, als ik vlak voor een deadline je weer een stuk doorstuurde met de vraag om die 
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fellows kon optrekken in dit vakgebied waar al zo lang mijn passie ligt. Tijdens de vele 
ingrepen, waar ik ook van u een vertrouwen kreeg, kon u met enkele opmerkingen een 
ander licht werpen op de materie, zeer verfrissend. Een speciaal woord van dank is op 
zijn plaats voor Prof. Dr. andré Van assche. Hoewel ik weet dat u al veel dankwoorden 
heb mogen ontvangen, was het toch altijd een genoegen om in uw huidige ‘vrije’ tijd uw 
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schap te mogen ervaren op onze wekelijkse maandagmiddag bijeenkomsten van onze 
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en annick Bogaerts. Sara en Goele, jullie staan aan de poort van het afronden van jullie 
doctoraat, en ik ben zeker dat jullie het heel goed gaan doen. Het was fijn om samen 
met jullie te kunnen reflecteren over de dagelijkse gang van zaken en het onderzoek 
specifiek. Merci. Annick, ik zal de nachtelijke e-mail conferenties die we hadden (of heb-
ben) nooit vergeten. Je bent een zeer energieke positieve ingestelde vrouw met een 
hoog I- en E-Q. Dank voor alle aanmoedigende bewoordingen en ik hoop nog steeds 
eens bij jullie in de mooie bossen met het gezin te mogen langskomen! Natuurlijk wil 
ik de andere leden van het foetale team en de prenatale diagnose van harte bedanken: 
Prof. Dr. luc De Catte voor alle scherpe inzichten, Prof. Dr. liesbeth lewi voor de fijne 
wetenschappelijke en klinische samenwerking en ook uw uitgesproken waardering 
hiervoor. Dr. Dominique Van schoubroeck wil ik bedanken vanuit professioneel, maar 
ook persoonlijk standpunt. U heeft uw ‘OK’ gegeven voor de 12 en 20 weken echo van 
onze beide zonen, wat Alies (en mij) veel rust gaf in de zwangerschap. Uiteraard wil ik de 
‘lagere stafleden’ (ja, zo staat het echt op de bouwtekeningen vermeld –‘junior stafleden’ 
zou charmanter geweest zijn-) Prof. Dr. kristel Van Calsteren en Prof. Dr. Tim Van 
mieghem bedanken. Kristel als m’n juryvoorzitter, uiteraard. Ik weet zeker dat je dat 
masculiene cohort kunt geleiden (je hebt er wat ervaring mee, inmiddels!) en dank voor 
het toegang geven tot een ‘eigen’ werkplek (wat binnen UZ Leuven niet vanzelfsprekend 
is), waardoor ik de laatste maanden m’n onderzoek in alle rust kon afronden. Tim, voor 
alle humoristische schetsen en het ‘overhalen’ tot het doen van onderzoek, wat je al in 
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2008-2009 met je kenmerkende enthousiasme deed. Hetzelfde enthousiasme waarmee 
je om vier uur ‘snachts binnen kwam op de bevallingskamer toen onze jongste zoon 
werd geboren. Alies en ik zullen het niet snel vergeten! Een speciaal woord van dank aan 
Prof. Dr. Johan Verhaeghe voor de excellente teaching de afgelopen vier jaar, dat ik 
met u samen de ‘Women’s Health’, het endocrinologie spreekuur mocht doen. Uiteraard 
wil ik mijn mede fellows, Jute richter, Philip Deconinck, Joachim Van keirsbilck en 
op het laatst ook eva simoens bedanken voor alle samenwerking en fijne tijden binnen 
de foetale therapie en diagnostiek. Vier jaar lang de wekelijkse hoog-risico (monocho-
riale) tweeling spreekuren op vrijdag namiddag heeft veel ‘leeringh ende vermaeck’ 
opgeleverd. Ook de ontwikkeling van de spina bifida repair was een uitdagende en 
enthousiasmerende onderneming. suzanne Pasman, dank voor de fijne gesprekken 
en reflecties, die soms ook nodig waren als mijn ‘Hollandse’ zuster! Dank ook aan de 
foetale case-managers najima, nancy, evi en goedele voor julie mede-bereikbaarheid 
binnen de 24/7 beschikbaarheid voor de foetale therapie. En verder de ‘bali-dames’ van 
de echo, Tinne, nathalie en imke voor jullie altijd coöperatieve houding als ik weer iets 
voor studie- of klinische patiënten moest omzetten. Niet te vergeten de vroedvrouwen 
van de raadpleging en natuurlijk bevallingskwartier, die zo meegeholpen hebben met 
de opvang van studiepatiënten en materiaal. Dank ook om mij dan direct te bellen! Een 
woord van dank ook aan de logistieke medewerkers op de raadpleging en wel speciaal 
aan ann Thys. Merci voor de speciale  ondersteuning op het laatst. Hou die ontdekking 
van de persoonlijke mens erin! Buiten natuurlijk alle assistenten met wie ik heb mogen 
samenwerken op de berg, wil ik graag mijn twee ‘maten’ uit de Genkse tijd (2008-2010) 
van harte bedanken, Johan Quispel (gynaecoloog in Den Helder) en karoy gludovacz 
(gynaecoloog in Leiderdorp) bedanken. Johan voor zijn steun en altijd humoristische 
relativerende vermogen, Johan, je bent een aanwinst binnen ieder team! Hopelijk zullen 
we elkaar vanaf augustus 2015 weer meer kunnen zien! Karoy, omdat jij het initieel was 
die mij overhaalde om de opleiding in België te overwegen, in plaats van in Nederland. 
We hebben hier samen toch meerdere gesprekken over gehad en je bent altijd open 
en eerlijk geweest dat het in anders was dan in Nederland en hard en langer werken. 
Ook de ontmoetingen na ‘de Genkse tijd’ zijn altijd heerlijke momenten en Alies en ik 
hopen jou en Inge, je Belgische ‘lief’ (of vrouw moet ik nu zeggen) weer meer te kunnen 
zien. We zouden weer eens moeten fietsen, bijvoorbeeld tussen Den Helder-Rotterdam 
en Leiden! Ook wil ik heel graag mijn en inmiddels ook onze vrienden, niet alleen in 
Nederland maar ook ‘in den vreemde’ bedanken voor alle onvoorwaardelijke steun en 
interesse voor mij, maar vooral ook voor Alies en onze jongens, als ik weer eens niet mee 
kon naar de sociale evenementen. Vooral de laatste tijd hebben jullie mij weinig gezien 
en kon Alies als ‘single-mom’ gelukkig bij jullie terecht. Lieve schoonouders, nanko en 
gery, uiteraard een zeer groot dank voor jullie inzet op achtergrond en voorgrond. Ook 
de schouderklopjes (physiek en mentaal) waren altijd zeer welkom! Beste schoonbroer, 
Jakko! Ik heb je de laatste maanden weer eens anders leren kennen. Vond ik je al een 
hele fijne jongen, dan blijk je ook nog eens breed georiënteerd en zeer intelligent te zijn. 
Heel, heel erg veel dank voor de tekstuele en inhoudelijke reflecties van de afgelopen 
maanden. Je hebt een constructieve bijdrage gehad in dit werk en dank aan je gezin (Ju-
dith, isis en abel) dat ik je aandacht mocht lenen. Lieve ouders, lieve pappa en mamma. 
Het zijn julllie geweest die mij hebben geleerd hard te kunnen werken en ergens voor 
te gaan in het leven. Die basis is zo belangrijk. En ook om de mens in ieder persoon te 
waarderen, niet door zijn of haar afkomst. En hoewel ik nooit het gevoel gehad heb jullie 
‘gouden ei’ te zijn, waren jullie natuurlijk ook bezorgd wanneer ik niet vreemd was van 
on-orthodoxe keuzes in het leven. Jullie zagen dat al van jongs af aan aankomen toen ik 
met de driewieler (en een pak melk achterop –blijf natuurlijk een Hollander-) de wijde 
wereld introk. Heel erg dank dat jullie die veilige en ondersteundende ‘extra-uteriene’ 
omgeving hebben gegeven! Last, maar eigenlijk most of all, lieve alies, mijn grootste 
steun en toeverlaat! Jouw positieve insteek in het leven geeft mijn pieker-neigingen de 
beste aanvulling die ik mij kan wensen. Vrijwel nooit een onvertogen woord, de afgelo-
pen maanden (en jaren), hoewel wel eens een traan. Ik hoop dat ik dat niet meer hoef 
te veroorzaken! Groot respect heb ik voor jou, om alles draaiende te houden met werk, 
twee kleine kinderen en vrienden. Ik ben echt een zondagskind, denk ik wel eens. Maar 
dat zeg jij van jezelf ook. Ik begrijp goed dat je mij nu weer voor jezelf terug wilt hebben. 
En voor onze twee prachtige jongens, lennard en yannick. 
Voor de deelnemende patiënten.
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Sander Galjaard werd geboren op  22 augustus, 1975 te Leiden, Nederland. Van 1988 
tot 1994 doorliep hij het Stedelijk Gymnasium te Leiden met een extra hoofdvak. In 
1995 werd hij direct ingeloot voor de studie Geneeskunde aan de Universiteit Leiden 
(Rijks Universiteit Leiden, indertijd) en in 2002 behaalde hij zijn artsexamen. Hiervoor 
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periode werd hij genomineerd voor de Leiden International Student Funds (LISF) award. 
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(opleider dr. Hans van Huisseling). Van 2004 tot en met 2006 werkte hij in het Leiden 
University Medical Centre (LUMC), Nederland, op de afdeling prenatale disgnostiek en 
foetale therapie, onder supervisie van professor Humphrey Kanhai en professor Dick 
Oepkes. Van 2006 tot en met 2008 werkte hij in het Maastricht University Medical Centre 
(MUMC), Nederland, als prenatale arts, met de speciale bevoegdheid om zelfstandig 
invasieve prenatale diagnostiek te mogen uitvoeren, onder de supervisie van profes-
sor Jan Nijhuis. Sander volgde hier ook een opleiding tot tutor ‘probleem gestuurd 
onderwijs’ van de Universiteit Maastricht. In augustus 2008, begon hij zijn opleiding tot 
gynaecoloog in het Universitair Ziekenhuis (‘Gasthuisberg’) te Leuven, België (opleider 
professor Ignace Vergote). De eerste twee jaar van zijn opleiding ronde hij af in het Ziek-
enhuis Oost Limburg (ZOL), Genk, België (opleider professor Willem Ombelet). In 2011 
werd hij door professor Roland Devlieger (promotor), professor Jan Deprest en profes-
sor Dirk Timmerman (co-promotores) aangesteld als promovendus, dat leidde tot de 
huidige thesis: ‘The Cradle of Metabolic Disease -vascular development and fetal body 
composition during pregnancy-’. Tijdens dit promotietraject was Sander, samen met zijn 
promotor, intensief betrokken bij de coördinatie van de DALI (vitamin D And Lifestyle 
Intervention study) studie, een Europees FP7 programma, en verzorgde hij hiervoor 
trainingen voor de foetale en neonatale metingen als onderdeel van de Work Package 
4, ‘core foetal measurements’. Deze technieken werden ook gebruikt voor zijn doctoraat. 
Tijdens zijn doctoraatsperiode, was hij ook klinisch betrokken als fellow aan de sub-
afdeling ‘foetale therapie’ van de Universitaire Ziekenhuizen KU Leuven, onder supervisie 
van professor Jan Deprest. Sander leeft samen met Alies van Kampen, van wie hij erg 
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en Yannick geboren. 
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